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vAbstract
The aim of this research was to investigate the structures and processes of
pharmacist prescribing in Great Britain, focusing on primary care settings. A
‘sequential-mixed methods’ was employed in the conduct of the research.
The first phase was a cross-sectional postal questionnaire of all pharmacist
prescribers (n= 1654 in January 2009), to quantify the extent and nature of
prescribing and key factors associated with prescribing practice.
Response rate was 42.3% (n=695). The pharmacy practice setting was
significantly associated with prescribing (those in hospital or general medical
practice were more likely to have prescribed (p< 0.05), than respondents in
community practice). Factor analysis of attitudinal statements on prescribing
implementation revealed factors, grouped as: ‘administrative structures and
processes’, ‘perceptions of pharmacists’ prescribing role’ and ‘facilities for
prescribing’. Scores for ‘facilities for prescribing’ varied depending on practice
setting. Respondents in community practice recorded lower median scores
compared with those in general medical practices. However, there were no
statistically significant differences in median scores between respondents based
in GP and hospital settings.
In-depth qualitative work undertaken in the second phase further explored
facilitators of, and challenges to prescribing practice (e.g. the lack of defined
prescribing roles) identified in phase one. Semi-structured interviews were
conducted with a purposive sample of 34 prescribers. Prescribers were selected
from diverse settings, including secondary care from England and Scotland, to
highlight key factors contributing to prescribing success which could potentially
inform extrapolations of successful practice from one setting to the other.
The ‘framework’ approach to qualitative data analysis was rigorously applied,
revealing that the professional isolation and issues around access to clinical
data and administrative support in the community setting may have negatively
impacted on prescribing implementation. Notably, a perceived lack of clarity and
definition of the pharmacist prescribing role was a key theme in hindering
prescribing practice of pharmacists irrespective of setting. Participants
vi
described ‘ideal’ roles which they perceived as potentially providing clarity,
definition and direction to facilitate implementation.
The original data generated through this research highlights that prescribing
implementation is less than desired, especially in community pharmacies.
Pharmacist prescribing appears to have progressed little since supplementary
prescribing developments in 2004, even with the much heralded arrival of
independent prescribing in 2006. Interestingly, phase 2 participants suggested a
‘hybrid supplementary/independent’ prescribing model, as more likely to
succeed. In this model, pharmacist prescribers favour a cooperative practice
arrangement in which doctors diagnose and pharmacists prescribe. The
implication of these findings and specific recommendations for policy makers,
other key stakeholders and practitioners are discussed in detail within the
thesis.
Key words: Prescribing, pharmacist, supplementary, independent, non-
medical, primary care, Structures, processes, Great Britain.
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Forward
This thesis is a report of the research work I conducted over the past three and
half years, in fulfilment of the requirements of the Robert Gordon University
(RGU) Aberdeen, for the award of a PhD. In the research, I investigated the
structures and processes of pharmacist prescribing practice focusing initially on
the primary care setting, but subsequently expanding the scope to include
secondary care. This iterative process has developed my research skills and
enabled me to make original contributions to the growing field of pharmacist
prescribing practice and research.
Pursuing a PhD in Pharmacy Practice at RGU was the culmination of a life-long
ambition an interest in enhanced pharmacy services. Having obtained a
Bachelor of Pharmacy with honours from the University of Jos, Nigeria, I worked
as a pharmacist in various settings, including practice experience as a clinical
pharmacist in secondary and tertiary hospitals. However, I realised that my
interest was more in academic teaching and research than actual practice. This
led me to take up appointment as a lecturer in the Department of Clinical
Pharmacy, University of Jos. To enhance my career prospects in academia, I
enrolled for an MSc, in pharmacology, with bias in clinical pharmacology, where
I researched the prescription patterns and treatment outcomes for hypertension
in four hospitals in Jos, Nigeria. It was after this that I decided to join the vibrant
pharmacy practice and education research group at RGU, to further develop my
skills and experience in research.
The doctoral research training at RGU capitalised on many internal and external
training opportunities to broaden my research experience. Presenting aspect of
my research work at national and international conferences, served as a useful
peer review mechanism for the research. In addition, the internal symposia of
the School of Pharmacy and Life Sciences provided opportunities for other PhD
students and academics to scrutinise the research. Therefore, this thesis is a
product of a rigorous research that contributes to the knowledge base in the
field of pharmacist prescribing.
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Throughout the thesis, I have described details of the project reported in this
thesis which is organised in two phases covering quantitative and qualitative
approaches in a mixed methods research design.
The first chapter provides a general introduction to the research. The chapter
opens with historical developments in the practice of pharmacy, starting from
the early apothecaries to clinical pharmacy practice in the 1960s,
pharmaceutical care in the late 1980s, and finally focusing on pharmacist
prescribing. This provides the introduction and background to non-medical
prescribing in Great Britain, with particular attention to pharmacist prescribing.
The rest of the chapter reviews key publications on the subject of pharmacist
prescribing in Great Britain, and highlights the gaps in knowledge, which the
current research hopes to answer with original data.
Chapter 2 outlines a general introduction to methodology and related concepts,
and shows how these concepts informed the use of specific quantitative and
qualitative methods in a mixed-methods approach in the conduct of the current
research. I have outlined the key philosophical assumptions underlying the
research traditions, but I have argued for the pragmatic choice of methods that
are driven by the research question rather than philosophical debates. I have
used this argument to justify the selection of the specific methods employed in
this doctoral research project. Throughout the chapter, I have focused my
discussion on how each set of philosophies underpin research in the health
services and pharmacy practice domains.
Chapter 3 presents the quantitative phase of the research project, using a
cross-sectional questionnaire survey approach which investigated the nature
and extent of prescribing activities undertaken by pharmacists. However, it was
not possible, using the survey approach, to gain in-depth explanations of all the
issues involved. How some respondents were able to prescribe despite the
challenges shows that much can be learnt from exploring the experiences of
pharmacist prescribers. These issues are best addressed by qualitative
methods, which informed designing a mixed methods project.
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Chapter 4 presents Phase 2, in which the views, experiences and perceptions
of pharmacist prescribers on the implementation of prescribing practice were
explored in semi-structured telephone interviews. Results of the quantitative
phase of the research on the apparent lack of clarity in the prescribing role of
pharmacists were also explored.
In Chapters 3 and 4, specific strengths and limitations of quantitative and
qualitative methods were discussed in order to put the finding in contexts. The
key findings in each phase were then considered in relation to published
literature.
Chapter 5 integrates findings of both quantitative and qualitative phases which
were brought together and considered in terms of their implications for policy
and practice of pharmacist prescribing. This informed specific recommendations
from the current study for policy makers and other stakeholders in the
implementation of pharmacist prescribing practice. Key issues that warrant
further research are considered before drawing an overall conclusion to address
the aims of the research.
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Chapter one: General introduction
This chapter provides a general introduction to the research reported in this
thesis. The overall aim of the research was to investigate the different
dimensions of structures and processes of pharmacist prescribing
implementation in Great Britain. Section 1.1 highlights some historical
developments in the practice of pharmacy, starting from the early apothecaries
to clinical pharmacy practice in the 1960s, pharmaceutical care in the late
1980s, and finally pharmacist prescribing within the last decade. Section 1.2
gives a background of non medical prescribing (NMP) in Great Britain with
particular attention to pharmacist prescribing, which is the focus of the project.
Section 1.3 defines prescribing and reviews pharmacist prescribing
internationally, highlighting differences and similarities with the concept as
applied in Great Britain. The rest of the chapter reviews key publications on the
subject of pharmacist prescribing in Great Britain.
The geographical scope of this research is Great Britain (GB) encompassing
England, Scotland and Wales. However, some legislation and policy directions
guiding the implementation of NMP are determined by the central Government
of the United Kingdom (UK) which also includes Northern Ireland (NI).
Consequently, the sections covering background and review of key publications
on pharmacist prescribing will occasionally refer to the UK rather than GB.
1.1 Some historical milestones in the development of pharmacy
practice
The history of pharmacy can hardly be separated from that of medicine. The
Sumerians of Mesopotamia (present day Iraq) around 2700 BC were known to
have treated patients using crude plant drugs and other remedies. They
regulated the practice of medicine between 1795 and 1750 BC; a period in
which they separated diagnosis and treatment of disease from preparation and
supply of medicines, the latter being carried out by apothecaries (1). At about
the same time as the Sumerians, other cultures in Egypt, Greece, Rome, Arabia
India and China were independently developing and recording significant events
in the history of medicine and pharmacy. The Arabians introduced into Europe
Chapter 1-General introduction
2
the concept of separating diagnosis and treatment from preparation and supply
of medicinal products. However, the defining moment in the history of pharmacy
practice probably came in 1231 AD with the Edict of Palermo. Fredrick II of
Hohenstaufen, Emperor of Germany and King of Sicily, passed an Edict which
clearly distinguished between the responsibilities of physicians and those of
apothecaries. This distinction was not yet applicable in the territories known
today as GB (1, 2).
In the early twentieth century the profession of pharmacy continued the
historical role of apothecaries, compounding and dispensing medicinal products
requested by patients or physicians. However, during the 1960s pharmacy
progressed towards full professional status with the emergence of clinical
pharmacy practice (3). Clinical pharmacy is defined as: “the science and
practice of pharmacy concerned with the optimisation of medication therapy and
the promotion of health, wellness and disease prevention” (4). This emphasises
a focus on individual patients, or patient groups through clinical services
including: therapeutic drug monitoring, rational use of medicines and medicines
information services (3, 5).
Clinical pharmacy practice allows pharmacists to combine expertise in the
physical and chemical properties of drugs, with appropriate clinical knowledge
and skills. They perform extended roles beyond dispensing that involve clinical
judgements and decisions on appropriate, safe and effective use of medicines
in patient care (6). However, clinical knowledge is not the only requirement for
achieving optimum pharmaceutical services. A new philosophy termed
‘Pharmaceutical Care’, emerged in pharmacy practice in which pharmacists
work with other health professionals to identify and resolve drug-related
problems in patient care (3). By the early 1990s, the concept of pharmaceutical
care had become embedded in the professional functions of pharmacists (7).
Hepler and Strand defined pharmaceutical care as; “the responsible provision of
drug therapy for the purpose of achieving definite outcomes that improve the
patient’s quality of life” (3). This practice philosophy requires the cooperation of
pharmacists with other health care professionals and patients to identify existing
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or potential drug-related morbidities, and to resolve or prevent them (3). Drug-
related morbidity has been a major problem in patient care. Published data
suggests between 3.5 and 7.3% of hospital admissions are linked to adverse
drug reactions, about half of which are preventable (8, 9). Similarly, a
prospective study of adverse drug reactions in one UK hospital reported an
adverse drug reaction incidence of 14.7%, and estimated the cost to the NHS in
England at above £171 million annually (10). Inappropriate prescribing has
been documented as the leading cause of preventable drug-related morbidity
(11). Therefore, any measure to improve the prescribing process will ultimately
improve patient care through prevention or resolution of drug related morbidities
(12).
Pharmacy practice, having progressed from the earlier roles of compounding
and dispensing medicines, now includes such tasks as giving medicines advice
to health care professionals and patients. Pharmacists may identify medication
needs of individual patients, then recommend appropriate remedies or adjust
drug dosage(s) to achieve definite therapeutic outcomes (3). These activities of
pharmacists constitute part of the prescribing process, and may be described by
the loose term ‘pharmacist prescribing’ (13). The rest of this chapter will focus
on prescribing by pharmacists.
1.2 Definition of prescribing
The Medicines Act 1968 classifies medicines into three categories under which
they can be supplied to patients (14). Prescription only medicines (POMs) can
only be supplied on presentation of a valid prescription written and signed by an
authorised health professional. Pharmacy (P) medicines can be supplied from
pharmacies without prescription, but under the supervision of a registered
pharmacist. Medicines on the general sale list (GSL) can be supplied from
pharmacies and supermarkets over-the-counter, without necessarily requiring
the supervision of a pharmacist (14). According to the Medicines Act 1968, to
prescribe is ‘to order in writing the supply of a prescription-only medicine for a
named patient’. Under this Act, physicians and dentists were the only health
professions authorised to prescribe for human use (15). However, the term
Chapter 1-General introduction
4
prescribe has been used in a general sense to mean an order to authorise the
supply of any category of medicine, which may not be a POM at the expense of
the national health services (NHS) of the UK. This extended definition also
includes any advice given to patients on suitable remedies including medicines
which may be purchased over-the-counter (16).
1.2.1 Pharmacist prescribing
The legal classification of some medicines into the P and GSL categories, (14)
and the extensive training of pharmacists in the actions, uses and side effects of
medicines place them in a position to be involved in advising or deciding the
most appropriate medicines for patients in hospitals or community. Moreover,
community pharmacists provide clinical advice to patients over-the-counter to
resolve drug-related problems, and to treat minor ailments (17). Therefore, the
term prescribing used in the context of pharmacists’ activities describes different
levels of pharmacists’ involvement in the selection and use of medicines (13).
For the purpose of clarity the term ‘pharmacist prescribing’ is used throughout
this thesis with particular reference to supplementary and independent
prescribing. This form of prescribing implemented for pharmacists, nurses and
allied health professionals in GB within the general concept of non medical
prescribing, confers legal authority on these groups of professionals to
prescribe medicines for human use at the expense of the National Health
Services (16), details in sections 1.3.5-1.3.8. Although the focus in this thesis is
supplementary and independent prescribing by pharmacists in GB, the next
section will provide a global overview of pharmacists’ activities related to
prescribing.
1.3 Pharmacist prescribing in the global context
There are eight models of pharmacist prescribing practice operating in different
countries; described variously as ‘collaborative’, ‘dependent’, ‘supplementary’ or
‘independent’ prescribing. These terms refer to different sets of activities in
different countries. Moreover, each country and sometimes different states
within the same country have authorised pharmacists in their particular
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jurisdictions to prescribe medicines with different levels of autonomy (18). Most
of the published literature describes the situation in the United States of
America, Canada, Australia and the UK; a summary of these models is
presented next.
1.3.1 Pharmacist prescribing in the United States of America and Canada
The United States of America (USA) and Canada have similar pharmacist
prescribing models in operation. There are three levels of prescribing activities
undertaken by pharmacists, depending on jurisdiction (19),(18), (20). The first
level, ‘independent prescribing’ authority, is held by professionals with sole
responsibility for the clinical outcome of patients. The independent prescriber in
this context must possess legally defined levels of knowledge and skills in
diagnosis before they can be licensed. The second level of prescribing,
‘dependent prescribing’, involves formal written agreements in which
independent prescribers delegate their prescribing authority to dependent
prescribers. Under this arrangement, pharmacists in some provinces of Canada
are authorised to prescribe under protocol, prescribe according to formulary, or
prescribe by referral (21). The third level of prescribing authority ‘collaborative
prescribing’ requires a co-operative practice relationship between the physician
and the pharmacist. Physicians diagnose diseases based on their expert
consultation and physical assessment skills, and then pharmacists apply their
expertise in pharmacotherapy in the selection and maintenance of drug regimes
(21), (19).
The State of Florida in the USA has, since 1984, granted pharmacists legal
authority to independently prescribe from a range of medicines (19). Recent
reports suggest that six other States in the USA are in the process of granting
independent prescribing rights to pharmacists, similar to the one in Florida,
while forty-three States have granted pharmacist prescribing authority under
collaborative arrangements with physicians (22), (18), In Canada, the provinces
of Alberta and Manitoba have granted collaborative prescribing rights to
pharmacists, while Saskatchewan and British Columbia are considering
proposals to do likewise (21).
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1.3.2 Pharmacist prescribing in Australia and New Zealand
In Australia, there are two schedules of medicines, schedule 2 (‘pharmacy
medicines’) and schedule 3 (‘pharmacists only medicines’) from which
pharmacists have been prescribing independently for many generations (23).
However, for the purpose of enabling pharmacists to prescribe from other
schedules of medicines, four prescribing models have been developed for
possible implementation in Australia (23) (18). Under the four prescribing
models, pharmacists in Australia will potentially do one of the following:
i. Prescribe under protocol (patient group directions, and repeat
prescribing)
ii. Prescribe under no protocol (independent prescribing from
schedules 2 and 3)
iii. Limited formulary prescribing (prescribing schedules 2 and 3
medicines for patients referred to pharmacists)
iv. Broad formulary prescribing (supplementary prescribing and
collaborative prescribing)
It is envisaged that pharmacists in Australia will be able to exercise varying
degrees of clinical freedom and prescribing responsibility once the four models
are implemented in practice (23).
In New Zealand any registered health professional can enter into a
collaborative or supplementary prescribing agreement with an independent
prescriber under standing orders or protocols (24). This opportunity has been
explored by pharmacists, who enter collaborative arrangements for prescribing
with doctors. However, a move by the Pharmacy Council of New Zealand to
gain official recognition for the Advanced Pharmacist Practitioner (Pharmacist
Prescriber) role, has not received the desired support (25).
1.3.3 Pharmacist prescribing in Africa and Asia
There are no published accounts of the implementation of prescribing by
pharmacists in Asia and Africa. The majority of the African population depends
on Traditional African Medicine (TAM) for health need. In some countries up to
Chapter 1-General introduction
7
90% of the population use TAM, but have very limited access to trained medical
doctors (26). Leach et al. suggest the training of physician assistants up to
diploma level to prescribe for, and competently manage common conditions
especially in the rural areas. This, they proposed as a way of resolving the
challenges posed by inadequate manpower on the access of patients to
medicines in Africa (27). It is of particular concern, that the health system and
pharmacy practice in Africa are not as developed as those in western countries.
Medicines that should only be available on prescription are sold over the
counter, without accompanying prescriptions (28). Moreover, health
professionals often extend the scope of their practice beyond their statutory
roles and responsibilities. Therefore, it is common to find doctors and
pharmacists who prescribe and dispense at the same time (29).
The closest pharmacists in Africa have come to obtaining legal prescribing
authority is in Ghana. The Government has recognised community pharmacists
as the preferred health professionals to treat sexually transmitted infections
among the population (30). Although there are no formal reports of pharmacist
prescribing in Africa and Asia, Governments in these regions are adopting
various innovative strategies including, the reorientation of pharmacists to take
on more specialised non-dispensing roles such as formulation and management
of medicines policy in order to enhance access to essential medicines (27).
1.3.4 Pharmacist prescribing in Europe
To date, the United Kingdom (UK) is the only country in Europe with legal
pharmacists’ prescribing rights, in the form of supplementary and independent
prescribing (31,32). This has been implemented in all sectors of pharmacy
practice including general medical practices. Supplementary and independent
prescribing in GB, the subject of this research will be described in detail next.
1.3.5 Non medical Prescribing
In the UK, prescribing by professionals other than doctors and dentists was
introduced in 1986 when the Department of Health commissioned the
Cumberlege committee to review nursing care of patients in their homes. The
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report of that committee highlighted delays experienced by nurses in the home
care of patients, because they had to wait for GPs to prescribe simple items like
wound dressings. Therefore, the committee recommended that nurses be
authorised to prescribe for some conditions, from a limited range of medicines
(33). Subsequently in 1989, an Advisory Group on Nurse Prescribing
established by the Department of Health reviewed circumstances under which
community nurses might prescribe. The advisory group recommended that
district nurses and health visitors be authorised to prescribe in the four clinical
areas of minor injury, minor illness, palliative care and health promotion. They
could prescribe dressings and six medicines classified as POMs, in the nurse
prescriber formulary (34). This was the beginning of nurses’ involvement in
prescribing.
Later in 1997, the Department of Health established a committee to review the
Prescribing, Supply and Administration of Medicines. This review produced two
reports known as the Crown reports. The first, in 1998, recommended the
implementation of regulations for the supply of medicines under group protocol;
later termed patient group directions (PGDs). This is, strictly speaking, not a
form of prescribing, but a written policy to permit some health professions,
including pharmacists and nurses, to supply or administer medicines to
specified categories of patients (35). The second Crown report, in 1999,
recommended the extension of prescribing rights to pharmacists, optometrists,
physiotherapists, radiographers and podiatrists. These health professions along
with nurses make up the group of prescribers included under the general term
of non medical prescribers (NMP) (16). The Crown review being central in the
background to NMP warrants close attention. Therefore, key highlights of that
report, particularly relating to pharmacist prescribing, will be considered next.
1.3.6 Summary of the final report of the Crown review
Prior to the Crown review, doctors and dentists were the only health professions
authorised to prescribe POMs for patients, which were reimbursed by the NHS
(15). One of the aims of the Crown review was to determine how health
professionals could change the way services were delivered in terms of
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prescribing, supply and administration of medicines (16). To this end, the
committee set out to develop a framework under which health professionals
could adopt new roles for the benefit of patients. These benefits included the
optimal use of professional skills of staff and other resources, and also widening
the access of patients to medicines (16).
Innovative approaches to the prescribing of medicines became imperative
because of changes that had already taken place in the patient care
environment. Firstly, the training, education and clinical practice of various
health professions were changing rapidly. Secondly, patients had become more
aware of issues related to their health, and were taking charge of the treatment
of their conditions. This brought about changes in what patients expected from
health professionals. Finally, patient care had become a multi-disciplinary team
responsibility, partly because of the complexity of medicines which makes it
difficult for a single clinician in any profession to claim sufficient expertise
across the whole spectrum of drugs applicable in their practice (16).
Consequently, the framework developed by the Crown review proposed that
new groups of health professionals in the UK could apply for the legal authority
to prescribe medicines in specific clinical areas. Therefore, the review
recommended that:
“Government should take general powers in primary legislation,
enabling ministers, through regulations, to designate new
categories of dependent and independent prescribers for the
purpose of the Medicines Act, to authorise them to prescribe
medicines for reimbursement by the NHS, and to limit or specify the
medicines or classes of medicines which they may prescribe.” (16).
By this recommendation the Crown review committee categorised two types of
prescribers: independent and dependent, to be recognised in the UK as legal
prescribers of medicines for human use in compliance with the Medicines Act of
1968.
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1.3.7 Independent, dependent and supplementary prescribing
Independent prescribing (IP), in the context of the final report of the Crown
committee refers to the initial contact between a patient and the healthcare
professional, who prescribes for that patient. Accordingly,
“The independent prescriber is responsible for the assessment of
patients with undiagnosed conditions and for decisions about the
clinical management required, including prescribing” (16).
Similarly, dependent prescribing refers to the scenario in which the clinical
management of diagnosed patients is transferred from the independent to the
dependent prescriber. “A dependent prescriber is responsible for the continuing
care of patients who have been clinically assessed by an independent
prescriber. This continuing care may include prescribing, which will usually be
informed by clinical guidelines and will be consistent with individual treatment
plans; or continuing established treatments by issuing repeat prescriptions, with
the authority to adjust the dose or dosage form according to patients’ needs”
(16). The term dependent prescribing was later replaced by supplementary
prescribing.
“Supplementary prescribing (SP) is a voluntary partnership between
the independent prescriber (a doctor or dentist) and a
supplementary prescriber, to implement an agreed patient-specific
clinical management plan (CMP) with the patient’s agreement” (16)
SP was implemented in 2003 to enable pharmacists, nurses and optometrists,
after undergoing additional training and registration, to prescribe any medicine,
including controlled drugs, within the framework of a patient-specific CMP. This
provision was changed in 2005 to accommodate other health care professions,
namely chiropodists/podiatrists, physiotherapists and radiographers, as
supplementary prescribers (36, 37).
Independent prescribing for pharmacists, nurses and optometrists was
implemented in the UK in 2006 (32, 38). Under this arrangement, nurses could
prescribe any medicine for any medical condition, within their competence,
including some controlled drugs. The same applies to pharmacist independent
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prescribers who may prescribe any medicine, including unlicensed products
within their professional competence excluding CDs. However, a pharmacist IP
my may prescribe CDs using a CMP a supplementary prescribing arrangement.
Optometrist independent prescribers were only permitted to prescribe any
licensed medicine for ocular conditions (38). Currently, the Department of
Health defines independent prescribing as:
“prescribing by a practitioner e.g. doctor, dentist, nurse, pharmacist
or optometrist responsible and accountable for the assessment of
patients with undiagnosed and diagnosed conditions and for
decisions about the clinical management, including prescribing”
(39).
This marked the beginning of pharmacist prescribing in the UK. The rest of this
chapter and subsequent chapters will focus on the implementation of
prescribing by pharmacists in GB. However, the concept of pharmacist
prescribing as practised in other countries will be reviewed first, before
proceeding with details of implementation in GB.
1.3.8 Pharmacist supplementary and independent prescribing in GB
The Crown review marked the watershed in the implementation of prescribing
by pharmacists in GB. Having accepted the recommendations of the Crown
review, the Department of Health introduced changes to legislation, and made
administrative and policy changes to facilitate implementation of prescribing by
pharmacists in GB (36, 37). However, the policy requires that pharmacists
meet a national minimum standard of educational qualification and training prior
to registration and practice as prescribers (16, 18). Legislative changes
permitted higher education institutions to organise training courses for
pharmacists who wished to qualify as prescribers. Consequently, the Council of
the Royal Pharmaceutical Society of Great Britain (RPSGB) now the General
Pharmaceutical Council (GPhC) agreed with the Medicines Commission and
the Committee on Safety of Medicines in October 2002 on the curriculum for the
training of pharmacist prescribers (36, 40). Pharmacists with two years post-
registration experience can undertake additional GPhC-accredited training. The
training programme leads to the award of a practice certificate in supplementary
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or independent prescribing, which qualifies the pharmacist to apply for
annotation as a prescriber on the GPhC register. Training involves a minimum
of 200 hours didactic learning delivered over 25 days, either face to face, or in
combination with distance-learning modules. This is then followed by a period of
at least 12 days supervised learning in practice (PLP), under a designated
medical practitioner (36, 40).
The first supplementary prescriber was registered by the RPSGB in February
2004 (41), and a Scottish pharmacist became the first in primary care to write a
prescription in April of the same year (41, 42). Independent prescribing for
pharmacists was introduced in 2006 (43), and pharmacists qualified as
supplementary prescribers for less than five years could take additional courses
to convert to the independent prescribers status (43). The conversion course
was an equivalent of two days didactic learning and a minimum of two days
PLP to develop autonomous working skills. At the same time, qualified
pharmacists who were not yet supplementary prescribers could take up full
training to become independent prescribers according to the curriculum
designed by the RPSGB (40). In 2007 the first pharmacist independent
prescription was written in a secondary care hospital, marking what can be
described as the official implementation of pharmacist prescribing in GB (44).
There are now over 2000 pharmacists trained and registered as prescribers,
practising in secondary care, general medical practice, and community
pharmacy settings across GB (45).
1.4 Review of literature on pharmacist prescribing in GB
This section will focus on empirical research published in peer reviewed
journals in order to critically appraise the current state of knowledge on the
subject of supplementary and independent prescribing by pharmacists in GB.
The objective of this review is to summarise what is known and to identify gaps
in the literature on the subject of pharmacist prescribing. It was noted in the
introduction that the legal framework for the implementation of supplementary
and independent prescribing is applicable UK wide (GB and Northern Ireland).
Therefore, this section will refer to both GB and UK as appropriate.
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1.4.1 Search strategy
A Medline search was conducted for research papers published between
January, 2003 and January, 2011. The search used a keyword combination of
pharmacist*, with a phrase search for “independent prescribing” or
“supplementary prescribing”. The search was limited to English language
journals based on the scope of the review. The search was repeated in the
databases International Pharmaceutical Abstracts (IPA) and Cumulative Index
for Nursing and Allied Health Literature (CINAHL). Results of the search were
managed in Reworks® bibliography database, where duplicates were
eliminated and the full text of included papers sought and read repeatedly
before attempting critical appraisal.
1.4.2 Inclusion and Exclusion criteria
Papers published on the subject of pharmacist prescribing in GB, Northern
Ireland (NI) or across the whole of the United Kingdom (UK) were included.
Papers were also included if the subject of the research was nurse and
pharmacist prescribing in the UK, which had a direct bearing on the objectives
of the present research. Papers were excluded if they reported pharmacist
prescribing outside the UK, as the geographical scope of this project is limited
to GB. Also excluded from the review were commentaries, editorials, views and
opinions, since these are mostly subjective accounts of individuals. In addition,
for the assurance of methodological rigour, reports and journalistic articles
describing pharmacist prescribing were all excluded because these have not
been subjected to peer review mechanisms.
1.4.3 Search results
Applying the search criteria retrieved ninety research publications (Medline 24,
CINAHL 27 and IPA 49). Retrieved papers were screened and organised as
shown in Figure 1.1
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Figure 1.1 identification and sorting of literature for review
Twenty eight primary research papers were reviewed and findings presented
according to the main themes that emerged from the literature as follows:
Implementation of pharmacist prescribing, inter-professional relationships and
patients’ or general public’s perspectives.
10 papers added from
hand search and
snowballing of references
to published papers
42 eliminated as irrelevant
from preliminary reading
of titles and abstracts
28 published paper eligible for the review
14 papers eliminated based
on exclusion criteria
23 duplicates removed
32 papers identified for possible review
90 publications retrieved from data bases
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1.4.3.1 Implementation of pharmacist prescribing in GB
Most of the research published on the subject of pharmacist prescribing
described implementation in GB. Sixteen of the studies reviewed, addressed
this theme (Table 1.1) and are discussed under the following subthemes: early
views and experiences of pharmacist prescribers; impact of pharmacists’
prescribing practice; development of pharmacist prescribing; and training
pharmacists for prescribing implementation.
A. Early views and experiences of pharmacist prescribers
Pharmacist prescribing as a new policy presented various implementation
opportunities to the early cohorts of pharmacists who adopted this practice
(Table 1.1). Some studies reported views and experiences of pharmacist
prescribers who implemented SP. Dawoud and colleagues revealed that some
pharmacist prescribers encountered severe challenges while trying to
implement SP especially within primary care (46). Similarly, Hobson and Sewell
reported more SP implementation challenges among pharmacist prescribers in
primary care, than those in secondary care trusts (47). However, a large
proportion of the samples in these studies were based in secondary care
hospitals. This may have biased the findings that were reported. Moreover, both
studies were limited to England, so the views and experiences of pharmacists in
other parts of GB may have differed. This assertion was supported by contrary
findings in a study by George et al., who conducted a national survey of
pharmacist prescribers in GB. They reported higher use of the prescribing
qualification in primary care than secondary care settings (48). Two previous
reviews of the NMP literature in GB revealed that pharmacist prescribers had
made appreciable impact on the health care environment, despite many barriers
and challenges to their prescribing practice (49, 50).
B. Impact of pharmacist prescribing
Among the studies that reported pharmacist prescribing implementation, few
had the primary objective to assess impact on patient care. However, many
highlighted perceived benefits to patients, pharmacists, and other health
professionals. Tonna et al., studied the feasibility and value of pharmacists
Chapter 1-General introduction
16
prescribing antimicrobials in Scotland, and reported positive findings (51).
Another study that analysed the volume and cost of pharmacists prescribing in
England, reported a ten-fold increase in the number and net ingredient costs of
items prescribed between 2004 and 2006 (52). In addition, Cooper et al.,
reported positive views about perceived benefits of SP among a wide range of
stakeholders. However, the authors reported conflicting opinions about the
economic impact of SP on the NHS (53). Whilst data presented in the reported
studies were collected between 2004 and 2007, this literature review did not
identify subsequent research that specifically determined clinical, economic or
humanistic outcomes of pharmacist prescribing. These aspects of pharmacist
prescribing implementation need to be addressed in order to accumulate the
necessary evidence for the continued development of the service.
C. Development of prescribing practice
This literature review did not identify any papers that specifically reported
experiences of pharmacist prescribers with the implementation of IP. However,
it is interesting that many pharmacist prescribers view IP as the logical
progression from SP (48,54), although some considered SP only as a stepping
stone to IP(46). Many studies reported conflicting views of pharmacist
prescribers about their skills and confidence to prescribe without direct medical
involvement (49). George et al. revealed in a sample of Scottish community
pharmacists that IP was considered likely to improve patient care. However,
participants had concerns about the competence of pharmacists in clinical
examination and diagnosis (55). Similarly, Hobson and Sewell identified risks
and safety concerns about pharmacist prescribing, due to a lack of standard
monitoring systems for evaluating the competence of pharmacist prescribers
post-qualification (56). It is reassuring, therefore, that pharmacist prescribers
have given priority to patient safety issues, and only prescribe within their
competence (49, 50). As IP continues to develop, it is apparent that acquiring
appropriate clinical assessment and diagnostic skills will remain a major focus,
as demonstrated by Stewart et al. who developed and validated a tool for the
assessment of pharmacist prescribers’ consultations (57). Tools such as this
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should become an integral part of the training of pharmacists for prescribing in
the future.
D. Training pharmacists for prescribing
The studies that reported implementation of pharmacist prescribing consistently
highlighted issues of education and training. Benefits of training in terms of
increased competence and confidence of pharmacists to implement prescribing
have been identified. George et al. reported pharmacist prescribers’ views that
the period of learning in practice (PLP) provided them with opportunities to
broaden their clinical skills (58). Similar findings were reported by others;
pharmacist prescribers and designated medical practitioners (DMPS) used the
PLP to develop shared learning (59) (60). However, other aspects of the
pharmacist prescribing training have been criticised. Researchers found some
dissatisfaction among pharmacist prescribers about the content and mode of
teaching on SP courses (61, 62). This may have hindered some pharmacists
from undertaking the training to qualify as prescribers.
Cooper et al., reported improvements in both content and delivery of prescribing
training courses over the years (61). However, this has not been matched by a
dramatic increase in the number of pharmacists that enrol for prescribing
training. Stewart et al., reported that the majority of pharmacists who described
themselves as ‘innovators’ and ‘role models’, had either never thought of
training, or had taken little action in terms of training (63). Yet it is apparent that
full implementation of pharmacist prescribing cannot be achieved in GB unless
pharmacists train to become prescribers. It is relevant, therefore, to investigate
issues related to training of pharmacist prescribers. This may reveal findings
that have a direct bearing on the policy and practice of pharmacist prescribing.
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Table 1.1, Published papers relating to implementation of prescribing by pharmacists in GB (n=10)
Author(s)/Title Aims /objectives Method Population Key findings Comments
Dawoud et al.
Pharmacist
supplementary
prescribing: a step
toward more
independence (46)
To investigate
pharmacist prescriber’s
views and experiences
of the early stages of SP
implementation
Qualitative longitudinal
interviews with each
participant 3 and 6 months
after registering as prescriber
16 pharmacist
prescribers in
southern
England,
purposively
sampled to
gain maximum
variability
Three types of
pharmacists’
experiences were
described in relation to
prescribing
implementation, and
some perceived SP
only as a stepping stone
to IP
A longitudinal design aimed to
capture changes in practice, but no
direct analysis was done to show
this. The authors acknowledged that
a longer follow-up period would have
been more useful, yet they did not
justify the choice of six months as the
optimum follow-up period. The paper
was published in 2010, but earlier
research had made similar findings
with more robust designs
Stewart et al.
Developing and
validating a tool for
the assessment of
pharmacist
prescribers’
consultations (57)
To develop and validate
an assessment tool
based on the Royal
College of General
Practitioners (RCGP)
video assessment tool,
for assessment of
pharmacist prescribers’
consultations
Experienced GP assessors
rated performance of
pharmacist prescribers’
consultations recorded on
video. Patient also completed
satisfaction surveys
Interclass correlation
coefficient tested the
agreement between
assessors’ scores, and
patients’ satisfaction.
2 GP
assessors, 10
pharmacist
prescribers
and 14
patients
The tool (PharmaCAT)
had discriminatory
power between
pharmacist prescribers;
reliably confirmed by
two independent
assessors. However,
assessor scores did not
correlate well with
patient satisfaction
The study was limited by small
sample size, and non representation
of secondary care pharmacists.
Notwithstanding, findings add a new
dimension in the evaluation of
pharmacists prescribers’ consultation
skills. The tool can be developed
further to be used in the training and
assessment of non medical
prescribers generally.
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Table 1.1 cont’d, Published papers relating to implementation of prescribing by pharmacists in GB (n=10)
Author(s)/Title Aims /objectives Method Population Key findings Comments
Cooper et al.
stakeholders’
views of UK nurse
and pharmacists
supplementary
prescribing (53)
To explore the
views of
stakeholders
involved in SP
policy, training, and
practice.
Semi-structured interviews
generated the data, while
constant comparison and the
framework approaches were
used to analyse data.
43 stakeholders
including nurses,
pharmacists,
doctors, policy
makers and
academics.
Stakeholders had a positive
view of SP but it was
envisaged that IP
implementation would
supersede SP.
The study incorporated views from a
wide range of stakeholders. However,
sample recruited through personal
contacts of researchers raised the
possibility of selection bias. Authors
recognised that findings were limited,
especially because patients were not
represented in the sample.
Hobson and
Sewell-
Supplementary
prescribing by
pharmacists in
England (47)
Investigate the
implementation of
pharmacist SP by
primary and
secondary care
trusts (PCT/SCT) in
England
Cross-sectional questionnaire
survey collected data on:
demographics, recruitment of
DMPs and implementation of
SP, as well as attitudes about
SP. Non parametric tests
assessed association between
variables.
Pharmacists who
will oversee
implementation of
SP in PCT (n=
303) and SCT (
n =168)
68% response for both PCT
and STC pharmacists. PCT
pharmacists thought it was
more difficult to recruit DMPs
their SCT counterparts.
Implementation of prescribing
was more likely in GP
practices than in community
pharmacies
Study achieved a reasonable response
rate, and applied rigorous statistical
tests. However, the study population
was made up of pharmacists that
supervised prescribing implementation.
Hence findings did not reflect the views
of pharmacists who practiced
prescribing.
George et al.
Independent
prescribing by
pharmacists: a
study of the
awareness, views
and attitudes of
Scottish
community
pharmacists (55)
To investigate
Scottish community
pharmacists’
awareness, of
independent
prescribing and
perception of
competence and
training needs for
the management of
some common
conditions.
Postal questionnaire survey
on: pharmacist awareness of
IP, perception of patients’
accessibility to medicines,
safety of IP by community
pharmacists, perception of
necessary skills for
implementation of IP, attitudes
towards becoming an IP,
pharmacy and pharmacists
demographics.
Scottish
community
pharmacists (n =
500) randomly
selected.
43% response rate.
Pharmacists perceived IP
would improve patients’
access to medicines. Clinical
training for diagnosis of
common diseases was
regarded as important by
majority.
Identified education and
training benchmarks relevant
to the development of
prescribing from SP to IP.
Authors acknowledged the limitations of
their study in terms of the low response
rate and the restriction to Scotland
which had unique contractual
agreements for community pharmacists
than those in other parts of GB. The
study applied robust statistical
procedures to yield valid and reliable
findings.
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Table 1.1 cont’d, Published papers relating to implementation of prescribing by pharmacists in GB (n=10)
Author(s)/Title Aims /objectives Method Population Key findings Comments
George et al.
Supplementary
prescribing: early
experiences of
pharmacists in GB(48)
To determine
demographics of all SP
pharmacists in GB and
to explore early
experiences and
perceptions of SP
pharmacists on training
course.
Postal questionnaire survey
on: SP training, activities as
prescribers, first CMP and
demographics. Chi square,
Mann-Whitney U test to
identify predictors of practicing
SP; then binomial logistic
regression of significant
variables.
All SP
Pharmacists in GB
( n= 518)
82% response rate.
Demographics were
presented. 71% of
respondents identified better
patient care as benefits of SP
while 36% identified funding
as the greatest barrier to
implementation.
High response rate gave
fairly good idea of the key
factors in the implementation
of SP. The findings were
replicated by many
subsequent studies utilising
both qualitative and
quantitative methods.
Hobson and Sewell-
Risks and concerns
about supplementary
prescribing: survey of
primary and secondary
care pharmacists (56)
To investigate the
perceptions of
secondary care trust
chief pharmacists and
primary care trust (PCT)
pharmacists on the risks
and concerns of
supplementary
prescribing
Postal questionnaire survey
on: demographics, recruitment
of DMPs and implementation
of SP, as well as attitudes
about SP.
Factor analysis to explore
relationships between
attitudinal statements
Chief pharmacists
of hospitals (n=
151) and PCT
pharmacists (n=
271) in England
68% response rate in both
respondent populations. Some
concerns about SP related to
the lack of clinical assessment
during training and monitoring
competence after qualifying.
Authors acknowledged
limitation in some questions.
The PCT questionnaire had
weak reliability, and low
internal consistency of
extracted factors.
Cooper et al. Learning
to prescribe pharmacist
experience of
supplementary
prescribing training in
England (61)
To explore pharmacists’
perceptions and
experiences of learning
to prescribe on SP
course focus on inter-
professional learning,
course content and
subsequent use of
prescribing in practice
Cross-sectional questionnaire
survey. Descriptive statistics;
chi square to test possible
correlations between variables.
Open comments analysed
qualitatively
All pharmacist
supplementary
prescribers in
England who
completed SP
training between
2003 and 2007.
Response 51%, less than half
were using qualification. Most
useful aspect of training was
PLP, but inter professional
teaching was of mixed valued
due to difference in
professional background
The study had a small
sample size, and was
restricted to England
therefore, findings be
generalised to other
situations in GB.
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Table 1.1 cont’d, Published papers relating to implementation of prescribing by pharmacists in GB (n=10)
Author(s)/Title Aims /objectives Method Population Key findings Comments
George et al. Views
of pharmacists and
mentors on
experiential
learning for PSP
trainees (62)
To explore the views and
experiences of SP
pharmacists and DMPs
about the PLP; and to
evaluate the extent to
which PLP had prepared
SP pharmacists for
prescribing
Focus group
discussion with
pharmacist
prescribers and
telephone
interviews with
DMPs
12 pharmacist
prescribers and
their linked DMPs
Planning the PLP in consultation with
the DMP necessary for optimal
learning experience. Formal
independent assessment of
competence may improve the quality
of training.
The study sample came from a
cohort of pharmacist prescribers who
undertook prescribing training in one
University. Hence, experiences may
vary from those of pharmacists who
trained in other institutions. However,
the findings were similar to other
those of Cooper et al.
George et al.
Experiential
learning as part of
pharmacist
supplementary
prescribing training:
feedback from
trainees and their
mentors (60)
Evaluate the views and
experiences of SP
pharmacists and
Designated Medical
Practitioners (DMPs) on
the period of learning in
practice (PLP)
Postal
questionnaire
survey. Descriptive
and comparative
statistical analysis
of data to describe
demographics and
experiences of PLP
All pharmacists
who had started
SP Training at
Robert Gordon
University (n =
242) and their
DMPs (n = 232)
Response rate 77% for pharmacists
and 62% DMPs. A little above half of
SP pharmacists knew what was
expected of them during PLP.
Opportunities for professional
development and teamwork were
identified by both SPs and DMPs as
benefit. However, lack of time was
reported as a challenge by SP
trainees and DMPs.
The study sample received
prescribing training from the
institution of researchers, and these
may have influenced the findings.
The authors recognised the inherent
possibility of response bias.
Tully et al.
pharmacists’
changing views of
their supplementary
prescribing
authority (64)
Explore the views of
pharmacists in England
regarding SP before and
after they became
supplementary
prescribers.
Semi-structured
interviews pre and
post registration
8 pharmacists
from a population
of 45, undergoing
SP training in the
north of England
Pharmacists anticipated that training
would legitimise and enhance their
prescribing practices prior to
registration but experienced
procedural delays in implementation.
The study gave useful insights into
pharmacists’ supplementary
prescribing as a starting point for
further research, although some
participants were training in the
institution of the researchers with
possible response bias.
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1.4.3.2 Inter-professional perspectives of Pharmacist prescribing in
GB
Views and perceptions of different health professionals regarding pharmacist
prescribing are important, considering the multi-disciplinary environment in
which the service operates. Accordingly, eight studies were identified that
explored this theme (Table 1.2). This theme is discussed in terms of inter-
professional tensions and opposition to pharmacist prescribing by other
members of the health team.
Blenkinsopp et al. identified among some GPs, opposition to the idea of
pharmacist prescribing because those doctors felt that SP would undermine
their role in patient care (65). Similarly, Tann et al., reported a perception
among some GPs, that pharmacist prescribing was implemented as part of a
grand plan to undermine the future existence of doctors (66).. Cooper et al.
reported that doctors seemed more willing to support pharmacist
supplementary, rather than independent, prescribing. The authors argued that
the preferential support of pharmacist SP by doctors was because doctors
viewed the SP model with its CMP requirement as less of a challenge to
medical leadership of the health team unlike the IP model (67). Weiss and
colleagues had previously drawn similar conclusions as Cooper et al. that IP,
unlike the SP model, may challenge medical dominance in healthcare. In
response, doctors were said to have downgraded the importance of prescribing.
Instead, they emphasised diagnosis as the ultimate role in healthcare, wherein
no other health profession but doctors had the requisite knowledge and skills
(67,68). Doctors felt at ease with SP, since they could use the CMP to regulate
prescribing activities of pharmacists. Moreover, doctors actively encouraged
pharmacist supplementary prescribers to seek advice from them, in ways that
suggested powerlessness of the pharmacist prescriber and dependence on the
doctor (66).
Buckley had earlier argued that doctors would likely accept pharmacist
prescribing within protocols, more than independent prescribing (69). This view
was also captured in the findings of other researchers who investigated
pharmacist prescribing in different parts of the UK (54, 70). Similarly, non
prescribing pharmacists and nurses were reported to have displayed some
resistance to pharmacist prescribing (65, 66). Such inter-professional tensions
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are likely to undermine the implementation of pharmacist prescribing. Therefore,
as prescribing by pharmacists becomes more established, it is important to
investigate inter-professional relationships in order to indentify and resolve
those issues that may directly impact on the policy and practice of pharmacists
prescribing. A summary of inter-professional relationships explored in the
published literature are presented in Table 1.2
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Table 1.2 Published papers relating to inter-professional perspectives of pharmacist prescribing (n=8)
Author(s)/Title Aims /objectives Method Population Key findings Comments
Blenkinsopp et al.
Opportunity or thread
GP perceptions of
pharmacist
prescribing (65)
To explore the perceptions
of general practitioners
(GPs) on the advantages
and disadvantages of
pharmacist supplementary
prescribing
Focus group
discussion.
Content
Analysis of
data using the
framework
approaches.
Thirteen GPs from a
purposive sample of
three GP practices that
had experience of
working with
pharmacist
supplementary
prescribers
GPs perceived benefits from
pharmacist prescribing in terms of
improved patient care and cost
savings. They acknowledged the
expertise of pharmacists on
medicines and felt pharmacists were
more likely to independently manage
patients than nurses. Yet doctors still
wanted to maintain control of the
prescribing process.
The research was restricted in
terms of geographical
coverage, and there was no
indication of when data was
collected. However,
perspectives of other health
professions were captured.
This has a direct bearing on
the implementation of any new
policy in a multi-disciplinary
environment.
Tann et al. Beating
the bounds? The
introduction of
pharmacist
supplementary
prescribing in the UK
National Health
Service (66)
Explore GP and pharmacist
perceptions of the
introduction of
supplementary prescribing
focusing on consequences
for professional boundaries
Focus group
discussion
with GPs, and
interview with
pharmacists
Pharmacist prescribers
and GPs who had
worked with them
Pharmacists perceived themselves
more expert with drugs than GPs.
Doctors exercised professional
dominance by determining the scope
of prescribing practice for other
health professions.
Same study that produced the
paper opportunity or thread,
but this adds details of
pharmacists’ perspectives
regarding intra and inter
professional tensions in
pharmacist prescribing.
Tann et al. The great
boundary crossing:
perceptions on
training pharmacists
as supplementary
prescribers in the
UK(59)
To explore the perceptions
of GPs and pharmacist
supplementary prescribers
on the training and also
explore experiences of
pharmacist supplementary
prescribers on subsequent
continuing professional
development.
Qualitative
interviews
focus group
discussions,
documentary
and critical
incidents
analyses.
General medical
practitioners and
pharmacists
supplementary
prescribers
Pharmacists and doctors enjoyed
reciprocal learning during the PLP
because of pharmacists’ good
knowledge of drugs. Recording
critical incidents and discussing them
was suggested as one way of
enhancing shared learning.
All the pharmacist prescribers
were trained in the same
university so findings may not
reflect the views of those who
trained in other institutions.
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Table 1.2 cont’d, Published papers relating to inter-professional perspectives of pharmacist prescribing (n=8)
Author(s)/Title Aims /objectives Method Population Key findings Comments
Weiss et al. The
changing nature of
prescribing:
pharmacists as
prescribers and
challenges to
medical dominance
(68)
To investigate the role of
prescribing as an
indicator of professional
power; and the potential
threats posed by
pharmacists prescribing
to medical dominance in
healthcare.
Semi-structured
interviews with
pharmacist
prescribers
followed by case
study of selected
prescribing sites.
Only interviews
reported.
23 pharmacist
prescribers
The pharmacy profession has
prescribed under various
definitions and has established
a role in prescribing. However,
doctors have maintained control
by emphasising the competence
of pharmacist prescribers. This
suggests that supplementary
prescribing does not yet
threaten medical dominance.
This research draws on complex
sociological principles and theories.
However, findings have direct
application in the policy and practice of
pharmacist prescribing.
Cooper et al.,
Further challenges
to medical
dominance? The
case of nurse and
pharmacist
prescribing (67)
To reflect upon whether
the introduction of
supplementary
prescribing constituted a
challenge to medical
dominance.
Case study
approach using
Semi-structured
interviews and
non participant
observation. Also
documentary
analysis
Pharmacist
supplementary
prescribers, but
included the views of
doctors, nurses and
patients as
stakeholders.
Medical dominance was not
challenged by supplementary
prescribing, because doctors
actively maintained overall
control. Besides, pharmacist
prescribers and patients
passively accorded superior
status to doctors.
The study presented a wide
perspective of stakeholders in the
implementation of prescribing and
advanced the arguments of Weiss et
al. However, pharmacist prescribers in
community setting were not
represented. There was no indication
of when the study was conducted,
therefore, not possible to judge the
currency of findings.
Lloyd et al. ‘It’s
showed me the
skills that he has’:
pharmacists’ and
mentors’ views on
supplementary
prescribing (70)
To explore the context
and experiences of
pharmacists and their
training mentors at least
twelve months after the
pharmacists qualified as
supplementary
prescribers
Follow-up study
using focus group
discussions and
interviews
Pharmacists and
mentors who
participated in a pre
training study were
followed up between
May 2005 and
September 2007
Benefits of supplementary
prescribing were identified in
terms of reduced workload of
doctors. Pharmacist prescribers
view independent prescribing as
the logical progression in their
career, but doctor had
reservations about that.
Barriers identified in the first study did
not appear to have been resolved in
this study, just as observed with from
the implementation literature in GB.
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Table 1.2 cont’d, Published papers relating to inter-professional perspectives of pharmacist prescribing (n=8)
Author(s)/Title Aims /objectives Method Population Key findings Comments
Lloyd et al.
Pharmacist and
mentors’ views on
the introduction of
pharmacist
supplementary
prescribing (54)
Explore the views and
professional contexts of
pharmacists and their
DMPs prior to starting SP
training.
Focus group
discussions with
pharmacists and
face-to-face
interviews with
DMPs
63 pharmacist
prescribers in the
first four cohorts of
SP training in
Northern Ireland, and
54 DMPs
Supplementary prescribing was
well received and was anticipated
to improve patient care and inter-
professional relationships.
However, some concern about
safety and professional boundary
encroachment.
Qualitative study whose findings can
not be generalised outside the study
area. However, the study revealed
similar issues of implementation in
other parts of the UK.
Buckley et al. Inter
and intra
professional
barriers to non
medical prescribing
(69)
Explore inter and intra
professional barriers to
non medical prescribing.
Semi-structured
interviews
Fifteen stake holders
in one NHS trust
SP was expected to legitimise
previous informal arrangements of
doctors signing pharmacists’
prescriptions. Medical staff
preferred to maintain control.
Pharmacists were seen as
experts in drug therapy but
lacking diagnostic skills and close
knowledge of the patients.
The research was limited to one NHS
trust but findings were similar to
those of other researchers and point
out issues that pharmacists could
reflect on as SP is implemented.
Further research could also benefit
from information provided by this
research.
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1.4.3.3 Patients’ and the general public’s perspectives of pharmacist
prescribing in GB
In addition to the views of other health professionals, the literature contains
reports of research focused on patients’ and the general public’s perspectives of
pharmacist prescribing. Five studies addressed this objective (Table 1.3).
Hobson et al. reported that patients acknowledged the inherent merits of having
pharmacists as prescribers, because of their expertise on medicines and
accessibility. Yet, the same patients still perceived pharmacists as inferior
prescribers compared to doctors in terms of knowledge and clinical skills.
Moreover, the study reported patients’ preference for consulting nurse
prescribers above pharmacist prescribers (71). In contrast, Stewart et al., found
that patients trusted the knowledge and skills of pharmacist prescribers, whom
they thought offered better management of medication problems than nurses.
(72) These findings also reflected the views of patients in a cross-sectional
questionnaire survey across Scotland (73). Similarly, a survey of the Scottish
general public revealed that the public was more aware of pharmacist than
nurse prescribing and that they regarded pharmacist prescribers more highly
than nurse prescribers (74). This is in line with the report of Smalley, which
suggested that hypertensive patients thought the standard of care they received
from a pharmacist prescriber was better than the regular GP care (75). It is
therefore apparent that patients appreciate pharmacist prescribing. However,
research needs to generate the necessary evidence of patient benefits in order
to enhance the implementation of pharmacist prescribing policy.
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Table 1.3 Published papers relating to patients’ and general public’s perspectives of pharmacist prescribing in GB (n=5)
Author(s)/title Aims /objectives Method Population Key findings Comments
Hobson et al.
Pharmacists and
nurses as
independent
prescribers:
exploring patient’s
perspective (71)
To explore perceptions
of patients on the
development of non
medical prescribing
focusing on patients’
preferences between
nurse and pharmacist
prescribers of whom
they consulted.
Semi-structured
interviews.
Descriptive and
explorative
analysis of
interviews using
interpretive
phenomenological
analysis.
18 patients in 4
NHS trusts in
England managed
by pharmacist
prescribers. Also,
patients managed
by GPs for
comparison.
Patients’ preference of doctors
and nurse prescribers appears
to be in response to practical
concerns about pharmacists
implementing prescribing in
community pharmacies which
lack facilities like private
consultation rooms and access
to electronic medical records.
Interviews were conducted between January
and August 2006, when independent
prescribing was just being introduced.
Therefore, patients may have given views
based on speculation. Moreover, no patients
were recruited from community pharmacies,
yet they made strong claims in relation to the
suitability of community pharmacies for
prescribing. Authors provided no clear basis
for comparison between nurses and
pharmacists, therefore hard to objectively
evaluate findings.
Stewart et al.
Exploring
patient’s
perspectives of
pharmacist
supplementary
prescribing in
Scotland (73)
To explore patients’
perspectives of
pharmacist
supplementary
prescribing in Scotland
Cross-sectional
questionnaire
survey,
measuring
attitudes towards
pharmacists SP
and satisfaction
with consultation
180 patients in
primary and
secondary care
spread across
Scotland. 10
pharmacists
recruited 20
patients each
Response rate 57.2%. Patients
had mainly positive experiences,
and high level of satisfaction
with consultation of pharmacist
prescribers. Yet, more than half
would prefer to see their doctors
instead of the pharmacist
prescriber.
Sample size was small, but the patients all
had experience of SP including some from
community pharmacy. The findings were
contrary to those of Hobson et al.,; but in this
case SP was directly studied so findings may
be more indicative of real experiences.
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Author(s)/title Aims /objectives Method Population Key findings Comments
Stewart et al. Views of
pharmacist
prescribers, doctors
and patients on
pharmacist prescribing
implementation (72)
To explore the perspectives
of pharmacist supplementary
prescribers, their linked
independent prescribers and
patients in Scotland towards
pharmacist prescribing.
Telephone
interviews, and
data analysed for
emergent themes
using the
framework
approach.
10 pharmacist
supplementary
prescribers across
Scotland recruited
at least one DMP
and 3 patients for
interviews.
18 patients interviewed
were initially confused
about what to expect from
a consultation with
pharmacist prescriber but
this quickly changed as
they actually experienced
SP.
The interviews were between
October to Dec 2006 with findings
opposite Hobson et al. findings in this
study were confirmed by other
studies.
Stewart et al. Cross-
sectional survey of the
Scottish general public
‘s awareness of views
on, and attitudes
towards NMP (74)
To determine the awareness
views and attitudes of
members of the Scottish
general public on NMP.
Cross-sectional
questionnaire
survey. Appropriate
statistical analyses
applied.
5000 members of
the Scottish general
public.
Response rate was
34.6%. Respondents
more comfortable with
pharmacist prescribers
than nurses. However,
many did not know
enough to rate the
professions.
Authors recognised limitation in
terms of low response rate but
argued that respondents’
characteristics were very similar to
that of the whole population.
This appeared to be the only study
that attempted to get the public’s
views on the implementation of
prescribing by pharmacists.
Smalley L Patients’
experience of
pharmacist
supplementary
prescribing (75)
To evaluate patients’
experiences of a pharmacist
led supplementary
prescribing hypertension
clinic.
Postal
questionnaire
survey.
All patients
attending one SP
clinic for
hypertension in a
GP practice. (n =
127)
87 % response rate.
Percentage frequency of
patients’ experiences was
presented.
Small sample size, but study
provides insight into the patients’
experience of SP. Author considered
possible response bias as patients
most satisfied with the service of the
pharmacist prescriber were more
likely to have responded
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1.4.4 Summary of the literature
From the publications reviewed, the views, perceptions and early experiences
of pharmacist prescribers have been identified. At the same time key factors in
the implementation of prescribing by pharmacists have been highlighted by
various research papers. Significantly, all data reported in the published papers
were collected prior to the full implementation of pharmacist independent
prescribing. Therefore, although much has been reported in the publications
reviewed, there is still a gap in knowledge on the issues surrounding SP and IP
implementation. It is not clear whether barriers and challenges identified in early
studies have been resolved, and how they were resolved if at all (48, 60, 63, 75,
76). Indeed those studies that have been repeated subsequently have found
that initial barriers to the implementation of pharmacist prescribing had either
persisted or the expectations of pharmacists had not been met (46, 64, 70).
With the current experience in supplementary and independent prescribing by
pharmacists in GB, there is a clear need for more quantitative research to
determine the structures of prescribing implementation. Also, there is the need
for in-depth qualitative research to understand the process involved in
successful implementation of prescribing by pharmacists. These are the aims of
the current research project.
1.4.5 Key points from the literature
 SP implementation faced with challenges such as the need for CMPs
which limit practice
 There was no evidence to indicate whether the subsequent introduction
of IP had increased practice considering that IP does not require CMPS.
 The literature reported some resistance to SP by some doctors who feel
professionally threatened. This may get worse with IP.
 The literature had documented evidence of the PLP component of
prescribing training. It is important to explore the option of incorporating
prescribing training in the undergraduate curriculum.
Chapter 1-General introduction
31
1.5 Aims of the project
The overall aim of the research was to explore developments in SP and IP
since implementation; focusing on an investigation of the structures and
processes of prescribing practice by pharmacists in Great Britain. In order to
achieve this aim, the research was designed to be executed in two phases.
In Phase 1 of the project, the aim was to determine the nature and extent of
prescribing activities undertaken by pharmacist prescribers, to establish
background information and update on the status of pharmacist prescribing
practice in GB. In Phase 2, the aim was to apply qualitative approaches to study
in depth, the issues that may be identified in Phase 1; to provide a
comprehensive explanation of the processes involved in the prescribing practice
of pharmacists in GB. Detailed and specific research objectives will be
described in each phase of the research project as appropriate.
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Chapter Two: Methodology
This chapter outlines a general introduction to methodology and related
concepts, and shows how the concepts informed the use of specific methods in
the conduct of this research. The chapter is divided into three main sections
covering quantitative, qualitative, and mixed-methods research traditions. Each
section begins with a discussion of the key philosophical assumptions
underlying a particular research tradition which is followed by a brief critique of
the methods applicable in that research tradition, and then the detail of selected
methods is described. Therefore, this chapter on methodology will present and
justify the selection of the specific methods employed in this doctoral research
project. Throughout the chapter, the discussion of methodology moves from a
general description to a focus on how each set of philosophies underpins
research in the health services and pharmacy practice domains, to which the
current project pertains.
2.1 General introduction to research methodology
This section defines research methodology and the related concepts of ontology
and epistemology. These are the components of the philosophical debates that
surround the conduct of social research generally, and health services research
in particular.
Blaikie defines research methodology as “discussions of how research is done,
or should be done, and the critical analysis of methods of research.” In this
context, methodology covers the logic surrounding how new knowledge is
generated and justified (77). Methodology, therefore, extends beyond a simple
description of the techniques used to collect and analyse data (research
methods). It includes a discussion of the philosophical assumptions that govern
these techniques as a rationale for the selection and application of appropriate
methods in research. Philosophical assumptions, described as ‘paradigms’, by
Guba and Lincoln, underpin research in the sense that choice of a particular
methodological approach adopted by any researcher, depends on the
researcher’s response to ontological and epistemological questions (78).
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According to Blaikie, ontology is concerned with the nature of social reality or
what exists, while epistemology describes the possible ways of knowing social
reality (assumptions about how what exists can be known) (77). Denzin and
Lincoln explained the relationship of these concepts in the research process as
follows:
“...the researcher approaches the world with a set of ideas, a
framework (theory, ontology) that specifies a set of questions
(epistemology) that he or she then examines in specific ways
(methodology, analysis)” (79)
The research project reported in this thesis falls within the domain of pharmacy
practice, a sub-specialty of health services research. Bowling defines health
services research as:
“...an applied field of multi-disciplinary research concerned with the
relationship between the provision, effectiveness and efficient use
of health services and the health needs of the people” (80).
Health services research follows defined rules and procedures to gather
relevant information useful for answering questions related to the health needs
of the population. Health needs include the social interactions and relationships
between health professionals, as providers, and patients, as recipients, of
health services (81). Health services research primarily applies quantitative
methods, rooted in the natural sciences, qualitative methods, rooted in the
social sciences, or a mixture of both approaches. The rest of the chapter will
focus on these approaches to traditions and highlight the unique strengths and
weaknesses of each one in order to justify and guide the selection of
appropriate methods for the research questions being addressed in this doctoral
research.
2.2 Quantitative research methodologies
This section introduces quantitative research methodology, highlighting the
main philosophical assumptions behind it. Also, experimental and quasi-
experimental techniques of quantitative enquiry are described briefly, before
focussing on the survey method in more detail.
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Quantitative research measures the relationship between two or more variables
as a means of quantifying numerically. The relationship between variables is
expressed in the form of theories or hypotheses and measured using
standardised instruments. Data from measurements are represented by
numbers and subjected to statistical analyses, in order to explain the
relationship between the variables of interest (82). In other words, quantitative
research begins with well defined concepts or hypotheses about which data to
collect and analysed to derive new scientific knowledge, through deductive
reasoning (80). The collection and analyses of data in quantitative research
assumes the existence of ‘reality’ or ‘truth’ in social phenomena. It is these
realities that are measured objectively using standardised instruments. These
assumptions represent the positivist/ post-positivist philosophies of research
described in the next section.
2.2.1 Philosophical assumptions underpinning quantitative research
The positivist philosophy in research assumes a ‘realist’ ontology; that is the
existence of a single reality or ‘fact’ within the phenomenon being investigated.
In terms of epistemology, positivism believes it is both possible and essential to
observe and measure that single reality without interference by the researcher
(objectivity) (78). Positivism is concerned with the determination of ‘cause’ and
‘effect’ relationships, and argues that science must be concerned with only
variables that can be measured objectively, devoid of any influence of the
interaction between the researcher and the observed phenomenon (83).
However, this claim of a single objective reality in positivism presents practical
challenges in health services research. Positivism assumes that social
phenomena can be measured in the same way as medical science would use
instruments to measure parameters such as temperature or blood pressure
(80). This is often impractical as it is seldom possible for scientific observations
to be made totally indifferent to the context within which the observer operates
(84, 85). This limitation of positivism, led to the emergence of post-positivism as
an alternative research philosophy.
Chapter 2- Methodology
35
The ontological basis of post-positivism is ‘critical realism’ which retains belief in
the existence of a single ‘reality’, but argues that reality can never be fully
attained (78). In other words, post-positivism holds that it is not possible to
completely prove theories or hypotheses. Rather, theories are considered as
provisional explanations of ‘reality’ and not absolute truths (81). The post-
positivist epistemology acknowledges the influence of interactions between the
researcher and the researched. It accepts ‘objectivity’ as an essential guiding
principle in research, but argues that it is never possible to completely achieve
objectivity (78). Post-positivist assumptions have tended to dominate social
research, and have often been called the scientific method (86).
Some research questions can be investigated within the premise of the post-
positivist philosophy. For example, the effectiveness of two drugs in the
treatment of a disease can be tested and compared using randomised,
controlled experiments. Similarly, where background information about health
services research questions are available, researchers can deploy quantitative
methods using standardised instruments for data collection (80). The
quantitative techniques applied in health services research are presented next.
2.3 Quantitative methods (experimental and quasi-experimental
designs)
Quantitative research designs encompass a wide range of specific methods
which broadly group as experimental, quasi-experimental or non-experimental.
Experimental research has the general aim of establishing causal relationships
between variables. However, non-experimental quantitative research mainly
describes the characteristics of variables hence the methods are often referred
to as descriptive (87).These two categories of quantitative research are
discussed briefly focussing on their distinguishing characteristics. The strengths
and limitations of these methods for the research questions addressed in this
doctoral research project are also described.
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2.3.1 Experimental research
Experiments are the means by which researchers ensure control in the
environment under study. In the natural sciences such as biology, scientists
keep all conditions constant while manipulating the independent variables. The
influence of extraneous factors on the outcome (confounding variables) is kept
to the barest minimum possible. Consequently, the observed effect can be
potentially ascribed to the intervention, or manipulation of the independent
variable. The main distinguishing feature of experimental research is the
random allocation of subjects into test and control groups, to permit the
manipulation of the independent variable (87). Randomisation uses statistical
calculations to ensure that every member of the study population gets an equal
chance of being in either the test or control group. This then ensures that
outcomes of experimental research can only be attributed to the independent
variable. Research into some human actions and behaviours relies on
statistical analyses of quantitative data to produce inferences. The findings are
regarded as facts or general theories about the characteristics of interest in the
study population, especially when other experiments replicate the findings in
different populations and sub-populations (88). The concept of experimental
research has been applied in the health setting in the form of randomised
controlled trials RCTs (81).
Results of RCTs are considered to yield valid explanations or evidence that a
particular intervention caused the observed effect. In other words, RCTs can be
used to determine cause and effect with a high degree of precision or accuracy
(internal validity). Consequently, the strength of evidence from RCTs is usually
graded highest in the hierarchy of health services research (89). However,
findings from an RCT may be inapplicable outside the population from which the
sample was drawn (90). Steps taken to eliminate the influence of confounding
variables permit the accurate determination of cause and effect between
manipulation of independent variables and outcome. At the same time this
narrows the conditions for which the results could apply (external validity) (80,
87). Therefore, many health services research questions are investigated by
non experimental designs.
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2.3.2 Limitation of experimental designs for this research project
Randomisation, the main requirement of experimental research designs is not
always feasible, due to practical and sometimes ethical considerations. In
addition, the procedure of manipulating independent variables may not be
tenable in the case of human research subjects. Research participants do not
passively respond to external stimuli; instead, they contemplate and interpret
information about their environment and then respond appropriately (80). This
imposed key limitations to the use of any experimental design in this doctoral
research project. The research did not aim to determine any causal
relationships for which an RCT would have yielded results with the strongest
internal validity (accuracy). Rather, the research questions were mainly
descriptive and hence, were more suited to non-experimental designs (87),
particularly the survey method. Non-experimental quantitative research designs
will be described next.
2.3.3 Quasi-experimental designs
Quasi-experimental designs do not require random allocation of subjects into
control and test groups, but research participants are assigned into two or more
groups. These designs still permit the investigation of causal relationships, but
yield findings that are weaker than true experiments in terms of internal validity
(87). Observed outcomes may be open to alternative explanations because of
the external influence of uncontrolled factors. The main features of
experimental and quasi-experimental research designs are summarised in
Table 2.1. Descriptive surveys fall within this category of quantitative research
and they will be considered next.
2.3.4 Survey research design
This section introduces survey research design, highlighting the main
characteristics of cross-sectional questionnaire surveys. The postal method of
delivering questionnaires will be described, along with a brief critique of
strengths and limitations of surveys in health services research. The discussion
will also cover the rationale and justification for choosing this particular method
in the current research project.
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Surveys are the most widely used research design adopted by pharmacy
practice researchers to address a wide range of objectives (91). The design
could be descriptive or analytical depending on the type of research question.
Analytical survey designs explore the association between particular variables
in search of causal relationships and explanation of the phenomenon under
investigation in a manner similar to experiments (80). Descriptive surveys, on
the other hand, mainly estimate proportion or count variables of interest in a
whole population or representative samples of them. Such surveys may also
determine how often certain events occur together (association), but they are
not suitable for explaining why the observed relationships occur (causality) (92).
Descriptive designs collect numerical data, which are statistically analysed to
elucidate information on trends, attitudes or opinions of a population. Data
collection in surveys may be cross-sectional, to compare different subgroups of
the population at a single point in time, or longitudinal, in which case the same
group of respondents is examined repeatedly over a period of time to reveal
trends and associations (80, 90, 92).
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Table 2.1 Summary of experimental and quasi-experimental research designs applied to health services research
Main features Strengths Limitations Example of Designs
Experimental designs (Randomised controlled trial (RCT)
Experimental and control groups with
similar characteristics
Intervention of interest withheld from
control group
Random assignment of participants
to experimental or control group
Participants have equal chance of
being in either group.
Requires a hypothesis to test a
causal relationship
Randomisation minimises the likelihood of
selection bias and increases accuracy to infer
that observed difference is due to manipulation
of the independent variable (internal validity).
Can predict cause and effect relationships and
clarify the direction of causation.
Possible to determine which independent
variable accounts for the outcome of interest.
Greater flexibility, efficiency and statistical
manipulations; consequently more robust
findings and inferences
Difficult to completely eliminate external influences
(confounding variables) in human studies
Confounders often make it impossible to identify a
specific variable as the cause of the outcome observed
in human phenomena
The controlled environment of experiments bear little
resemblance to real life human health issues in health
services research (weak external validity)
Experiments cannot capture all factors involved in
human health; example choices and preferences of
health professionals and patients
1. Post test only,
2. Pre and post test
3. Factorial
Quasi-experimental designs
There may or may not be controlled
groups
No random assignment of research
participants to groups
Researcher may not manipulate
independent variable
Relatively cheap compared to experiments
Relatively quick results
Useful in studying rare health conditions
Better than experiments at generalising from
research findings to real life situations in human
research (external validity)
Potential for selection bias and confounding higher
than for experiments.
Limitation on the conclusions possible from these
studies and cannot establish causality.
Difference between case and control groups cannot be
fully explained by the independent variable (weak
internal validity).
1. Case-control
studies
2. Cohort studies
3. Data base studies
4. Descriptive surveys
5. Analytical surveys
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A limitation of surveys compared to experiments is the absence of a control
group, and the non-manipulation of variables being investigated. This implies
that any inferences from surveys never completely exclude the influence of
uncontrolled variables, hence the design is less suitable for proving causal
relationships (92).Notwithstanding, by following the trend of events in the
natural setting, and surveys give rise to findings that are closer to reality than
those from the controlled-environment of experiments (92). Surveys conducted
on sufficiently large samples are likely to produce findings which can be
generalised to the population from which the sample was drawn (81).This
presents a practical advantage for health services research concerned with
estimating the association between demand, provision and utilisation of health
services in the community. Moreover, sample surveys are cheaper than full
population studies and are easier to conduct across wide geographical areas
(80).These practical advantages make surveys the methods of choice in health
services research.
2.3.5 Cross-sectional questionnaire surveys
Questionnaires are the standardised instruments used for the collection of data
in survey research designs. The term questionnaire survey in its broadest
context covers several methods of administering the instrument, including
postal questionnaire surveys, group or self-administered questionnaires, and
structured interviews, conducted face-to-face or by telephone (92, 93). A
questionnaire survey is cross-sectional when the collection of data is done at
one point in time. The data collection instrument may be delivered to
respondents by post for self-completion, as in postal questionnaire surveys.
This method of delivery removes face-to-face contact between the researcher
and respondents, therefore it minimises undue influences of the researcher on
respondents. In addition, the method provides a rapid and cost-effective means
of reaching respondents across wide geographical regions (92). The use of
questionnaires in health services research has been on the increase.
Unfortunately, this popularity of the method has also been associated with a
higher potential for inappropriate use arising from poor questionnaire design
(94). The quality assurance of questionnaire surveys in terms of validity and
reliability are central considerations, therefore, in the development of
questionnaires. These issues are addressed in the next section.
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2.3.5.1 Reliability of questionnaire surveys
Reliability refers to the extent to which the data collection instrument will re-
produce the same measures of a variable when administered repeatedly
(repeatability), or the probability that the instrument is free from random error. It
is also the estimate of the extent to which the questions measure the same
concept (internal consistency) (80, 92). It is therefore important that the
questionnaire is standardised to collect accurate information about the variables
of interest. There are several procedures for assessing the reliability of
questionnaires including: test-retest, Cronbach’ alpha, split half, multiple form,
item-item correlations and item-total correlations,(80) but a description of the
first two will suffice for this thesis. Repeat-reliability or reproducibility of a
questionnaire is commonly estimated by a procedure of test-retest, in which the
questionnaire is administered to the same individual on two different occasions.
Assuming no change in the variable being measured, a respondent is expected
to record the same score each time the questionnaire is administered.
Computing the correlation between scores recorded in each of the two
measurements gives an indication of the consistency of respondents’ answers
to the same questions when repeated. This correlation is used as a proxy to
measure how respondents interpreted the questions (91). A reliable
questionnaire should produce high correlations with values close to 1; however,
a low correlation may reflect a change rather than poor reliability of the
instrument (80).
Practical considerations often make it impossible to carry out the test-retest
reliability check procedure. Moreover, research participants may respond to a
questionnaire the second time based on their experience with the first one, so
that results may not in reality be a comparison of the same instruments (92). In
these circumstances, the internal consistency of questions is used as an
estimate of reliability. This is determined using the Cronbach’s alpha coefficient
(α), by calculating the correlation coefficient among the questions. The literature
suggests that α value above 0.7 indicate good reliability (91). Internal
consistency does not require the repeated administration of the questionnaire,
unlike the test-retest procedure for estimating reliability. These principles will be
applied in Phase1 of the current research project (see Chapter 3).
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2.3.5.2 Validity of questionnaire surveys
Validity is the level of assurance that the data collection tool actually measures
what it was designed to measure (92). Pharmacy practice research considers
validity of survey questionnaires as the extent to which the questions elicit
accurate responses that are relevant to the research objectives (91). This is the
internal validity of the questionnaire, in contrast to external validity, which is a
measure of how much the research findings reflect the true situation in the
population of interest. In questionnaire development several aspects of validity
are considered, but two types of validity are particularly relevant in pharmacy
practice research; face and content validity. (91) Face validity is the subjective
assessment of the physical appearance, relevance and clarity of the question
(80). Checking for face validity also ensures that the data collection instrument
is devoid of questions that respondents would be reluctant to, or unable to
answer. (91) Assessment of the face validity is improved upon by adopting the
more systematic approach of content validity. This involves a panel of experts
who check the questions to ensure that all relevant issues are exhaustively
covered, both from the researcher’s and respondent’s perspectives (80, 91).
The external validity of a survey, defines how the results of research conducted
with selected individuals could be generalised, and thus applied to other
populations. This is determined most importantly by the sampling procedure,
sample size and response rates (91). Assuming that sampling is adequate, in
terms of selection, size and response rate, it may then be possible to apply
probability-statistics to generalised findings from the sample to the wider
population (86). This is particularly important in health services and pharmacy
practice research, where the aim is often to deliver better services through a
change in policy or practice. In the current research project, specific sampling
considerations are presented in Chapter 3, but the general principles as it
relates to external validity of surveys is described below.
2.3.5.3 Sampling procedures in survey research
Ideally, a survey would collect information from every member of the population
of interest; in the case of this doctoral research project, that would be all
pharmacist prescribers who worked in GP practices and community
pharmacies. This would have guaranteed that the findings completely and
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correctly described implementation of prescribing within these settings. This
was not feasible however, and as it is the case with any research utilising the
survey approach, some respondents may not be willing or able to participate
(91). Moreover, there may not be any real advantage of recruiting every
individual from large study populations, as this would demand huge time and
resources to process the resultant data (80). Therefore, surveys rely on
information from some individuals in the study population, a representative
sample, who possess all the characteristics of interest (92).
Samples can be drawn by a simple random procedure to ensure that every
member of the population has a statistically equal chance of being selected
(92). A random sample is necessary in order to apply probability statistical
analyses which permit generalising any inferences to the wider population, (86)
(external validity described above) . Random sampling depends on the
availability of a complete and accurate sampling frame, which is a list of every
member of the population of interest (91). In this doctoral research, the
sampling frame was the register of all pharmacist prescribers qualified and
registered with the RPSGB. The sample of interest however, was those based
in community pharmacies and general medical practices. The RPSGB register
did not distinguish individuals according to their practice settings; therefore, a
truly random sampling procedure was not feasible in this instance. Alternative
sampling procedures, such as clustered or stratified sampling, involve grouping
large populations into smaller units which are randomly selected, and individual
members in the smaller units are in turn randomly recruited for the study (91).
These were neither necessary nor feasible in the current doctoral research
project. In such situations, the most readily accessible or willing members of the
population are selected in a convenient sampling strategy (91). This was the
approach used in the current project, administering questionnaires to everyone
on the register of pharmacist prescribers, and using screening questions to
select the desired sample (see details in Chapter 3).
2.3.5.4 Maximising response rate in postal questionnaire surveys
Achieving high response is central among the points taken into account while
planning a questionnaire survey, if findings are to be generalised to the wider
population of interest. Pharmacy practice researchers who use the postal
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method of questionnaire administration have adopted several strategies to
achieve this. Researchers enclose covering letters along with questionnaires, to
explain objectives of the research. The covering letter also explains criteria
used for selecting respondents, assures confidentiality, and points out potential
benefits or risks of the project to respondents. Other strategies used by
researchers to maximise questionnaire response include sending reminders to
participants, and the use of incentives (91). These principles were applied in the
design of the current research project, although no incentives were offered. The
practice of inducing research participants with incentives is contentious in
Europe, where it is mostly considered unethical (80). Moreover, the benefit of
incentives on questionnaire response has not been verified (91). This doctoral
research project adhered to principles of best practice of questionnaire surveys
through all stages, including the planning and development of the questionnaire,
covering letter and participant information sheet (92-94). Specific details of the
questionnaire development process and validation of the questionnaire are
discussed in Chapter 3, where the method is applied in the first phase of the
research project.
Many health services research questions are suitable for investigation using
quantitative methods. However, others such as individual’s perceptions and
considerations that motivate them to seek treatment are ‘abstract’ and less
suitable for investigation using quantitative approaches. In these circumstances,
qualitative methods present viable alternatives in health services research.
Therefore, a discussion of qualitative research will follow in section 2.5 before
ending this chapter with a brief discussion of mixed-methods research to
provide the rationale and justification for the specific methods applied in
Phases1 and 2 of this research project.
2.4 Qualitative research designs
This section will discuss qualitative research methodology highlighting key
comparisons and contrasts with quantitative research. As with the section on
quantitative research, the discussion will move from the philosophical
assumptions to the range of qualitative methods, and then focus on a detailed
description of qualitative interviews.
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Qualitative research produces findings by procedures other than statistical
analysis or quantification of numerical relationships between variables (95). The
focus of qualitative research is gaining understanding of the meaning(s)
research participants attach to their experiences of the social world (80). The
emphasis in qualitative research is the understanding of phenomena in their
social contexts; rather than controlling the environment and manipulating
variables as is the case with quantitative research.
2.4.1 Philosophical assumptions underpinning qualitative research
The philosophical assumptions that underpin qualitative research are highly
contested subjects and sometimes generate controversial debates among
scholars in different disciplines. However, philosophical discussions highlight
the links between beliefs about the nature of social reality and the possible
ways of investigating and knowing that reality. Therefore, philosophy or
paradigms shape the views and actions of qualitative researchers.
According to Denzin:
“All research is interpretive; it is guided by the researchers set of
beliefs, and feelings about the world and how it should be
understood and studied.... Each interpretive paradigm makes
particular demands on the researcher including the questions the
researcher asks, and the interpretation he or she brings to them”
(79).
Denzin then described four interpretive paradigms that generally underpin
qualitative research as: positivist, constructivist, critical and feminist (79). A
comprehensive discussion of these paradigms is beyond the scope of this
thesis. Moreover, Barbour has argued that it is neither feasible nor desirable to
distinguish clearly between the many philosophical traditions of qualitative
research (96).
“Any attempt to categorize qualitative traditions in terms of their
distinctiveness is doomed from the outset...the problem of providing
a clear and comprehensive run-down of the principal traditions is
exacerbated by the existence of variants of virtually any approach”
(96).
Barbour stated further that individual qualitative researchers would choose to
emphasise some, and de-emphasise other aspects of a philosophical approach,
Chapter 2- Methodology
46
depending on their personal preferences and disciplinary dispositions (96). In
this sense, the constructivist philosophy which contextualised the second phase
of my doctoral research project will be introduced briefly. Positivism and related
philosophies that underpin quantitative research were discussed in the previous
section on quantitative research designs.
2.4.2 Constructivism
Constructivism assumes that social realities are constructed out of individual’s
experiences of phenomena. The ontology (nature of social reality) of
constructivism assumes that ‘social reality’ does not exist as discrete tangible
‘facts’ that can be measured. Rather, it assumes that individuals create ‘social
reality’ by constructing subjective and multiple meanings of their experiences as
they live and work in the society (86). In terms of epistemology (relationship
between the researcher and the social reality they seek to know), the
researcher from the point of view of constructivism should take into account
local contexts, and meanings that individuals create out of their experiences.
This acknowledges mutual influences between the researcher and researched
(97). Constructivism is related to phenomenology, which assumes that people
construct social reality as they interpret the world around them, interact with
each other, and assign meaning to their perceptions and experiences (98, 99).
Consequently, the philosophy of phenomenology dictates that research into
human issues, such as health services, should be conducted in the natural
environment, which encourages active engagement between the researcher
and research participants (80). This is in contrast to the positivist philosophy
predominant in quantitative research where the researcher is completely
‘detached’ from the subject being investigated and the researcher takes the
position of an objective observer of phenomena (78). Constructivism and
phenomenology require that the researcher occupies the centre stage of the
research process in order to understand the social world (99). Phenomenology
utilises open-ended and unstructured instruments to generate in depth accounts
from a small number of participants. Researchers engage with, and immerse
themselves extensively in, participants’ narratives. They try to identify patterns
of relationships in the data and gain insight into the meanings of phenomena
from the perspective of the study participants (80, 86, 98). The presence and
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personal experiences of the qualitative researcher are acknowledged as
important in understanding the contexts of the issues being studied (100). The
researcher is perhaps the most important research tool, and generates, rather
than collects, data to provide a ‘thick’ description of phenomena as the
researcher actively engages in the setting under study (96).
2.4.3 Main features of qualitative research
Qualitative research seeks to explain how people understand concepts and the
processes by which they translate these concepts into every day practices (96)
such as, how patients interpret and respond to information from health
professionals that result in favourable or adverse treatment outcomes.
Qualitative research by observations, unstructured interviews or documentary
analyses, relies on textual data rather than numbers to explain phenomena (80,
86). In achieving this purpose, qualitative research puts little emphasis on pre-
defined concepts or hypotheses at the beginning of a research project. Rather,
hypotheses are developed and refined as the research progresses (100).
Categories for data analysis emerge by an inductive process where the
researcher begins with the observations and forms ideas which are refined into
general concepts or hypotheses that can be tested by further observations (80).
The main limitation of qualitative research relates to the tendency of data
generation and analysis being tedious and time consuming (88). This is more so
in the field of health services, where research outcome may be needed for the
formulation and implementation of policy interventions within a short span of
time (88,101). This limitation does not in any way diminish the many
advantages of qualitative research. The main advantage in health services
research is suitability of qualitative methods to study topics about which little is
known, or complex and sensitive issues (80). Qualitative methods are also
acknowledged for the advantage of studying phenomena in their natural
contexts, such that findings are more likely to reflect stakeholders’ needs, unlike
the strictly controlled environment of the laboratory (88). Qualitative research,
therefore, provides opportunity to closely examine lived experiences of the
social world in a way that is not possible with quantitative methods (96). As a
result, qualitative research has gained popularity among health services
Chapter 2- Methodology
48
researchers for studying complex human interactions associated with the
planning, provision, demand and utilisation of health services (102).
2.4.4 Sampling in qualitative research
Unlike quantitative research, the aim of qualitative research is not to test
hypotheses or generalise findings to the wider population. Therefore, samples
in qualitative research do not necessarily have to be representative of the
general population. Qualitative research is more interested in understanding the
complex processes behind phenomena through a detailed study of a few
participants. Also, human characteristics studied in qualitative research often do
not follow a ‘normal’ distribution among populations, and hence random
sampling becomes inappropriate (103). Consequently, qualitative research
adopts alternate, but appropriate, strategies in the selection of study
participants. Four sampling strategies (convenience sampling, purposive
sampling, snowballing and theoretical sampling) are the most commonly used in
health services research (80).
Convenience sampling strategy recruits participants mainly on the grounds of
being the most readily available participants; sometimes described as
opportunistic sampling (80). This strategy is resource-efficient, in terms of
saving time, money and efforts, but may result in low quality of data. (103)
Purposive sampling deliberately selects participants based on particular
characteristics relevant for producing the needed data that best illuminate the
topic under investigation; for example, participants having experienced the
phenomenon under investigation (104). Participants included in purposive
sampling are often chosen to reflect varied perspectives on the research topic
(maximum variability), including those with negative experiences. This
enhances the quality and depth of the data (103). Snowballing relies on
recruiting the initial participants who then suggest others that have the
characteristic of interest to the researcher; this is mostly used in the absence of
clear sampling frames (80). Theoretical sampling is more commonly applied in
grounded theory research, where emerging concepts and theories determine
the category of respondents that need to be recruited in order to develop and
refine those concepts (103). Irrespective of which sampling strategy is adopted
in qualitative research, there appears to be an overlap in the sense that
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participants are often selected for specific purposes in accordance with the
research objective (105). This was the case in the current project (see Chapter
4).
2.4.5 Reliability, validity and rigour in qualitative research
Reliability and validity were introduced as concepts that define the integrity of
the quantitative research process and outcomes. It was mentioned that
reliability can be assessed in quantitative research by the statistical calculation
of internal consistency, or the test-retest procedure (91). However, the
traditional meaning of reliability and validity, derived from the positivist paradigm
of research cannot apply directly to qualitative research. Since the two research
traditions have different ontological and epistemological beliefs, knowledge
derived through the two research processes is different (78). Whilst quantitative
research builds knowledge in the form of ‘accurate’ explanations of relationships
among variables in phenomena, qualitative research generates understanding
of the ‘real-world’ complexities and social contexts of phenomena (96,102,106).
This difference in purpose between the two research paradigms is one reason
why it is not possible to apply the same criteria, for the assessment of their
quality (107). Stenbacka has argued that using reliability, validity and related
concepts in qualitative research is irrelevant and often misleading; as qualitative
research is never out to measure anything (106).
Notwithstanding, qualitative researchers need to demonstrate the quality of their
process and outcome. Many qualitative researchers have attempted to draw
parallels with the quality concepts of quantitative research, but the meaning of
validity has remained contentious. (108). One of the problems is the semantics
of these concepts, which as Stenbacka pointed out, may not be suited to the
qualitative research paradigm (106). Therefore, the traditional quantitative
terms of reliability and validity are conceptualised as ‘trustworthiness’, ‘quality’
and ‘rigour’ in qualitative research (107). In considering ‘trustworthiness’ of the
qualitative research process, Lincoln and Guba suggest that researchers focus
attention on four key issues: ‘credibility’, ‘transferability’, ‘dependability’, and
‘confirmability’ (109). Lincoln and Guba explained these terms as follows
i. ‘Credibility’ is an evaluation of how research findings represent the ‘truth’
about the phenomenon under investigation; i.e. confidence that research
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findings truly portray a conceptual interpretation of participants’ original
data.
ii. ‘Transferability’ gives an indication of the degree to which other
researchers can apply or transfer the findings to their own situations.
iii. ‘Dependability’ measures the stability of the findings over time which
captures the quality of the entire process from data generation, data
analysis, and interpretation.
iv. ‘Confirmability’ links the data to the findings indicating how well research
findings are supported by research participants’ accounts (109)
The concept of ‘trustworthiness’ has been made operational by replacing
internal validity in quantitative research with ‘credibility’ in qualitative research.
Similarly, external validity is replaced by ‘transferability’; reliability is replaced by
‘dependability’; and objectivity is replaced by ‘confirmability’ (110). Qualitative
researchers have therefore, incorporated steps to safeguard the credibility or
quality of both the research process and outcome. These include: researchers
being honest and open about their theoretical inclinations and background at
the outset of the research project. Also, issues of design, sampling, data
generation, analysis and interpretation should by systematic, avoiding as much
researcher bias as possible (80). In addition, rigour has been achieved in
qualitative research by using two or more approaches to arrive at the same
finding (triangulation). Other ways include asking respondents to check
transcripts and verify that their perspectives have been adequately reflected
(respondent validations). In all these, the qualitative researcher remains
sensitive to any personal preconceptions, biases and possible influence on
response of participants (reflexivity) (91,111). These principles will be applied in
phase two of the current research reported in Chapter 4.
2.4.6 Range of qualitative research methods
There are three main methods of generating data in qualitative research:
interviews, ethnography/observational research and focus group discussions
(100). These methods actively generate data through interactions with research
participants. However, some other procedures can involve the examination of
documents in the form of diaries, audio or video materials (96). The methods
will be introduced briefly, and then interviews described in detail. The
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justification and rationale for the choice of interviews in this doctoral project will
be explained later.
Observational research is the main approach of ethnography which affords the
researcher opportunity to directly observe human behaviour in the natural
setting (100). Ethnography observes the sequences of human activities in a
manner that is open to discovering new data, and then connects observed data
to local contexts of the study (112). Observational research aims at
understanding more than what people say about complex phenomena (80).
Focus group discussion as a technique of generating qualitative data has its
origins in market research, organisational research, community development
and social science (113). The term focus group has often been construed as
synonymous with group interviews. Whereas focus group discussions rely on
the interactions between participants to generate data, group interview involves
the researcher asking group participants the same question in turn (96). A
broad description encompassing both perspectives defines any group
discussion as a focus group, so long as the researcher actively encourages and
is attentive to the group interaction (114). Focus group discussions have
become increasingly utilised in health services research for the initial
exploratory phase of research to develop items for inclusion in surveys (113). In
addition, focus group discussions have been found to be successful in
producing rich data about the public’s views of priorities for health service (80).
It is also useful in exploring culturally-sensitive beliefs of ethnic minorities about
health. Group interaction allows participants to approach the issues in ways
that are less threatening than they might otherwise find in one-to-one interviews
(114). However, this method is not the most appropriate for accessing views or
attitudes of participants. One-to-one interviews are better at generating and
clarifying narratives than focus groups which are more suitable for studying how
views are created and modified (96).
2.4.7 Qualitative interviews
One-to-one interviews are the most common qualitative research method.
Interviews generally involve more than merely asking questions, but elicit
comprehensive exchanges between the researcher and research participants
(96). Interviews are either conducted by telephone or face-to-face, which can be
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one-on-one or in groups. Interview formats use open-ended and unstructured
questions to elicit the views and opinions of the participants (86). The
unstructured nature of the interaction ensures that issues relevant to
participants drive the discussion. This is in contrast to the fixed agenda of
quantitative research, which uses structured survey instruments to conduct the
interviews (96). Qualitative interview exchanges are kept within the topic of
investigation using loose guides in semi-structured interviews (115). The
interview guide comprises a few specifically-worded questions with appropriate
prompts to increase the depth of interaction (80, 96).
2.4.8 Telephone interviews
Face-to-face interview has been the dominant mode of data generation in
qualitative research. Researchers, using this procedure, can take added
advantage of non-verbal cues from participants, to gain a deeper insight into the
data. However, the presence of the researcher may influence the responses. In
addition, this approach is both time-consuming and expensive (116). In
contrast, telephone interviews are less commonly used in qualitative data
generation; for reasons that may include: low response rates, need for shorter
interviews, absence of visual cues, and also because telephones may not be
available to everyone (117,118). This notwithstanding, telephone interviews
allow access to participants across wide geographical areas, and hard-to-reach
respondent groups. In addition, telephone interviews are cheaper and
respondents may find the method less imposing than face-to-face interviews
(116,119). Consequently, the use of telephones has gained prominence as an
alternative procedure for administering qualitative interviews in research.
Importantly, the depth and quality of data generated by telephone does not
significantly differ from those generated by face-to-face interviews (119).
The limitations of qualitative methods, particularly interviews, underscore the
continued importance of quantitative methods in health services research.
Therefore, combining different, complementary methods is likely to lead to a
more holistic understanding of a research issue. This is the crux of mixed-
methods research which is discussed next, in section 2.5
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2.5 Mixed-methods research design
This section begins with a discussion of the philosophy of mixed-methods
research, and then describes various strategies of mixing methods, before
focusing on the sequential strategy of mixed-methods research. The section
then concludes with a discussion of the criteria considered in selecting mixed-
methods strategies in health services research.
There are multiple definitions of mixed-methods research depending on what is
combined, when or where the combination is made, the breadth of combination,
the purpose of combination and whether or not the research question drives the
consideration for combining research methods (120). Johnson et al., drawing
from 19 other definitions described mixed-methods research as the
“… type of research in which a researcher or team of researchers
combine elements of qualitative and quantitative research
approaches (for example the use of qualitative and quantitative
viewpoints, data collection, analysis, inference techniques) for the
broad purpose of breadth and depth of understanding and
corroboration” (120).
This implies that the research stages from conceptualisation through to the
inference may be combined. Quantitative and qualitative research traditions are
not polar opposites of each other. Instead, elements of the two research
traditions could be integrated at different stages to yield valid inferences (121).
Mixed-methods research may also combine two data collection and analysis
techniques within the same research tradition, for example, combining two
qualitative or two quantitative methods. However, it is important that in mixed-
methods research, quantitative and qualitative perspectives are applied in
investigating the same research question, either for corroboration of findings
(triangulation) or using one method to complement findings of the other, in a
way that provides a more elaborate understanding of the research question
(120).
Researchers often disagree on the logic of combining qualitative and
quantitative methods. However, practical reasons usually warrant the
combination of the two methods in solving applied problems in health services
research (122). In the United Kingdom, the mixed-methods revolution of the mid
1990s helped to diminish the traditional dominance of quantitative methods in
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health services research. Researchers mostly combined surveys and interviews
to address complex issues of real world access to, and effectiveness of, health
care intervention programmes (123,124). In mixed-methods research design,
qualitative textual data illuminate and add meaning to numerical inferences and
predictions based on statistical analyses of quantitative data. Individual
strengths of qualitative and quantitative methods are harnessed to overcome
the limitations of either method. Consequently, stronger conclusions are drawn
through convergence and corroboration of findings. These advantages come at
the price of increased research workload which is often more expensive and
time consuming. In addition, there are still grey areas that weaken mixed
method research, for example, how to qualitatively analyse quantitative data or
how to interpret conflicting results. Yet the practical reasons for mixing
quantitative and qualitative research methods cannot be overlooked (88).
Therefore, the philosophical reasoning behind mixed-methods approaches
needs to be understood.
2.5.1 Pragmatism the philosophical basis of mixed-methods research
Aspects of mixed-methods research arise from different dimensions in the
research process, and either the quantitative or qualitative approach would take
priority depending on the reasons for combining them (125). Consequently,
mixed-methods research is not committed to any one philosophy, because one
philosophy cannot fit all. Instead, mixed-methods research adopts a more
pragmatic perspective.
Pragmatism is a middle-ground philosophy which is more concerned with the
application of research strategies in problem-solving than debates about such
abstract concepts as the ‘truth’. In this case ‘truth’ is what works (86,126). With
this approach, researchers focus on the research problem and use all available
strategies to address the issues, rather than emphasise the methods (127). The
task of finding answers to research questions takes prominence over
philosophical arguments, and it is research questions that drive the methods of
knowledge acquisition (121).
Health services research questions are complex in the sense that they are
investigations of the multiple dimensions of human interactions. The
interdisciplinary nature of health services research also adds complexity to the
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diverse philosophical backgrounds of researchers in this field. Moreover,
patients are perceived not only in terms of malfunctioning biological systems but
also as people attempting to make sense and cope with their health care issues
(81). One approach to addressing research questions in health adopts the
quantitative perspective. This approach objectively identifies variables (cause)
to be manipulated in disease to obtain cure (effect). A second approach adopts
a qualitative or interpretive strategy to gain insight into the subjective
experiences of patients. In the process, researchers interpret, from the patients’
perspectives, the meaning of their health condition, and subsequent therapeutic
actions. These two approaches are both valid and this underscores the
pragmatic philosophy of mixed-methods research. The logic of enquiry in
pragmatism combines induction to discover patterns, deduction to test theories
and abduction for identifying the best explanation that helps to achieve
understanding of the research results (88).
2.5.2 Strategies for mixing research methods
At this point it is useful to make a distinction between methods in mixed-
methods as a distinct research design (methodology), and the specific
techniques (methods) of data gathering and analysing data. Mixed-method
refers to the overall design in much the same way as quantitative or qualitative
research is a design. Along with multiple definitions of mixed-methods research,
around forty types of mixed strategies have been described in the literature
(121). Many of these variations do not add clarity to the plans and actions of
researchers (86), instead they emphasise abstract theoretical possibilities (125).
Researchers may design project-specific types of mixed methods depending on
their particular circumstances (88).
Three general strategies, with several variations are available for combining
quantitative and qualitative research methods: transformative mixed-methods
strategies, concurrent mixed-methods and sequential, mixed-methods (86). A
detailed discussion of these strategies is beyond the scope of this thesis.
However, the sequential mixed-methods approach which was the strategy
adopted in this project will be described briefly. Sequential mixed-methods
strategy applies one method to elaborate or expand on the findings from a
previous one. The design could be exploratory, where qualitative methods are
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used to explore an unknown topic, followed by a quantitative phase to build on
the findings of the qualitative phase. On the other hand, a sequential
explanatory design begins with a quantitative phase followed by a qualitative
phase (86). This was the approach used in the current project and will be
described in the next section. The description will cover main features of the
strategy along with its strengths and limitations.
2.5.3 Sequential mixed-methods strategy
The sequential strategy began with an initial quantitative phase, the results of
which informed qualitative data collection and analysis in a subsequent phase.
This strategy is straight-forward and easy to implement with clear distinct steps
in each phase. However, conducting each of the two phases in sequence
prolongs the data collection and analysis process (86,128). In this doctoral
research, a quantitative survey was first conducted to identify and quantify the
factors associated with the implementation of prescribing by pharmacists in GB.
This was followed by qualitative interviews to elucidate the processes of
implementing prescribing by pharmacists. The rationale and justification for
choosing this approach are discussed in the next section before applying
individual quantitative and qualitative methods in subsequent chapters.
2.5.4 Criteria for selecting mixed-methods strategy
The use of mixed-method research designs in social or health services
enquiries have been well-documented in the literature (123,124); (128). The
research project reported in this thesis, investigated policy issues of pharmacist
prescribing in relation to the real world experiences of pharmacist prescribers
delivering the service in the National Health Service of Great Britain. In this
research, the process started with a quantitative, cross-sectional postal
questionnaire survey in Phase 1. The survey established baseline parameters
which described structures that supported prescribing implementation by
pharmacists. Additionally, the processes adopted by pharmacists in carrying out
their prescribing roles, and factors that facilitated or hindered pharmacists from
implementing prescribing, were highlighted through the survey.
The strengths or advantages of cross-sectional questionnaire surveys were
discussed in previous sections on quantitative research. The method was
considered logistically most appropriate in view of the wide geographical
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coverage of the study area (all GB). Also, external validity was particularly
important in the current study in order to promote translation of study findings
into practice. The cross-sectional questionnaire survey design was thought to
be most appropriate to maximise the chances of achieving this link between
research and practice, because pharmacist data would arise from real practice
scenarios of pharmacist prescribers such that any issues identified would
approximate the reality on the ground. Specific aspects of this method as
applied in the research project will be discussed in Chapter 3.
Factors associated with the implementation of prescribing by pharmacists,
identified from the quantitative phase, needed to be considered in terms of how
they fitted into every day activities of prescribing implementation. This informed
the design of in-depth qualitative interviews in Phase 2 after the quantitative
phase. The unique advantages of qualitative interviews in providing depth of
explanation of phenomena were discussed earlier in the section on qualitative
research. The telephone method of interviewing was deemed the most
appropriate approach for the particular questions addressed in this doctoral
research project, again because of the wide geographical distribution of
participants, which would have placed extensive demands on time and
resources if face-to-face interviews were to be used. Details of this method as
applied in phase two of the research project will be discussed in Chapter 4.
2.6 Chapter summary
In this chapter, the philosophical basis of quantitative research was discussed
with emphasis on how this philosophy influences experimental techniques used,
determine causal relationships. Non-experimental techniques that describe
relationships among variables were also considered under quantitative
research. Qualitative research philosophies and methods were also discussed,
with reference to how these lead to understanding and elaboration of the
contexts in which health services research is conducted. The apparent
inadequacy of either quantitative or qualitative research designs to sufficiently
address health services research questions were highlighted in the chapter.
Therefore, the pragmatic advantage of mixed-methods research as a strategy
for harnessing the individual strengths, and at the same time overcoming the
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individual weaknesses of both quantitative and qualitative research, were
presented.
The concluding part of the chapter outlined various criteria applied in the choice
of mixed-methods research, with emphasis on how these were applied in the
selection of cross-sectional questionnaire survey and in-depth telephone
interviews as the preferred methods for use in the current doctoral research
project. A detailed discussion of cross-sectional questionnaire survey method
follows in Chapter 3 where the method was applied in the first phase of the
project.
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Chapter Three cross sectional questionnaire survey
In the previous chapter the mixed methods approach was justified as the
preferred approach for the current project. This choice was based on the
pragmatic reason that applying both quantitative and qualitative methods in the
investigation of pharmacist prescribing in GB was likely to yield a more
complete explanation of the topic. This chapter presents the quantitative phase
of the project; it utilises a cross-sectional, postal questionnaire survey approach.
The research question, aims and objectives relevant for the quantitative phase
of the project are stated. Then follows a brief description of research
governance procedures, including the ethical permission sought and obtained.
The chapter then goes on to describe the details of questionnaire development,
data collection, statistical tests and procedures applied in data analysis. Finally
the quantitative results are presented and discussed.
3.1 Overview of research questions
The questions addressed in this phase of the research included:
A. What was the level of pharmacist prescribing implementation in
GB?
At the time of data collection in 2008/2009, supplementary prescribing by
pharmacists had been introduced in GB for five years, while experience with
independent prescribing was less than three years (41, 42, 44). In that period,
researchers had used mainly quantitative questionnaire surveys to identify key
issues post-implementation of pharmacist prescribing (49, 50); but many of the
studies were limited to small geographical areas of GB. In one national survey
of all pharmacist prescribers registered at the time, nearly half of those who
responded had started practising as prescribers (48). The number of
pharmacists qualified and registered as prescribers was established in the
workforce census (45). However, no published evidence of the extent or scope
of pharmacist prescribing activities implemented in GB was found. Therefore, it
was necessary to update the status and determine the level of prescribing
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activities undertaken by pharmacists, before proceeding with any further
studies.
B. What were the factors that promoted or inhibited the
implementation of prescribing by pharmacists?
The literature reviewed in chapter one had identified some challenges in the
early periods post implementation of SP/ IP in studies limited to small
geographical units of GB. It was therefore, necessary to examine and compare
factors that possibly influenced prescribing implementation across the whole of
GB.
C. What were the operating procedures pharmacists adopted in the
course of implementing prescribing?
The interest here was to identify how pharmacist prescribers were engaging in
the practice of consulting with, and prescribing for patients, specifically: how
they identified which patients they prescribed for; how they communicated with
other members of the health care team; and how they handled prescribing and
dispensing functions together, if they did.
3.2 Aims and objectives of the quantitative phase
The aim in this phase of the project was to determine the nature and extent of
prescribing activities undertaken by pharmacist prescribers in GB. The nature of
prescribing practice was described in terms of the specific activities (processes)
adopted by pharmacists in delivering prescribing services. The extent of
prescribing practice was measured in terms of the amount of prescribing
activities undertaken by pharmacists. This involved an investigation of the
structures comprising the total environment of pharmacist prescribing services.
The specific objectives in this phase of the project were:
1. To describe the demographic characteristics of pharmacist prescribers
as the basis for determining the extent of prescribing activities of
pharmacists.
2. To identify barriers and facilitators to the practice of pharmacists as
prescribers.
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3. To examine the relationship between facilitators/barriers and
demographic characteristics of pharmacists engaged in actual
prescribing practice.
4. To describe the processes adopted by pharmacist prescribers in
delivering prescribing services.
3.3 Methods
This section will outline the specific techniques and procedures applied in the
collection and analysis of quantitative data in order to fulfil the objectives stated
above.
3.3.1 Research governance and study approval
The research was conducted in accordance with the ethics and research
governance policies of Robert Gordon University (129). The research student
project ethical review (RSPER) form (appendix 1) was completed prior to the
commencement of the doctoral research. This was reviewed and approved by
the ethical review panel of the School of Pharmacy & Life Sciences. Project
participants were to complete structured questionnaires, and the research
governance priority was to minimise any possible data protection issues to
participants whilst responding to the questionnaire. Great effort was put into
checking the questions to ensure that the wording did not cause distress
(physical or psychological) to participants.
Project information (appendix 2) was made available to prospective participants,
and this explained details of the study objectives and potential benefits, so that
respondents knew enough before giving consent to participate. It was explained
that no direct financial benefits were accruable to participants, but the overall
benefits of the research to the development of pharmacist prescribing practice
were highlighted. The demand on the time of participants, and efforts they had
to commit in completing questionnaires was considered a likely source of
inconvenience. The researcher applied caution to minimise this inconvenience
for participants. In addition, participants were assured of absolute confidentiality
of information they provided, which was achieved by keeping the questionnaires
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anonymous. Although the list of names and addresses of pharmacist
prescribers registered with the RPSGB (now the General Pharmaceutical
Council) was used as the sampling frame, it was not possible to link returned
questionnaires to individual participants. Moreover, records of research
participants and questionnaire responses, including transcripts from them, were
anonymised and secured in locked cabinets. Electronic versions were stored in
password-protected computer files accessed only by the research student and
supervisory team. All research data was managed and stored in strict
compliance with the Data Protection Act 1998 (130). The records and
accompanying data will be destroyed after all dissemination of research findings
in publications at the end of the project.
The North of Scotland Research Ethics Committee (NoSREC) was approached
to review and give advice on the ethical issues raised in the research protocol.
NoSREC after due consideration advised that a full ethical application was not
necessary (appendix 3). This advice was based on the proposal that pharmacist
prescribers were to complete the questionnaires anonymously. Furthermore,
NHS employed pharmacist prescribers were not going to be involved beyond
completing demographic questions on the questionnaire. The plan at that time
was to use the demographic questions to sample only prescribers based in
primary care (community pharmacies and general medical practices). However,
as the project evolved, it became necessary to recruit NHS pharmacists (in
hospitals and other settings) for the interview stage in phase two. These
changes, and the research governance issues raised, are explained further in
Chapter 4.
3.3.2 Recruitment of participants
The overarching objective of this project was to characterise pharmacist
prescribing activities in the primary care setting (general medical practice and
community pharmacies) of Great Britain. This group of pharmacist prescribers
was the target population of interest for the study. The sampling frame was the
list of all pharmacist prescribers held by the (RPSGB). However, it was not
possible to specifically recruit only pharmacist prescribers based in primary
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care, because the sampling frame did not distinguish the practice setting of
individuals. Consequently, all registered prescribers on the RPSGB list were
sent questionnaires, and then screening questions were used to identify the
sample of interest. This approach has been adopted by many pharmacy
practice researchers in similar situations (91).
3.3.3 Questionnaire development
Questionnaire development took into account the research aims and the study
population, paying attention to themes from the literature, which had relevance
in this project. Questionnaires used in previous studies by George et al were
studied (48, 58, 60), and questions related to prescribing practices of
pharmacists and demographics were adapted. Drafts of the questionnaire were
written, modified and then circulated among the supervisors of the research
project. The supervisory team consisted of four academics with extensive
experience in pharmacy practice research. They were also among the pioneers
of pharmacist prescribing research in GB. The research team met repeatedly to
review questionnaire drafts. Questions that appeared ambiguous, complex or
potentially contentious were discussed and resolved during team meetings, to
yield a first working version of the questionnaire for piloting testing (appendix 4).
The first version (appendix 4) was a booklet eight pages long with twenty nine
questions numbered sequentially. The booklet incorporated two pages of
project information to participants. The main questionnaire was divided into five
sections: Section A had six questions covering two pages, on pharmacist
prescribers’ demographic characteristics. This section was placed at the
beginning of the questionnaire contrary to suggestions in the literature (91, 92),
so that screening questions could be used to identify the required sample.
Section B had five questions on the prescribing practice of the respondents at
the time of completion. Section C had eight questions on any changes that may
have occurred in the prescribing practice of respondents from when they first
registered as prescribers. Section D was about factors that possibly influenced
implementation of prescribing by pharmacists, and had four questions including,
one with 16 attitudinal items on a five point Likert scale. Section E comprised
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five questions related to the future of pharmacist prescribing in GB. The
principle that guided questionnaire development was ensuring validity and
reliability as discussed in Chapter 2. This was ensured following review by the
research team and pilot of the developed questionnaire.
3.4 Pilot survey
The pilot survey was conducted between January and March 2009. The primary
aim of the pilot survey was to test all aspects of the draft questionnaire
including: the physical appearance of the questionnaire, question sequence,
simplicity or difficulty of questions, internal consistency of attitudinal items, and
the statistical procedures to be used in the main study. Importantly, the pilot
survey aimed to identify any issues that respondents might raise. In addition,
the response of participants to an invitation for participation in the second phase
of the research was tested.
3.4.1 Pilot sample
In deciding on the pilot sample, consideration was given to the fact that the
population of pharmacist prescribers registered at the time (a little above1700),
also included those based in hospitals and PCTs or Health Boards. It was
therefore important to choose a sample size that was optimal, neither too big
nor too small. A sample that was too big would have depleted the final study
population, but at the same time the pilot sample needed to be big enough to
identify possible problems with the questionnaire. With due regard to Bowling
who suggested a sample size of 30-50 when piloting previously untested
questions and scale (80), the researcher decided to pilot the questionnaire on a
sample size of 50 pharmacist prescribers. The pilot sample was randomly
chosen using a random number generator applied to the sampling frame. The
random sampling procedure (described in chapter two) was adopted in the pilot
survey so that every prescriber listed on the sampling frame had an equal
chance of being recruited. This way, any issues raised by the pilot sample
regarding the questionnaire should be valid for the general population of
pharmacist prescribers (91, 92).
Chapter 3- Cross-sectional questionnaire survey
65
3.4.2 Collection of pilot data
Questionnaires were posted to the pilot sample in January of 2009. Enclosed
with each questionnaire was a reply card (appendix 8), inviting participants for
the second phase of the research. Interested participants were asked to
complete the reply card with details of their telephone and email contacts. Also
enclosed were a participants’ information letter and two prepaid, addressed
reply envelopes. The two envelopes served as additional guarantee of
anonymity so that participants could return completed questionnaires and reply
cards separately. This ensured that reply cards which contained identifying
information of respondents could not be directly linked to any particular
completed questionnaire. The pilot sample was asked to return completed
questionnaires on or before two weeks from the date of receipt.
3.4.3 Pilot results
The response from the pilot sample was 24% (n=12/50) after a single mailing.
Preliminary analysis of responses revealed that respondents found the
questions sufficiently easy to answer, with few questions left blank. The
attitudinal scale of items that measured factors influencing prescribing practice
had a Chronbach’s alpha value (α) of 0.72 for internal consistency. In addition,
respondents gave valuable comments in open questions about developments in
their individual prescribing practices. Notwithstanding, the pilot survey identified
the need to review aspects of the questionnaire before using it in the main
survey.
3.4.4 Modifications based on pilot results
It was considered that a questionnaire of eight pages was probably too long,
and that this may have contributed to the low response in the pilot survey (92).
The next stage of questionnaire development therefore, attempted to make the
instrument shorter. First the information sheet was removed from the
questionnaire and made into a separate document. A careful scrutiny of the
responses showed that some questions were redundant, and did not generate
useful data; for example, question five in appendix 4 was a complex table about
respondents’ SP/IP practice at the time. It was observed that questions in this
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table could be modified and merged to section B of the questionnaire to
generate the same information more efficiently. Some questions were removed
and others re-worded or had the order changed to simplify. The 16 item
attitudinal scale generated a lot of interest among the pilot sample. Therefore, in
the final version of the questionnaire (appendix 5), the attitudinal scale was
brought to section A, following recommendations in the literature for interesting
items to appear at the beginning of questionnaires (80, 91, 92). The documents
accompanying the questionnaire were also slightly modified before the final
survey. The two pages of participant’s information were simplified down to one
page (appendix 6). This was accompanied by an A4 sized poster, which
highlighted key information about the research aims, and instructions for
returning completed questionnaires (appendix 7). The poster was designed to
catch the attention of participants who may be reluctant to read the detailed
project information sheet. The reply card (appendix 8) inviting respondents to
indicate interest in the second phase was reduced in size. In addition, the card
now included contact details of the research student for respondents that may
want to clarify any issues.
3.4.5 Re-test of modified questionnaire
The modified questionnaire was re-tested in the same pilot sample as the first.
Using the same pilot sample was necessary for two reasons: first the small
number of prospective participants on the sampling frame would have been
depleted further had a new pilot sample been drawn from it; secondly,
administering the modified version of the questionnaire on the same sample
provided an opportunity to assess the potential impact of sending reminders in
the main survey. All 50 of the pilot sample were sent the modified version of the
questionnaire. Anonymity of the questionnaire, however, meant that it was not
possible to identify and exclude pharmacist prescribers that had already
responded to the first pilot questionnaires. This was to impact also on the main
data collection, as all pharmacist prescribers in the sampling frame had to be
sent reminder questionnaires. Two weeks after posting the modified
questionnaire, response was also 24% (12/50). The questions and
accompanying responses were much clearer and easier to process than the
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first version. Therefore, no further adjustments in the questionnaire were
deemed necessary, except for selection of paper type and print colour.
The final version of the questionnaire (appendix 5) was four pages long, and
contained both closed and open-ended questions. Again there were five
sections. Section A had six items, including the 16 item attitudinal questions.
Section B had nine questions dealing with the issues involved in the day to day
prescribing practice of respondents. Section C had seven questions on changes
in respondents’ prescribing practice. Section D had five items about the future
of prescribing; while section E collected demographic data. With the
questionnaire developed and tested, the next task was to apply the instrument
in the main survey as described below.
3.4.6 Main data collection
The final questionnaire and accompanying documents were mailed to all
prescribers (excluding the pilot sample) on the register of the RPSGB (n=1,653)
in April 2009. Respondents were asked to complete and return questionnaires
within two weeks of receipt. Reminders were posted out to all pharmacist
prescribers four weeks after the first set of questionnaires were posted. The
reminder contained the same documents as the original posting except that the
reminder information sheet (appendix 6) explained that to maintain anonymity it
was not possible to identify and exclude those who had already responded;
hence they were getting the questionnaires again. Those that had responded
were asked to ignore the reminder questionnaire, with apologies for any
inconvenience.
Pharmacist prescribers that that had not yet responded to the initial
questionnaire were invited to do so. A second reminder, similar in every way to
the first, was sent eight weeks after the first posting. Whilst this approached was
intended to improve the response rate, there was no way to guarantee that
pharmacist prescribers only responded once. An electronic survey would have
provided the assurance that respondents only reply to the questionnaire once.
However, this method of questionnaire delivery is also fraught with limitations
such as selective response by participants who have access to the internet and
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are able to use it. These kinds of limitations have resulted in sampling errors in
electronic surveys (131).
3.5 Data Analysis
Data from completed and returned questionnaires were coded into the statistical
package for the social sciences (SPSS® version 15) for data management and
analysis. Data coding and entry into SPSS® for analysis was checked
independently by a member of the project supervisory team, in 50 completed
questionnaires selected randomly. The data was then analysed using
appropriate statistical techniques aimed at meeting specific research objectives,
as described below.
3.5.1 Descriptive analysis of participant characteristics
Descriptive statistics for sample distribution of variables were conducted.
Simple frequency distribution was used to describe respondents according to
whether or not they had engaged in actual prescribing practice. Similarly,
univariate analysis of the sample distribution of demographic characteristics of
respondents was carried out to provide an overview and background of the
status of prescribing implementation by pharmacists in GB. Furthermore, chi-
square (X2) was applied to categorical variables, to test for association (if any)
for example, between demographic characteristics of respondents, such as
practice setting as a pharmacist, and their actual engagement in prescribing
practice. These statistical tests were applied pursuant to the realisation of
objective one.
3.5.2 Factor analysis of attitudinal statements related to prescribing
Prior to conducting factor analysis, the suitability of the data for factor analysis
was assessed in terms of adequacy of the sample size, and the strength of
inter-correlation among the 16 items on the scale (132). This was achieved by
performing Chronbach’s alpha coefficient test for internal consistency, KMO test
of sampling adequacy and Bartlett’s test of sphericity.
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3.5.2.1 Internal consistency of the attitudinal scale
The sixteen items on the attitudinal scale were analysed to identify facilitators
and barriers of pharmacist prescribing implementation. First the internal
consistency of the scale was tested using Chronbach’s alpha coefficient test
(described in relation to the reliability of surveys in chapter two, section 2.4.2).
Chronbach’s alpha coefficient of internal consistency gives an indication of the
extent to which the 16 items are measuring aspects of the same underlying
construct (133). The underlying construct in the current project represents
factors associated with the prescribing practice of pharmacists. A good internal
consistency means that individual items on the scale were collectively
measuring the same thing (factors associated with prescribing). A poor internal
consistency on the other hand would have meant that the scale was not a
reliable measure of factors associated with prescribing, and hence there would
have been no basis for continuing with factor analysis.
3.5.2.2 KMO measure for sampling adequacy and Bartlett’s test of
shpericity
There is some considerable debate among statisticians about the sample size
requirement for factor analysis. On one hand, some statisticians argue that the
absolute size of the sample determines the suitability of data for factor analysis.
On the other hand, others argue that the ratio of sample size to the number of
items intended for factor analysis, and not absolute sample size is important.
The general recommendation is for the number of participants to be more than
300, before data can be suitable for factor analysis. Alternatively, a minimum
ratio of five to ten participants is recommended per item to be factor analysed
up to a total sample size of 300; beyond this, the ratio does not matter (134).
The current project had a sample size of 695, and a sample to items ratio
greater than 43: 1 (695:16), which satisfied both requirements for factor
analysis. In addition to this abstract inspection of sample size, two statistical
tests: Bartlett’s test of sphericity and the Kaiser-Meyer-Olkin measure of
sampling adequacy (KMO) were applied to examine the strength of the
relationship among the 16 statements on the attitudinal scale as a means of
assessing suitability of the data for factor analysis (135).
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Bartlett’s test checks that there is some relationship between variables as a pre-
condition for the suitability of factor analysis. The technique tests the null
hypothesis that the correlation matrix is an identity matrix (where the correlation
coefficient of all items would be zero). It is expected that for the data to be
suitable for factor analysis, the test should be significant (p< 0.05) confirming
that there is a relationship between the variables to be included in the analysis,
and the correlation matrix is not an identity matrix (134). The principle of the
KMO measure of sampling adequacy is that if two variables share common
factors, then partial correlation between them should be small when the effects
of other variables are controlled (135). KMO values range between 0 and 1,
with the barest acceptable minimum being 0.50, and the closer the KMO value
is to 1 the more suitable the data is for factor analysis (136). These statistical
procedures were used to confirm suitability of the data for factor analysis.
Next, factor analysis was used to reduce the sixteen items on the scale to a
smaller sub set of components (132). These components combine individual
items on the scale into groups that measure the same underlying dimension(s)
or construct(s) that explain the maximum amount of common variance in the
data. In other words, factor analysis reduces data into the underlying
components by grouping variables which correlate highly with each other, but
have very little if any, correlation with the other variables in the data (134).
3.5.2.3 Extraction of components (factors) from the 16 attitudinal
statements related to the implementation of prescribing
Whereas the objective of conducting factor analysis was to reduce the 16
attitudinal statements down to a small number of underlying components, the
number of such underlying components could not be determined from the
outset. Deciding on the number of components to extract, relied on both the
Kaiser criterion (which recommends retaining those components with
eigenvalues of 1 and above), and Cattel’s scree plot which plots a graph of
eigenvalues against extracted components, and recommends retaining only the
components above the point of inflexion on the graph (132).
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Components represent the linear relationship among the items on the attitudinal
scale derived by calculating the eigenvalues of the correlation matrix of the
scale. The eigenvalues in turn determine the relative contribution of a
component in explaining as much of the variance in the data as possible. The
bigger the eigenvalue the more important the component; and that is the logic
behind the Kaiser recommendation of retaining any component with eigenvalue
of 1 and above (134). Alternatively, the scree plot is a graphical representation
of eigenvalues plotted on the Y-axis, against corresponding components plotted
on the X-axis. The resultant curve has the first few components with high
eigenvalues at the top left end of the graph. The slope of the graph drops
sharply, after which the curve tapers into an almost horizontal line where the
rest of the components with low eigenvalues spread across the X-axis. The last
eigenvalue with a sharp drop in slope before the curve becomes horizontal is
considered the cut-off point. Cattell, who first described this method of selecting
components, recommended the retention of only those above the cut off point
(134). Data in this research was examined using both the Kaiser criterion and a
visual inspection of the Scree plot, before deciding on the number of
components to retain in the final analysis.
3.5.2.4 Interpretation of components
Having decided on the number of components to extract from the attitudinal
scale, the next task was to interpret extracted components in a way that made
sense in realisation of the research objectives. The process of interpretation
was facilitated by factor rotation. This procedure ensures that each item on the
scale loads maximally on just one component. Two types of rotation,
orthogonal and oblique, are commonly used. Specific orthogonal methods of
rotation are: varimax, quartimax or equamax, depending on how they spread
the factor loading for each variable on the extracted components. Oblique
rotation methods, on the other hand, are direct oblimin and promax. Orthogonal
rotations are mostly preferred because they give rise to components that are
not correlated to each other, which are easier to interpret (134). A detailed
discussion of the two rotation techniques is beyond the scope of this thesis; but
it should suffice to mention that orthogonal (varimax) rotation was applied in the
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current project. Responses to the 16 attitudinal statements were re-analysed
specifying the number of components to be extracted, and performing
orthogonal (varimax) rotation on the extracted components. The statements
loaded under each rotated component were examined for common themes for
the purpose of interpreting and labelling the components.
Having reduced the 16 items of attitudinal statements into components, each
component was treated as a sub scale. First the eigenvalue for each
component was reported, along with the percentage of variance in the data that
was explained by the component singly, and in combination with other
components. Finally, the reliability of the components as subscales were
individually calculated using the same procedure as described for the whole
scale. Total scores for each component extracted were calculated by summing
the scores for the individual items loaded on that particular component. Each
item was scored on a five point Likert scale; with a score of 1 indicating strong
disagreement up to a score of 5 indicating strong agreement (scores of
negatively worded statements were reversed). Therefore, a component that had
seven of the sixteen items loaded onto it, for example, could have a minimum
total score of 7 (1x7) and a maximum total score of 35 (5x7). The total scores
for each component were calculated for all respondents that had written
prescriptions, and saved as variables for further analysis. It should be borne in
mind therefore, that all statistical tests on the components that are described
hereafter, will use the total scores for these components.
3.5.3 Exploring the relationship between prescriber demographics and
extracted components
As a means of realising objective 4, non parametric statistical tests were
performed on extracted components; to find out whether respondents’ scores
differed according to demographic characteristics. Non parametric tests were
particularly suitable because the predictor variables (demographic
characteristics) were categorical measures. Also, the distribution of
respondents’ scores on the predictor variables did not obey normality patterns
to otherwise permit the use of powerful parametric tests (134). Kruskal-Wallis
(K-W) test was used for the comparison of predictor variables that had more
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than two groups (age, length of practice experience as pharmacists and main
pharmacy practice setting) (132). However, Man-Whitney U test was used to
compare the total score of respondents for extracted components based on sex
as a predictor variable, because sex has only two categories (134).
Any differences observed with K-W tests were followed up with post hoc
procedures to determine which of the predictor variables were different from the
others. For this purpose Mann – Whitney U test was used to compare pairs of
demographic characteristics that were significant. Bonferonni adjustment was
applied to correct for type one error; this involved dividing the standard
significant level of 0.05 by the number of tests performed (134). Details are
provided where K-W results are significant.
3.5.4 Analysis of open questionnaire comments
The questionnaires sought additional information from respondents in the form
of open-ended questions. Texts of their responses to the open questions were
extracted and transcribed verbatim. Transcripts for analysis were managed
using NVivo® software version 8. The framework approach to qualitative data
analysis was used to develop a list of coding categories for the data. This
involved extensive reading of transcripts to gain insight into respondents’
comments, while noting dominant and frequent themes that emerged from the
transcripts. (101). The categories devised from reading the transcripts were
used to code the open comments of respondents in SPSS®. Coded data were
grouped into themes for further analysis by simple counting of comments in
each theme, complemented by in-depth description of the themes.
3.5.5 Analysis of prescribing implementation in primary care setting
The prescribing practice of respondents based in general medical practices and
community pharmacies (primary care), who had also prescribed was explored
further. This used descriptive statistics to describe the processes adopted by
respondents engaged in prescribing, such as how they identified the patients
they prescribed for, their communication with other health professionals, the
dispensing of prescriptions they wrote and the changes that had occurred in
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their prescribing practice since initial registration as prescribers. These
parameters were used to describe the nature of prescribing activities of
pharmacists in line with objective five.
3.6 Results
This section presents results of the quantitative cross-sectional questionnaire
survey.
3.6.1 Response rate
Of 1,653 questionnaires posted to pharmacist prescribers in the sampling
frame, four were returned blank and six were undelivered. Therefore, these ten
were excluded from the study population. From the first batch of 1,643
questionnaires posted, 406 were completed and returned. This number
increased by 169, and a further 120 following the first and second reminder
respectively to give an overall response rate of 42.3% (n=695/1643).
3.6.2 Characteristics of respondents
Table 3.1 summarises the demographic characteristics of respondents. The
majority (71.7%, n=498) were female and almost all (95.5%, n=657) were aged
between 30 and 59 years. Nearly half of all respondents (44.2%, n=307) had
more than 20 years experience of practice as pharmacists. Pharmacy practice
settings were mostly hospital (43.5%, n=300) with a minority (19.7%, n=137) in
community pharmacies.
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Table 3.1 Demographic characteristics of respondents (n=695)
Demographic Characteristic Number of Respondents %
Age in years
<29 22 3.2
30-39 251 36.1
40-49 242 34.5
50-59 164 23.6
>60 9 1.3
Missing data 7 1.0
Sex
Female 498 71.7
Male 189 27.2
Missing data 5 1.2
Main practice setting as a pharmacist
Hospital 300 43.2
General medical practice 196 28.2
Community pharmacy 137 19.7
Other practice settings * 57 8.2
Missing data 5 0.7
Years of experience as a pharmacist
<6 11 1.6
6-10 112 16.1
11-15 131 18.8
16-20 129 18.6
>20 307 44.2
Missing data 5 0.7
*Other practice settings included: academia, split working in community pharmacy and general
medical practices, intermediate care nursing homes, health boards and primary care trusts,
prison, substance misuse service centres and out of hour service centres.
3.6.3 Pharmacist prescribers not yet prescribing
Nearly one third of all respondents (31.9%, n= 222/695) were yet to prescribe.
The largest proportion of respondents yet to prescribe (41.2%, n= 56/136) were
based in community pharmacies with the smallest proportion (25.7%, n=
49/195) based in GP practices. Of the 222 pharmacist prescribers that had not
prescribed, a majority of them (75.7%, n= 168) described in open comments,
barriers they had encountered to using their qualification and skills for managing
patients. These were categorised into themes of: lack of opportunity,
administrative procedures, resources issues and lack of defined prescribing
roles. Table 3.2 presents a summary of these findings.
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Table 3.2 Themes describing reasons why qualified pharmacist prescribers were not prescribing
Themes Description of theme Illustrative quotes
Lack of opportunity
(59 comments)
Majority of pharmacists who cited lack of
opportunity as their reason for not prescribing
did not explain this further. A few related lack of
opportunities to change in jobs or roles.
“In reality no prescribing role for me before, during or after completing the SP course.”
(Female, hospital pharmacist, 11-15 years as a pharmacist, not prescribing)
“No opportunities to use my skills despite several discussions with …, doctors and primary
care trusts [PCTs]”
(Female, community pharmacist, over 20 years as a pharmacist, not prescribing)
Administrative
procedures
(38 comments)
Administrative procedures that hindered the
implementation of prescribing by pharmacists
were mainly aspects of clinical governance and
the legal framework for the operation of
pharmacist prescribers in hospital settings.
Within primary care, however, the administrative
workload of many respondents increased to the
detriment of patient-focused clinical duties
including prescribing.
“… My chief pharmacist persists in raising obstacles and objections including... staffing,
backfills and clinical governance issues which have so far prevented me from prescribing.”
(Male hospital pharmacist, more than 20 years as a pharmacist, not prescribing)
“Current workload and managerial role within NHS organisation has limited time available
to undertake clinical role …”
(Male Health Board pharmacist, 16-20 years as a pharmacist, not prescribing)
Lack of funding or
facilities
(29 comments)
Inadequate funds prevented commissioning of
prescribing clinics and also funding of staff
backfills to release pharmacists for prescribing
roles. In addition, implementing prescribing
added operational costs to pharmacist
prescribers without commensurate
remuneration. Other resource issues that
hindered prescribing were lack of clinic space,
prescription pads and information technology.
“My main deterrent factor is that there is no financial reward. Study in own time, extra
insurance costs and society's fees, more responsibilities and all for love yet we have
mortgages to pay. It is a demoralising situation”
(Female hospital pharmacist, 16-20 years as a pharmacist, not prescribing)
“Since qualifying as SP, I have tried to get funding from the local PCT to provide asthma
management services as an enhanced service from the community pharmacy that is
situated within the health centre; but lack of funding has been the major barrier in setting
up the service”.
(Female community pharmacist, less than 6 years as a pharmacist, not prescribing)
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Table 3.2 cont’d Themes describing reasons why qualified pharmacist prescribers were not prescribing
Themes Description of theme Illustrative quotes
Lack of defined roles
(14 comments)
Respondents who mentioned lack of
defined prescribing roles often stated
that they had to invent such roles
themselves. In some instances they
highlighted the absence of standard
operating procedures detailing roles for
prescribing.
“Moved from primary care to community pharmacy where I have been unable to
develop relevant role.”
(Male community pharmacist, over 20 years as a pharmacist, not prescribing)
Other reasons (28
Comments)
The other reasons that hindered the
implementation of prescribing by
pharmacists were mostly personal such
as maternity leave for some female
respondents. Also some had taken
career breaks, and others had retired.
“I was on maternity leave soon after qualifying and thereafter there were no jobs
around. I now work in community from12 to 6 which fits very well into my family
life. I therefore, stopped looking for prescriber’s job at the time being.”
(Female, community pharmacist, less than 6 years as a pharmacist, not
prescribing)
“I took a year off to travel after my prescribing course. On my return I wanted to
wait a few months to get up to speed before prescribing, unfortunately due to
staffing pressures and a drive in the department to pull us back to core services I
have not found time to complete CMPs. I have not yet had an opportunity to
upgrade to IP status which would solve this”.
(Female hospital pharmacist, 11-15years as a pharmacist, not prescribing)
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3.6.4 Comparison between prescribing and non- prescribing respondents
The characteristics of prescribing and non prescribing respondents were
compared to explore possible associations between demographics and whether
or not a respondent prescribed. Results are summarised in Table 3.3. Male
respondents were more likely to have prescribed compared to their female
counterparts. Also, the proportion of respondents who prescribed rose with
increase in age and longer duration of practice as a pharmacist. These
relationships did not reach statistical significance. However, the main pharmacy
practice setting of respondents was significantly associated with whether or not
they prescribed. Respondents based in general medical practices and hospitals
were more likely to have prescribed than those in community pharmacies; X2 (3,
n= 688) = 12.10, p< 0.05, Cramer’s V was 0.13 indicating a small effect size
according to Cohen’s recommendation that an effect size of 0.01 be regarded
as small, while .3 and .5 be regarded as medium and large effects respectively
(137). Conversely, barriers that prevented qualified pharmacist prescribers from
prescribing, affected those based in the community setting more than
pharmacist prescribers in hospitals or general medical practices.
Notwithstanding, a majority of respondents had prescribed and results of
analysis of their responses will be described next.
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Table 3.3 Comparison of prescribing and non prescribing respondents
Characteristic prescribing not prescribing
Main practice setting as a pharmacist N= 688 (non response =7) X2 = 12.10*, p-value = 0.007 N % N %
General medical practice 146 74.9 49 25.1
Hospital 211 70.3 89 29.7
Community pharmacy 80 58.8 56 41.2
Other practice settings 34 59.6 23 40.4
Age in years N= 686 (non response =9) X 2 = 7.21, p-value 0.206
<29 13 59.1 9 40.9
30-39 159 63.6 91 36.4
40-49 172 71.1 70 28.9
50-59 117 71.8 46 28.2
>60 8 88.9 1 11.1
Sex N=685 (non response =10) X 2 = 2.34, p-value 0.125
Male 138 73.0 51 27.0
Female 332 66.9 164 33.1
Experience as a pharmacists in years N= 688 (non response =7) X 2 =5.9, p-value 0 .206
<6 6 54.5 5 45.5
6-10 68 60.7 44 39.3
11-15 88 67.7 42 32.3
16-20 88 68.8 40 31.2
>20 221 72.0 86 28.0
* X 2 significant at p < 0.05, N = number of respondents
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3.7 Pharmacist prescribers that had prescribed
The majority of respondents (68.1%, n=473) had written prescriptions, mainly in
hospital (43.1%, n=204) and general medical practice settings (42.1%, n=199).
Further exploration of prescribing pharmacists (n= 473) identified a significant
difference between the setting of respondents as prescribers and their main
work setting as pharmacists. Only a minority of pharmacists (n= 38, 7.9%) were
prescribing in community pharmacies. Table 3.4 provides details of the
relationship between the main pharmacy practice setting of respondents and
where their prescribing practices were located. Nearly all respondents who
worked in hospitals and general medical practices engaged in prescribing within
the same settings. In contrast, those based in community pharmacies
implemented prescribing outside their main pharmacy practice setting, with half
prescribing in general medical practices (Table 3.4).
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Table 3.4 Relationship between main work setting of respondents as pharmacists and location of their prescribing practice
Prescribing setting
Community pharmacy General medical practice Hospital Other prescribing settings
Number
prescribing
% Number
prescribing
% Number
prescribing
% Number
prescribing
%
Practice setting
Community pharmacy 36 45.0 40 50.0 1 1.3 3 3.8
General medical practice 1 0.7 146 98.6 1 0.7 0 0.0
Hospital 0 0.0 4 1.9 208 96.7 3 1.4
other practice settings 1 2.9 11 31.4 1 2.9 22 62.9
Total 38 7.9 201 42.1 211 44.1 28 5.9
The percentages of respondents who prescribed in the same location as their main pharmacy practice setting are indicated in red.
Note: Practice setting is where respondents worked primarily as pharmacists. They may prescribe as part of that job, or be employed for prescribing in a different
sector described as their prescribing practice.
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Apart from practice setting, the other factors associated with the implementation
of prescribing by pharmacists were explored, using an attitudinal scale of
statements related to the practice of prescribing. Results from the analysis of
these statements are presented in the sections following.
3.7.1 Factors associated with the practice of prescribing by pharmacists
Pharmacist prescribers indicated agreement or disagreement with 16 attitudinal
statements as shown in Table 3.5. Highest levels of agreement were recorded
for statements related to respondents’ access to information technology, and to
patients’ medical records. Similarly, respondents indicated high agreement for
the adequacy of communication between them and doctors and they were
mostly satisfied with their prescribing role. In contrast, the highest disagreement
was in relation to adequate remuneration for prescribing. The agreement or
disagreement of respondents with individual attitudinal statements did not follow
any clear pattern, and hence was not easy to interpret. Therefore, it was
necessary to carry out exploratory factor analysis to reduce the 16 statements
down to a manageable number of variables representing the factors associated
with pharmacists’ prescribing practice (134).
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Table 3.5 Responses (%) to attitudinal statements relating to prescribing practice by pharmacists that prescribed (n=473)
Statements
Strongly
Agree Agree Unsure Disagree
Strongly
Disagree
Missing
data
I have adequate administrative support for my prescribing practice 14.4 44.6 11.6 21.6 5.7 2.1
I am remunerated appropriately for my prescribing practice 4.4 30.2 13.7 28.8 20.3 2.5
My access to information technology is adequate for my prescribing practice 29.0 56.7 3.0 5.9 3.0 2.5
I have sufficient access to patients’ medical records for my prescribing practice 56.2 33.0 1.7 6.1 1.1 1.9
Independent prescribing will/does facilitate my prescribing practice 43.3 39.7 7.8 5.1 0.6 3.4
I have inadequate peer support for my prescribing practice 9.5 29.0 12.5 37.8 9.5 1.7
My other health professional colleagues do not fully support my prescribing practice 2.3 9.5 8.7 57.3 19.7 2.5
I have adequate communication with doctors in relation to my prescribing practice 35.9 52.6 4.0 4.9 0.2 2.3
I have adequate communication with other pharmacist prescribers 11.2 41.0 13.5 27.1 4.4 2.7
My prescribing has had no impact on patients’ access to medicines 3.2 6.6 10.1 49.5 28.5 2.1
It would be convenient for patients to get medicines prescribed in a community pharmacy 14.2 43.8 25.4 9.5 3.6 3.6
My prescribing practice has had a positive clinical impact on patient care 36.6 50.3 8.7 1.9 0.6 1.9
My professional line manager has little awareness and understanding of non-medical prescribing 5.1 13.1 11.2 44.0 23.9 2.7
My professional line manager is supportive of my prescribing practice 26.0 52.6 11.0 5.3 2.3 2.3
My prescribing role has lived up to my expectations 16.3 50.1 17.8 12.1 2.1 1.7
I feel satisfied with my role as a prescriber 18.4 53.3 12.9 11.0 2.5 1.9
Highest level of agreement or disagreement with attitudinal statements indicated in bold
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Table 3.6 Responses (%) to attitudinal statements relating to prescribing practice by pharmacists that prescribed (n=473) grouped by their pharmacy
practice setting
CP= Community pharmacy, GP = General medical practice, Hosp = Hospital
*Indicate statistically significant differences in attitudinal statements based on pharmacy practice setting
Statements
%Strongly
Disagree/Disagree
CP GP HOSP
% Unsure
CP GP HOSP
% Strongly
Agree/Agree
CP GP HOSP
p-
value
I have adequate administrative support for my prescribing practice 21.5 22.1 34.4 11.4 11.0 13.2 67.1 66.9 52.4 NS
I am remunerated appropriately for my prescribing practice 51.3 49.0 52.1 20.5 15.9 17.1 28.2 65.2 36.2 NS
My access to information technology is adequate for my prescribing practice* 17.9 6.1 7.2 5.1 2.0 2.9 76.9 91.8 90.0 < 0.05
I have sufficient access to patients' medical records for my prescribing practice * 20.3 3.4 2.4 3.8 0.7 1.4 75.9 95.9 96.2 < 0.01
Independent prescribing will/does facilitate my prescribing practice * 11.8 5.5 4.8 15.8 4.8 6.2 72.4 89.7 89.0 < 0.01
I have adequate peer support for my prescribing practice 35.4 44.9 39.2 15.2 12.2 12.3 49.4 42.9 48.6 NS
My other health professional colleagues fully support my prescribing practice 21.5 11.0 10.0 8.9 9.7 9.5 69.6 79.3 80.6 NS
I have adequate communication with doctors in relation to my prescribing practice* 3.8 6.2 4.3 10.1 4.8 4.3 86.1 89.0 93.8 < 0.05
I have adequate communication with other pharmacist prescribers 39.2 32.9 29.3 10.1 17.1 12.5 50.6 50.0 58.2 NS
My prescribing has had an impact on patients' access to medicines 10.1 11.6 10.0 11.4 6.8 13.3 78.5 81.5 76.8 NS
It would be convenient for patients to get medicines prescribed in a community pharmacy* 1.3 15.2 18.0 7.6 31.0 31.6 91.1 53.8 50.5 < 0.01
My prescribing practice has had a positive clinical impact on patient care* 0.0 3.4 4.3 16.5 6.1 9.5 83.5 90.5 86.3 < 0.05
My professional line manager has full awareness and understanding of non-medical prescribing* 22.4 12.3 21.2 21.1 8.9 9.4 56.6 78.8 69.3 < 0.05
My professional line manager is supportive of my prescribing practice 7.9 6.8 8.0 17.1 8.2 11.8 75.0 84.9 82.4 NS
My prescribing role has lived up to my expectations 21.5 12.9 14.2 15.2 19.0 18.4 63.3 68.0 67.5 NS
I feel satisfied with my role as a prescriber 14.1 14.3 14.6 14.1 12.2 14.2 71.8 73.5 71.2 NS
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3.7.2 Factor analysis of attitudinal statements
The attitudinal statements in Table 3.5 were subjected to factor analysis, using
principal component analysis (PCA) as the extraction method. Chronbach’s
alpha (α) value for internal consistency of the scale of attitudinal statements was
0.75. This indicates reliability of the scale as a measure of the factors
associated with prescribing practice of pharmacists. In addition, the α value did
not improve with the deletion of any of the 16 items on the scale, indicating that
individual statements were measuring the same underlying construct (134).
Moreover, inter- item correlation of the scale fell mostly around the accepted
value of .3 indicating that individual items were sufficiently correlated with each
other for factor analysis to be appropriate (132). Appendix-I shows a matrix of
correlation coefficients for the sixteen attitudinal statements. Bartlett’s test of
sphericity also confirmed that correlation between items on the scale were
sufficiently strong, making the data suitable for factor analysis ( X2 (120) =
1392.21, p < .001, where p- values < 0.05 are accepted as suitable for factor
analysis (134)). In addition, the Kaiser-Meyer-Oklin measure confirmed the
sample size as adequate for factor analysis. (KMO= 0.79, the accepted
minimum being .50 (136)). KMO values for individual statements ranged from
0.70 to 0.88, which also favoured retention of all 16 items in the factor analysis.
Consequently, data provided by respondents in the study was deemed suitable
for exploration using factor analysis.
3.7.2.1 Determination of the number of components to extract
Exploratory factor analysis produced eigenvalues for all extracted components
in the data as shown in Table 3.6; four components had eigenvalues above
Kaiser’s criterion of 1; these collectively explained 49.5% of the total variance in
the data. However, in deciding the number of components to extract, Cattell’s
recommendation of visually inspecting the scree plot and retaining components
above the cut off point was also considered (134). The scree plot in Figure,3.1
revealed a clear drop from the third to the fourth component. Moreover, the
fourth, fifth, sixth and seventh components levelled out horizontally with
eigenvalues very close to 1. Therefore, Cattell’s recommendation, rather than
Kaiser’s criterion, was used as the basis for retaining the first three components
in the final analysis.
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Table 3.7 Total variance explained by the initial extraction of four components
Initial Eigenvalues Extraction Sums of Squared Loadings Rotation Sums of Squared Loadings
Component Total % of Variance Cumulative % Total % of Variance Cumulative % Total % of Variance Cumulative %
1 3.852 24.076 24.076 3.852 24.076 24.076 2.421 15.132 15.132
2 1.575 9.845 33.922 1.575 9.845 33.922 2.006 12.538 27.670
3 1.386 8.661 42.582 1.386 8.661 42.582 1.985 12.407 40.077
4 1.098 6.865 49.447 1.098 6.865 49.447 1.499 9.371 49.447
5 .997 6.230 55.677
6 .950 5.939 61.616
7 .935 5.843 67.459
8 .797 4.984 72.443
9 .708 4.424 76.867
10 .688 4.299 81.165
11 .652 4.074 85.240
12 .612 3.826 89.066
13 .561 3.508 92.573
14 .482 3.011 95.584
15 .467 2.918 98.502
16 .240 1.498 100.000
Extraction Method: Principal Component Analysis
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Figure, 3.1 Scree plot for the extraction of components (factors) from the sixteen
attitudinal statements related to pharmacist prescribing
Three components extracted base on Kaiser criterion (which recommends
retaining those components with eigenvalues of 1 and above), and Cattel’s
recommendation to retain only the components above the point of inflexion on
the Scree plot (132). Moreover, the three components provided a meaningful
grouping of attitudinal statements.
3.7.2.2 Extraction of three components from attitudinal statements
Using the criteria described for the determination of the number of components,
a decision was made to specify the extraction of three components from the 16
attitudinal statements. Therefore, a second round of PCA was performed, which
produced the matrix displayed in Table 3.7
Component
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Point of sharp inflexion favouring retention of three components
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Table 3.8 Component matrix of attitudinal statements related to prescribing
Statement Extracted component
1 2 3
I feel satisfied with my role as a prescriber .778 -.177 .181
My prescribing role has lived up to my expectations .741 -.245 .172
My other health professional colleagues do not fully support my prescribing practice .630 .045 .026
I have adequate administrative support for my prescribing practice .560 .250 -.132
I have adequate communication with doctors in relation to my prescribing practice .557 -.211 -.200
My professional line manager is supportive of my prescribing practice .553 .370 .247
I have adequate communication with other pharmacist prescribers .416 .152 .136
My prescribing has had no impact on patients' access to medicines .408 -.371 .335
Independent prescribing will/does facilitate my prescribing practice .405 -.221 -.187
My prescribing practice has had a positive clinical impact on patient care .357 -.575 .243
My professional line manager has little awareness and understanding of non-medical prescribing .349 .565 .183
I am remunerated appropriately for my prescribing practice .319 .485 -.089
I have inadequate peer support for my prescribing practice .256 .292 .135
I have sufficient access to patients' medical records for my prescribing practice .440 -.144 -.634
My access to information technology is adequate for my prescribing practice .489 .130 -.589
It would be convenient for patients to get medicines prescribed in a community pharmacy .138 .145 .413
Extraction Method: Principal Component Analysis. (3 components extracted); factor loadings above .4 indicated in bold
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Interpretation of the extracted components was aided by performing orthogonal
(varimax) rotation. Table 3.8 shows the factor loading of the three components
after rotation. These three components together explained 42.7% of the
variance, with the first component contributing 15.6%, the second component
14.7% and the third component contributed 12.4%. Statements that clustered
together in the rotated matrix of the three components suggested the following
interpretation for extracted components:
1. Component 1 represents the ‘administrative structures and processes’
that facilitate pharmacists’ prescribing practice.
2. Component 2 represents respondents’ ‘perceptions of their pharmacist
prescribing roles’.
3. Component 3 represents ‘facilities’ that support respondents’ practice as
prescribers.
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Table 3.9 Summary of factor analysis results of 16 item attitudinal statements related to the implementation of prescribing by pharmacists in GB (n =434)
Extraction Method: Principal Component Analysis - Rotation Method: varimax with Kaiser Normalization. (Factor loadings over .40 appear in bold)
Note:
 Factor loadings demonstrate the relative contribution of each statement to the extracted component.
 Eigenvalues indicate the relative importance of extracted components in explaining the observed variance in the data, represented by the percentage
variance explained.
Attitudinal Scale items Rotated factor loadings
Administrative structures
and processes
Perception
prescribing role
Facilities enabling
prescribing
My professional line manager has little awareness and understanding of non-medical prescribing .689 -.090 -.091
My professional line manager is supportive of my prescribing practice .687 .201 -.027
I am remunerated appropriately for my prescribing practice .541 -.165 .191
I have adequate administrative support for my prescribing practice .535 .159 .271
My other health professional colleagues do not fully support my prescribing practice .449 .331 .269
I have adequate communication with other pharmacist prescribers .393 .184 .088
I have inadequate peer support for my prescribing practice .392 .081 -.020
My prescribing practice has had a positive clinical impact on patient care -.123 .713 -.019
My prescribing role has lived up to my expectations .332 .709 .189
I feel satisfied with my role as a prescriber .403 .691 .181
My prescribing has had no impact on patients' access to medicines .028 .629 -.057
I have sufficient access to patients' medical records for my prescribing practice .035 .149 .755
My access to information technology is adequate for my prescribing practice .261 -.017 .728
I have adequate communication with doctors in relation to my prescribing practice .141 .401 .445
It would be convenient for patients to get medicines prescribed in a community pharmacy .264 .140 -.393
Independent prescribing will/does facilitate my prescribing practice .080 .335 .335
Eigenvalues 3.90 1.60 1.40
% of variance explained 15.6 14.7 12.4
Chronbach’s alpha (α) .61 .73 .45
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3.7.2.3 Interpretation of extracted components
Having reduced the 16 attitudinal statements to three components, the
components were explored in further analysis of the factors associated with the
implementation of prescribing by pharmacists. Component 1, interpreted in the
previous section as administrative structures and processes, contained seven
attitudinal statements as shown in Table 3.9. The total score of a participant for
each component was the sum of scores recorded for individual statements. For
example, a participant that strongly disagreed with all seven statements in
component one would record a score of 1 for each statement, and the total
score for this respondent on that component would be 7 (1x7). On the other
hand, a respondent that strongly agreed with all seven statements would record
a score of 5 against each statement; and their total score on that component
would be 35 (5x7). Similarly, Component 2, interpreted as pharmacist
prescribers’ perception of prescribing role, contained four items with potential
total scores of 4-20. Component 3, interpreted as facilities for pharmacist
prescribing, contained five statements with potential total scores of 5-25.
Subsequent results present the findings of analysis carried out on these
components.
Table 3.10 Grouping of attitudinal statements on extracted components
Component 1- administrative structures and processes for pharmacist prescribing (7 items)
My professional line manager has full awareness and understanding of non-medical prescribing
My professional line manager is supportive of my prescribing practice
I am remunerated appropriately for my prescribing practice
I have adequate administrative support for my prescribing practice
My other health professional colleagues fully support my prescribing practice
I have adequate communication with other pharmacist prescribers
I have adequate peer support for my prescribing practice
Component 2- pharmacists’ perception of prescribing role (4 items)
My prescribing practice has had a positive clinical impact on patient care
My prescribing role has lived up to my expectations
I feel satisfied with my role as a prescriber
My prescribing has had a positive impact on patients' access to medicines
Component 3- facilities for pharmacist prescribing (5 items)
I have sufficient access to patients' medical records for my prescribing practice
My access to information technology is adequate for my prescribing practice
I have adequate communication with doctors in relation to my prescribing practice
It would be convenient for patients to get medicines prescribed in a community pharmacy
Independent prescribing will/does facilitate my prescribing practice
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3.7.3 Influence of extracted components on prescribing practice of
respondents association with demographic characteristics
Exploring possible influences of extracted components on the prescribing
practice of respondents yielded the following results:
3.7.3.1 Influence of extracted components on the prescribing
practice of respondents using sex as a predictor variable
The relationship between pharmacist prescribers’ sex and extracted
components was examined using the Mann-Whitney U test. Table 3.10
presents a summary of the results. Findings revealed no statistically significant
difference between the median scores of male and female respondents in terms
of the administrative structures and processes, perceptions of prescribing role
and the facilities for implementing prescribing. This was inferred from the
probability (p) values, which were all greater than .05. The Z-score, which is the
standardised variance between the individual score of each participant and the
median score, provides a means of testing for statistical significance of any
difference observed between male and female participants. Z-score values
larger than 1.96 (whether positive or negative) indicate statistically significant
differences at p< .05 (138). In other words, the probability of any observed
difference in the median score of males and females occurring by chance when
Mann-Whitney test gives a Z-score greater than 1.96 is 5%. Results in Table
3.10 show very small Z-scores, therefore they are not statistically significant.
Moreover, Z-scores were used to calculate the effect size (r) according to the
formula in Table 3.10. If there were any significant differences in the median
score of participants based on their sex, r would give a measure of the effect
sex had on that difference. Cohen in 1988 recommended effect size of .1 to be
considered small effect, .3 medium effect and .5 large effects (137). All the r
values on table 3.10 were well below .1 confirming that facilitators and barriers
to prescribing implementation did not vary based on the sex of respondents.
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Table3.11 Influence of extracted components on the prescribing practice of respondents: comparison of t based on sex
N is the number of participants for each component sub-divided according to sex, r = Effect size
Component Sex Median score N Mann-Whitney’s U test p-value z- score (r) = z ÷ √ N
Administrative structures and processes
Female 24 315
19223.00 .371 -0.894 0.04
Male 25 129
Perception of prescribing role
Female 16 325
19999.50 .165 -1.387 0.06
Male 16 134
Facilities for prescribing
Female 21 315
19372.00 .791 -0.265 0.01
Male 21 125
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3.7.3.2 Influence of extracted components on the prescribing
practice of respondents using age, experience as a
pharmacist and practice setting as predictor variables
Possible associations between extracted components as outcome variables,
and the predictor variables of pharmacy practice setting, age and length of
experience of respondents as pharmacists, were assessed using Kruskal –
Wallis’ H test, which gives X2 values as described under the methods in section
3.4.5. Table 3.11 presents a summary of the findings. Kruskal-Wallis tests did
not reveal significant differences for the influence of extracted components on
the prescribing practice of respondents when they were compared on the basis
of age and length of pharmacy practice experience. The difference in the
median score of respondents on the component ‘administrative structures and
processes’ approached statistical significance, when were compared in terms of
the length of experience as a pharmacists (X2 (4) = 9.14, p = 0.06). However,
Kruskal Wallis test revealed statistically significant differences in the median
score of respondents on the factor, ‘facilities for prescribing’ depending on the
setting in which they practiced as pharmacists (X2 (3) = 8.04, p < 0.05.)
The observed differences based on pharmacy practice setting of prescribers
was followed up with post hoc procedures to determine which practice setting
accounted for the difference . Table 3.12 shows post hoc Mann – Whitney test
results, which indicate that the difference was mainly between prescribers
based in community pharmacies, and those based in general medical practices
(U= 4122.50, p= 0.005). Respondents in community pharmacies scored lower in
terms of the factor ‘facilities for prescribing’ compared with those in general
medical practices, with a small effect size (r = 0.12) according to the Cohen
criterion (132). Bonferonni adjustment controlled for type one error, with a new
significance level of 0.05/3 = 0.017. There were no statistically significant
differences in terms of the median scores of respondents based in hospitals and
those based in GP practices. The significance of these findings will be
discussed.
The influence of other factors on the prescribing practice of respondents, (who
had prescribed) was explored further, by the analysis of open comments they
gave in the questionnaire. Findings from these comments are presented next.
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Table 3.12 Comparison of respondents based on demographic characteristics
Component Demographic Characteristic N X2 df p- value
Administrative structures and processes Age 443 2.38 5 .795
Pharmacy practice setting 445 4.05 3 .256
Experience as a pharmacist 446 9.14* 4 .058
Perception of prescribing role Age 458 4.14 5 .530
Pharmacy practice setting 461 2.98 3 .395
Experience as a pharmacist 460 3.05 4 .550
Facilities for prescribing Age 439 7.42 5 .191
Pharmacy practice setting 441 8.04** 3 .045
Experience as a pharmacist 442 7.89 4 .096
* X2 approaches significance, ** X2 significant at p < .05, N = number of participants, df = degrees of freedom
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Table 3.13 Comparing the pharmacy practice setting
N is the total number of participants for each pair of comparison, r = Effect size * post hoc test significant at p< .017
Facilities for prescribing Median score N Mann-Whitney’s U test p-value z- score (r) = z ÷ √ N
Community pharmacy 20
214 4122.50* .005 -2.544 0.12
General medical practice 21
Community pharmacy 20
269 6596.00 .225 -1.196 0.07
Hospital 21
General medical practice 21
333 11702.50 .039 -2.075 0.11
Hospital 21
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3.8 Analysis of open comments from the questionnaire
This section presents findings from the analysis of open questionnaire
comments of respondents who had prescribed. Data was analysed using the
‘framework’ approach. Among the 68.1% (n=473) of respondents in the survey
who had implemented prescribing in practice, many reported circumstances that
either facilitated or challenged their prescribing. Challenges that limited the
prescribing practice of respondents are presented first, before the facilitators of
prescribing implementation.
3.8.1 Challenges to prescribing
Responses to the question, ‘Are there any factors that hinder your prescribing
practice?’ were analysed and grouped into main categories. Respondents
described the challenges that limited their prescribing practice. Many of the
themes that emerged were similar, or even the same as those described earlier
for respondents who had not yet prescribed. Therefore, some of the themes
may appear repetitive. The difference in this case was that respondents had
found ways of implementing prescribing practice despite the challenges. The
themes were: administration procedures, inadequate resources and lack of
understanding of the prescribing role of pharmacists, among others. Table 3.13
presents a summary of these themes, with some verbatim quotes to illustrate
each theme.
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Table 3.14 Challenges to the implementation of prescribing by pharmacists
Themes Description of theme Illustrative quotes
Administrative
procedures
( 136 comments)
Some respondents mentioned increased
administrative and managerial workload involved in
prescribing. They had to perform functions like
arranging patients’ appointments and other logistics.
Such duties were often described as cumbersome,
which forced some pharmacists, especially in the
community setting, who had initially started prescribing
in their own time to withdraw the service.
Administrative procedures were also related to clinical
governance issues, particularly regulations around the
prescription of controlled drugs and the need for a
second pharmacist check of any prescriptions written.
“I work in isolation of other practice pharmacists so have to make more of an
effort to meet and discuss prescribing. I do all my own administration; ePACT
monitoring myself usually in my own time” (Female GP practice pharmacist, 11-
15 years as a pharmacist, prescribing)
“When a medical prescriber writes a prescription it is reviewed by a pharmacist
before being dispensed. When I prescribe on my ward for an in-patient it is
difficult to have another pharmacist review my prescription which leads to
delays” (Male hospital pharmacist, above 20 years as a pharmacist, prescribing)
Inadequate
resources
(97 comments)
Inadequate resources for respondents to implement
prescribing practice, manifested most commonly in the
lack of appropriate IT facilities for pharmacist
prescribers to access patients’ records, or for them to
issue electronic prescribing. Inadequate resources
also meant constraints on the staff capacity, with
adverse consequences on the continuity of care and
the availability of backfill cover for pharmacists to
perform prescribing duties. For some respondents, the
main resource issues were about securing time and
space to consult and prescribe for patients.
“The frustration is that I cannot print off repeat prescriptions nor do my own
prescriptions electronically therefore, I am hand writing it and having to ask an
administrator to put it into the patients’ electronic records”. (Female community
pharmacist, above 20 years as a pharmacist, prescribing)
“Lack of other prescribing pharmacists to provide comprehensive service”
(Female hospital pharmacist, above 20 years as a pharmacist, prescribing)
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Table 3.14 cont’d Challenges to the implementation of prescribing by pharmacists
Themes Description of theme Illustrative quotes
Lack of understanding or
lack of support for the
pharmacist’s prescribing
role (57 comments)
Some pharmacist prescribers ascribed difficulties
with implementing prescribing to a general lack of
support from doctors, employing organisations,
and their peers. Respondents often perceived that
the pharmacist prescribers’ role was not fully
understood by other health care professionals,
including some non prescribing pharmacists.
“Lack of support from senior management and there is no role defined
for pharmacist prescribers so I had to invent my own role; plus
prescribing is extra to my core work”… (Male hospital pharmacist, 11-
15 years as a pharmacist, prescribing)
Other challenges
(34 comments)
Other challenges ranged widely from issues
around the lack of opportunities for appropriate
continuing professional development (CPD), to
the perception of competition for prescribing roles
between them and nurse prescribers. Moreover
some pharmacist prescribers perceived their role
in prescribing as being additional to their core and
“normal” roles, this often meant divided attention
between prescribing and non-prescribing roles
with the consequence that patients were often not
followed up appropriately.
“I have to develop my own role; fighting to find a place in between GPs
and prescribing nurses” (Female GP practice pharmacist, 16- 20 years
as a pharmacist, prescribing)
“I only prescribe one morning a week, and sometimes it is hard to
follow a patient through” (Male community pharmacist, above 20 years
as a pharmacist, prescribing)
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3.8.2 Facilitators of prescribing implementation
Respondents who had prescribed were also asked if there were other factors
that facilitated practice for them as prescribers. Many of the themes that
emerged from analysis of their comments were opposite to those mentioned as
challenges in the previous section. Themes that emerged included: relationship
and support of stakeholders for prescribing implementation, adequate
resources, specialist knowledge, defined prescribing role and the determination
or personal motivation of respondents. Table 3.14 summarises these findings.
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Table3.15 Facilitators of prescribing implementation
Themes Description of theme Illustrative quotes
Relationship and
stake holder support
for the
implementation of
prescribing
(169 comments)
Many of the comments in this theme were about the
support respondents got from stakeholders including:
doctors, employing organisations, nurses, other
pharmacists and administrative staff. Support was often
attributed to good inter personal relationship and
communication among members of the health team.
Other health care professionals provided clinical and
professional support in terms of peer reviewing
respondents’ prescribing decisions and giving them
feedback. Also, administrative staff supported
respondents’ prescribing practice by handling logistic
arrangements for running prescribing services.
“I had a good rapport with medical colleagues prior to starting the prescribing course and I
was already advising/shadow prescriber as supplementary prescriber prior to becoming an
independent prescriber. (Male hospital pharmacist, above 20 years as a pharmacist,
prescribing)
“Long term trusting relationship of mutual respect between medical, nursing and other health
care professionals and myself “(Female intermediate nursing care home pharmacist, above
20 years as a pharmacist, prescribing)
“Practice staff organise patient appointments, and advertise my services within the practice”
(Female GP practice pharmacist, above 20 years as a pharmacist, prescribing)
Availability of
adequate resources
(64 comments)
Availability of adequate resources encompassed
comments about pharmacist backfill and locum cover to
release respondents for prescribing duties. Financial
resources covered funding of prescribing clinics and also
remuneration. Similarly, availability of appropriate
infrastructure mainly IT facilities for access to patients’
medical records and private consulting rooms were
described as important facilitators by respondents
“There is pharmacist backfill to enable a professional pharmacist check of prescriptions
within the clinical team” (Male hospital pharmacist, 11-15 years, as a pharmacist,
prescribing)
“PCT had allocated a prescribing budget and was also very quick to supply prescription
pads...” (Female community pharmacist, 11-15 years as a pharmacist, prescribing)
“Computer generated prescriptions for efficiency and less error of transcription...” (Female GP
practice pharmacist, above 20 years as a pharmacist, prescribing)
Others
(52 comments)
Other themes were about the specialist knowledge and
skills of pharmacists in managing prescribing issues.
This they attributed to training and experience. In
addition some respondents reported having defined
prescribing roles, for which they were specifically
employed. Also mentioned in this category was the
personal motivation of some pharmacist prescribers
which propelled them to succeed against all odds
“I have worked in this community for 6 years so I have the confidence of patients; I know
them, their clinical history well etc” (Female community pharmacist, 11-15 years as a
pharmacist, prescribing)
“I was employed directly by the practice in advance of me working towards establishing
prescribing within clinics there....” (Female GP practice pharmacist, above 20 years as a
pharmacist, prescribing)
Chapter 3- Cross-sectional questionnaire survey
102
3.9 Pharmacist prescribing implementation in the primary care
setting
The remainder of findings presented in this chapter focus on primary care
settings comprising general medical practices and community pharmacies.
3.9.1 Prescribing processes of respondents
As stated earlier, there were 333 respondents working in primary care settings;
of these, 228 (68.5%) had prescribed. Aspects of current practice are given in
Table 3.15. The median number of patients prescribed for, per pharmacist per
week was 10; inter-quartile range 6-20. The most common patient group
managed by respondents was cardiovascular diseases, comprising mostly
hypertensive patients. This was followed by patients with respiratory and
diabetic conditions respectively. The majority of respondents used face to face,
or electronic mail communication for prescribing-related discussions with other
members of the health care team. Very few of the respondents were members
of any prescribing committees or groups. Table 3.15 gives details of the
prescribing practice of pharmacists in the primary care setting.
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Table 3.16 Prescribing activities of respondents based in the primary care setting
Aspect N (%)
How pharmacist prescribers chose their area of practice
Recommended by health team 87 38.5
Based on pharmaceutical needs assessment 28 12.4
Pharmacist expertise 69 30.5
other reasons 32 14.2
No response 10 4.4
Total 216 100.0
Prescribing patient group/therapeutic area
Hypertension 93 41.2
Other cardiovascular diseases 63 27.9
Asthma 41 18.1
COPD 36 15.9
Diabetes mellitus 35 15.5
Analgesia 21 9.3
Smoking cessation 13 5.8
Substance misuse 13 5.8
*Total 312 >100.0
Method of patient recruitment
By doctor 140 61.9
Patient self-referral 62 27.4
By pharmacist prescriber 127 56.2
By other members of the health team 140 61.9
Other referral processes 199 88.1
*Total 668 >100.0
Any involvement in dispensing own prescriptions
Yes 42 18.6
No 174 77.0
No response 10 4.4
Total 216 100.0
Prescribing within defined standard operation procedures
Yes 71 31.4
No 140 61.9
No response 15 6.6
Total 211 100.0
Any professional indemnity
Yes 196 86.7
No 18 8.0
No response 12 5.3
Total 214 100.0
N= number of prescribers * Total N > 226), and %> 100, because of multiple response by
pharmacist prescribers who used more than one patient recruitment method and/or prescribe in
more than one therapeutic area
Note primary care setting denotes general medical practices and community pharmacies
Other aspects of the prescribing practice of respondents related to their
continuing professional developments. Table 3.16 shows details.
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Table 3.17 development of respondents’ prescribing practice
Continuing professional development activity N %
Attendance at conferences and meetings 154 68.1
Peer support 134 59.3
Local CPD courses 130 57.5
Job shadowing 92 40.7
Higher education course for CPD 64 28.3
Other CPD programmes 188 83.2
* Total 762 >100.0
Hours of CPD taken in the previous one year
Less than 10 hours 7 3.1
11-20 hours 16 7.1
21-30 hours 20 8.9
Above 30 hours 166 73.5
No response 16 7.1
Total 226 100.0
Nature of feed back from patients
Formal questionnaires 22 9.7
Informal verbal feedbacks 153 67.8
No response 51 22.5
Total 226 100.0
Regularity of patient feedback
At each consultation 29 12.8
Occasional 71 31.4
No response 126 55.8
Total 226 100.0
N= number of prescribers, * Total n > 226), and %> 100, because multiple response was
allowed.
3.9.2 Changes in the prescribing practice of respondents
Respondents were asked to indicate changes that had occurred in their practice
as prescribers, since they had qualified from the prescribing course and
registered with the RPSGB. The most common change cited by respondents
related to the expansion of care to other patient groups and an increase in the
number of patients for whom they prescribed. Table 3.16 summarises the
changes.
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Table 3.18 Changes in pharmacist prescribing practice
Change activity N %
Added patient group or therapeutic area 120 53.1
Increased the number of patients prescribing for 112 49.6
Implemented independent prescribing 96 42.5
Moved to new patient group or therapeutic area 44 19.5
Move to a different prescribing setting 37 16.4
Changed referral process 35 15.5
Other changes 202 89.4
Total 646 >100.0
N = number reporting change * Total N > 226, and >100% because of multiple response by
some that reported more than one type of change. The other change category included such
examples as increased personal confidence of prescribers and more frequent home visits for
patients.
3.9.3 Development of prescribing by pharmacists in primary care
A majority of respondents who were already prescribing in primary care settings
n = 228 (69.9%), indicated plans to develop their prescribing practice. It is likely
that the training pharmacists undergo for prescribing will impact greatly on the
future development of prescribing services. The questionnaire sought the views
of respondents on the introduction of prescribing training for pharmacy students
at the undergraduate level. A majority (63.9%) of respondents who had
implemented prescribing in primary care (n = 158/228) objected to the idea,
while around a quarter (23.7% n=54/228) supported the idea. Table 3.18
presents a summary of the themes that emerged from a thematic analysis of
open comments of respondents regarding the training of undergraduates for
prescribing.
106 Chapter 3- Cross-sectional questionnaire survey
Table 3.19 Views of pharmacist prescribers on the training of pharmacy undergraduates for prescribing
Theme Description of theme Illustrative quote
Risk and patient safety
issues
This theme reflected the concerns of respondents
about the lack of experience and maturity of fresh
pharmacy graduates. Such concerns were common to
both proponents and opponents of introducing the
prescribing curriculum at the undergraduate level.
“I feel that pharmacists need at least 2 years experience first as when you qualify you are still
learning and putting new skills into practice - prescribing as well would be too much responsibility
and potentially dangerous.” (Female GP practice pharmacist 11-15 years as a pharmacist,
prescribing )
“Undergraduates are still taught therapeutics in ‘SILOS’, so when they attempt to manage
patients with multiple co-morbidities they struggle…” (Female GP practice pharmacist above 20
years as a pharmacist, prescribing)
Image and prestige Pharmacists who argued in support of training
pharmacy undergraduates as prescribers felt it was
good for the mage of the profession. They noted that
implementation would be structured, unlike the current
‘piece meal’ approach. They opined that the
prescribing needed to be ‘demystified’ by making it a
normal activity for any pharmacist who wanted.
Conversely, those who argued against training
pharmacy undergraduates for prescribing made
comments that portrayed prescribing as an exclusive
activity. They pointed out that the image and prestige
associated with prescribing will be devalued if every
pharmacist was allowed to prescribe. They feared that
fresh graduates as prescribers would embarrass and
tarnish the image of pharmacy.
“Pharmacists should all qualify as prescribers as it is the only way we can enhance our role and
ensure our future.” (Male community pharmacist above 20 years as a pharmacist, prescribing)
“I think it would be useful for prescribing to be incorporated into the pharmacy degree as it would
further enhance the professional image of pharmacy.” (Female GP practice pharmacist above
20 years as a pharmacist, prescribing)
“…Not all pharmacists have the necessary attributes to carry out this role efficiently...” (Female
GP practice pharmacist above 20 years as a pharmacist, prescribing)
“This should be a supplementary course for those who wish to put in the work and commit
themselves. If every pharmacist had this qualification it would de-value it.” (Female community
pharmacist 6-10 years as a pharmacist, prescribing)
Logistics of training It was common to find pharmacists who supported
undergraduate training of prescribers alluding to the
ease of taking the course at that level. On the other
hand, those that objected opined that it would amount
to a waste of time and resources if no immediate
prescribing roles were available.
“It is a lot easier to do the independent prescribing course whilst still a student” (Male community
pharmacist above 20 years as a pharmacist, prescribing)
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3.9.4 Summary of results
A cross-sectional questionnaire survey was used in this phase to establish the
demographic characteristics of pharmacist prescribers. The extent of
prescribing implementation in GB was measured in the sample of respondents.
In addition, the type of prescribing activities undertaken by pharmacists was
described. The survey identified resource-related issues of funding, clinic
space, time and IT facilities as the key factors that influenced implementation of
prescribing. Availability of resources enhanced pharmacist prescribers’
activities, while shortage or lack of resources hindered implementation.
Similarly, administrative procedures and lack of understanding or lack of
support for the pharmacist’s prescribing role were identified as major challenges
by respondents who had actually prescribed. Along with these challenges, a
lack of defined prescribing roles was also found to be a key barrier for
pharmacists who had not implemented prescribing. Moreover, among
pharmacists who were prescribing, the pharmacy practice setting was the main
prescriber characteristic associated with this activity. Pharmacist prescribers
based in hospitals and general medical practices were more likely to have
implemented prescribing. The implications of these findings will be discussed in
the next section.
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3.10 Discussion
In this section, the key findings of the cross-sectional questionnaire survey will
be discussed in line with the aims and objectives of Phase 1. The strengths and
limitations of the data collection instrument, the statistical procedures of data
analysis and the quantitative results will be considered before focusing on
implications of the quantitative results in relation to the policy and practice of
pharmacist prescribing. The study results will be critically appraised, in the
context of the published literature, in order to draw appropriate conclusions to
inform and refine the research questions, aim and objectives for Phase 2 of the
project.
3.10.1 Review of Phase 1 objectives
The aim of the quantitative phase of the research was to determine the nature
and extent of prescribing activities undertaken by pharmacist prescribers in GB.
The cross-sectional questionnaire survey approach was utilised to meet the
following specific objectives:
1. To describe the demographic characteristics of pharmacist prescribers,
as the basis for determining the extent of prescribing activities of
pharmacists.
2. To identify barriers and facilitators to the practice of pharmacists as
prescribers.
3. To examine the relationship between facilitators/barriers and
demographic characteristics of pharmacists engaged in actual
prescribing practice.
4. To describe the processes adopted by pharmacist prescribers in
delivering prescribing services.
3.10.2 Key findings
All pharmacist supplementary or independent prescribers registered with the
RPSGB as at January 2009 were invited to participate. Response rate was
42.3% (695/1, 643). The key findings from the analysis of completed
questionnaires are presented under each objective of the quantitative phase as
follows:
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1. To describe the demographic characteristics of pharmacist prescribers, as
the basis for determining the extent of prescribing activities of pharmacists.
 Only a minority (less than 20%) of all the respondents were based in
community pharmacies as the main setting in which they practiced as
pharmacists; more (44%) were based in hospitals.
 The majority of respondents (68.1%) had written prescriptions, but
almost one third (31.9%) were yet to prescribe.
 Of all the respondents that had written prescriptions, 43% prescribed in
hospitals, another 42% prescribed in general medical practices while less
than 8% prescribed in the community pharmacy setting.
 Respondents, who prescribed, mostly delivered the service in the same
location of their main pharmacy practice. However, of the respondents
based in community pharmacies, half of those who had written
prescriptions did their prescribing in general medical practices.
2. To identify barriers and facilitators to the practice of pharmacists as
prescribers.
 Statistical analysis, using Chi Squared test, revealed a small, statistically
significant association between the pharmacy practice setting of
respondents and whether or not they had written prescriptions.
 Descriptive analysis of 16 attitudinal statements related to prescribing
practice showed that respondents who had prescribed across all practice
settings, agreed to having adequate administrative and peer support.
They also agreed that their prescribing practice made positive impact on
patients’ access to medicines. However, they disagreed that they were
appropriately remunerated for prescribing.
 Factor analysis of the 16 attitudinal statements related to the prescribing
identified three underlying factors associated with the prescribing
practice of respondents, namely:
i. ‘Administrative structures and processes’ which comprised: general
administrative support, adequate remuneration, communication, other
health professional and peer support as well as the understanding and
support of line managers for pharmacist prescribers.
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ii. ‘Perception of pharmacists’ prescribing roles’ including: how
pharmacist prescribers perceived the impact of their prescribing practice
on patient care, and how prescribing practice had lived up to their
expectations, and their satisfaction with their role as prescribers.
iii. ‘Facilities for pharmacists’ prescribing practice’ covered pharmacist
prescribers’ access to IT facilities, PMR and their communication with
doctors.
 Analysis of open comments of respondents who had yet to prescribe
revealed their reasons for not prescribing to include: lack of
opportunity, administrative procedures, resource limitations and lack
of defined prescribing roles.
 For the respondents who had written prescriptions, lack of
stakeholders’ understanding and support for pharmacists’ prescribing
role was said to be a major challenge to pharmacists’ practice as
prescribers.
3. To examine the relationship between facilitators/barriers and demographic
characteristics of pharmacists engaged in actual prescribing practice.
 Non-parametric analysis revealed statistically significant differences in
the median score of respondents on the factor ‘facilities for prescribing’,
depending on the setting in which they practised as pharmacists.
 Further analysis indicated that the difference in practice setting was
mainly between respondents based in community pharmacies, and those
based in general medical practices. Respondents based in the
community pharmacy setting recorded lower median scores in terms of
the factor ‘facilities for prescribing’ compared with those in general
medical practices.
4. To describe the processes adopted by pharmacist prescribers in delivering
prescribing services.
 Of the 333 respondents based in primary care settings, 228 (68.5%) had
written prescriptions.
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 The most common patient group(s) managed by respondents as
prescribers were cardiovascular diseases, comprising mostly
hypertensive patients. This was followed by patients with respiratory and
diabetic conditions.
 Many of the patients prescribed for, by pharmacist prescribers were,
recruited by pharmacist prescribers themselves.
 Around 18% of respondents were involved in dispensing their own
prescriptions.
 The major changes in the prescribing practice of respondents since they
first registered as prescribers were described in terms of them adding
new therapeutic group(s) to the patient groups with which they started
prescribing practice. Other changes were: respondents increasing the
number of patients they prescribed for, and implementation of IP
practice.
The Implications of these findings on the policy and practice of pharmacist
prescribing will be discussed in section 3.11, after a consideration of the
strengths and limitations of the methodological choices made in this phase of
the project.
3.10.3 Strengths and limitations of the quantitative methods
A review of the strengths and limitations of quantitative research methods was
provided in Chapter 2. In particular, the cross-sectional postal questionnaire
survey was described as the reference example, to highlight main advantages
and disadvantages of non-experimental quantitative research. However, the
quantitative phase of the research had specific strengths and limitations
associated with the data collection instrument (questionnaire) and the resultant
data. In this section, a critical appraisal of these strengths and limitations of the
quantitative methods will be undertaken to provide a transparent means of
assessing its quality.
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3.10.3.1 Scope of data collected
The population of respondents represented pharmacist prescribers from across
GB, from a wide range of practice settings (primary care, secondary care and
specialist units including substances misuse centres, prison health centres,
nursing care homes and out-of-hours centres). Respondents also covered both
SP and IP practice models, including those that were not yet prescribing at the
time of data collection. This variety in the composition of respondents enhances
the potential to generalise quantitative findings from the current research project
to the wider population of pharmacist prescribers in GB. In contrast, previous
studies have tended to be restricted in geographical scope, and the focus has
often been limited to either SP or IP alone. Latter et al. used a combination of
methods, including questionnaire and telephone surveys, case studies and
multi-stakeholder workshops to investigate nurse and pharmacist IP in England
(139). Similarly, Bissel et al. utilised a combination of postal questionnaire
survey, case studies and prescribing data analysis to evaluate nurse and
pharmacist SP in England (140). Whilst key differences in terms of the research
design adopted in the current project and those of the two studies cited are
acknowledged; this project was the first to provide updated data on the status of
pharmacists SP and IP practice across the whole of GB.
Moreover, all pharmacist prescribers on the sampling frame were invited to
participate in the research. This eliminated the problems commonly associated
with specific sampling strategies. The non-representativeness of samples
selected through non-probabilistic methods was highlighted in Chapter 2.
Inviting every individual on the sampling frame enhanced the strength of the
quantitative phase because the results could potentially be generalised for all
pharmacist prescribers in GB. This was, however, limited by the response rate
(see later). Furthermore, the validity and reliability of the quantitative results
were enhanced by the rigour applied in the development of the data collection
instrument.
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3.10.3.2 Mode of data collection
The strengths of survey research methods in general were explained in Chapter
2. There were a number of reasons for choosing the questionnaire survey
approach in the quantitative phase of this project. Firstly, the decision to collect
quantitative data using the questionnaire survey method was based on the fact
that this method is likely to gather research findings that reflect as closely as
possible, real life practice (80,141). Since the information required in the current
project concerned the actual prescribing practice of pharmacists, the
questionnaire survey rather than alternate quantitative methods like the RCT is
best suited to accurately capture this data. Rigorous controls and randomisation
would otherwise render the research condition of RCTs ‘artificial’, and yield very
precise results with narrow applicability in situations outside the controlled
conditions of the research (92). Therefore, a major strength of the quantitative
phase of the project lies in the choice of a method which produced results that
are readily translated into the real world practice situation of pharmacist
prescribers.
Secondly, the postal delivery of the questionnaire for self completion by
respondents, rather than interview administration of the questionnaire in face-to-
face encounters, enhanced the quality of the data collected in this project.
Bowling in 2005, reviewed 73 relevant research papers out of a total of 382
publications retrieved by systematic and non-systematic searches of the
literature, on the effects of modes of questionnaire administration on data
quality. The author found that postal questionnaire surveys minimise the risk of
respondents giving socially desirable responses, which they may do to impress
researchers, if questionnaires are administered face-to-face in interviews. In
addition, the review found that postal questionnaire surveys are capable of
achieving wider and more complete coverage of the study population (142).
Therefore, the postal mode of questionnaire delivery in the current project,
possessed inherent advantages both in terms of the resultant data quality and
the cost-effectiveness of the process. Several pharmacy practice researchers
assert that postal administration of questionnaires provides a rapid and cheaper
means of data collection in large samples, compared with face-to-face surveys
(91).
Chapter 3- Cross-sectional questionnaire survey
114
3.10.3.3 Data collection instrument
Development of the data collection instrument in the current project adhered to
principles of best practice for questionnaire design recommended in the
literature; which were described in section 2.3.5 and applied in sections 3.3.3
and 3.4 of this chapter. McColl et al., integrated expert opinions from key
textbooks with high grade evidence from experimental and quasi-experimental
studies, in a selective review of the literature to identify elements of best
practice in the design and conduct of surveys. The authors listed four key
issues: mode of questionnaire delivery; the sequence of questions, wording and
response formats; the general appearance and format of the questionnaire; and
the strategies for enhancing response rate as the key issues of best practice in
questionnaire research design (93). The mode of questionnaire delivery has
been discussed above, and the response rate will be discussed later. However,
issues of questionnaire appearance and question wording in this project were
carefully considered in an iterative questionnaire development process that
designed, pilot tested, modified and re-tested the instrument to ensure that the
final data collection tool was robust and fit for purpose (see section 3.3).
Moreover, reliability and validity of the questionnaire used in the current project
were confirmed through various approaches. Firstly, a member of the
supervisory team performed independent checks of questionnaire data coding
and entry into SPSS® in 50 of the completed questionnaires selected at
random. This confirmed reliability of the process adopted by the research
student for data handling and analysis. Secondly, ethical requirements for
anonymity made it impossible to link returned questionnaires to individual
respondents, as a means of performing ‘test-retest’ reliability analysis (section
3.3.4), but other robust statistical techniques were applied to confirm the
instrument reliability. This was achieved by calculating Cronbach’s alpha (α), for
the internal consistency of questionnaire items. In the current questionnaire, the
scale of attitudinal statements designed to measure factors associated with
respondents’ prescribing practice, yielded α value of .75. This confirmed the
reliability of the questionnaire to collect relevant data, in accordance with
recommendations that pharmacy practice research questionnaires achieved α
values of 0.7 and above, in order to demonstrate high reliability (91).
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3.10.3.4 Statistical procedures of data analysis
Factor analysis, a major statistical procedure applied in the analysis of the
current project data, confirmed validity of the questionnaire. Evidence of the
close link between construct validity and factor analysis abound in the literature;
for example Hayton et al. in their seminal paper in 2004 included a brief review
of the literature on this subject (143). Applying factor analysis to reduce a large
set of measured variables to yield a few meaningful underlying constructs in the
prescribing practice of pharmacists provided the assurance that the
questionnaire was measuring what was intended. However, equally important,
was that appropriately applying factor analytical procedures enhanced the
strength of the quantitative results in this project. Fabrigar et al. systematically
reviewed 883 articles published between 1991 and 1995 in the Journal of
Personality and Social Psychology and found that 159 of them performed
exploratory factor analysis. The authors listed key methodological and analytical
decisions required to implement factor analysis, including: decisions on study
design, the use of multiple variables to measure a common factor,
considerations in the determination of the number of factors to extract and
interpretation of the factors using appropriate rotation methods (144). Also,
Russell in 2002, reviewed articles published in the same journal during 3
different years, 1996, 1998 and 2000; and listed similar methodological issues
as Fabrigar et al. (145); which were applied in the current project.
In terms of study design for example, the best practice recommendations are for
large sample sizes of at least 100 participants, 3 variables or more combining to
produce a single factor in the factor analysis. Similarly, it is recommended that
multiple methods are applied in determining the number of factors to extract,
and using rotation methods, to interpret extracted factors (144,145). These
methodological considerations of factor analysis were extensively explained and
applied in the methods section of Chapter 3. Significantly, the results obtained
from this procedure yielded extracted factors (components) of practical
significance to the practice of pharmacist prescribing. Performing further non
parametric statistical tests established the significant association between an
extracted component (facilities for prescribing) and the prescribing practice of
respondents, hence attesting to the robustness of the statistical procedures
utilised in the research. Despite the enumerated strength of the survey, the
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quantitative phase of the project still had some limitations which are discussed
next.
3.10.3.5 Response rate
The potential to generalise from results of the quantitative phase of this project
to the general population of pharmacist prescribers may have been limited by a
low response rate of 42.3%. This was further complicated by a sampling frame
that did not distinguish respondents according to their practice settings;
therefore, it is not possible to determine the representativeness of the
respondents to the target population of pharmacist prescribers based in the
primary care setting of GB in accordance with the aims of the quantitative phase
of the project. However, the response rate is consistent with the less than 50%
response rates recorded in several pharmacy practice studies (91). Moreover,
the characteristic of study participants reflect the same pattern on the register of
the GPhC. In 2010 there were 50,660 pharmacists registered in GB. Of these, a
majority were female and 51% were within the 30-49 years age group. Slightly
more than 2000 pharmacist were annotated as prescribers on the GPhC
register in 2010 (146). Most of the studies on pharmacist prescribers have
focused on specific sub-populations within narrow geographical areas(49).
The first large scale study of pharmacist prescribing in GB involving all
pharmacist prescribers n= 518 achieved a high response rate of 82.2%
(n=401/488 excluding the 30 who participated in the pilot survey). In this study,
George et al. utilised a cross-sectional questionnaire survey approach to
investigate the early experiences of pharmacist prescribers following the
introduction of SP in GB (48, 58). However, unlike the current study which had a
study population of 1,643, the study by George et al. had a study population of
less than 500 participants who may be demographically different from the
current study population. It appears that previous studies of pharmacist
prescribing which recorded relatively high response rates were mostly small
scale studies on small target populations. Cooper et al. conducted a thematic
review of the literature of nurse and pharmacist prescribing in GB and
concluded that many of the published quantitative studies were limited, because
they relied on small samples of pharmacist prescribers (49). Therefore, despite
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the low response rate in the current study, the findings provide the most current
and comprehensive national data on pharmacist prescribing practice.
Moreover, some of the best practice recommendations to improve response
rate to questionnaire surveys were applied in the design and conduct of the
current project. Edwards et al. in 2009, reported results of a systematic review
of 481 RCTs, from which 110 different strategies to improve the response rate
to postal questionnaire surveys were investigated. The authors found that giving
research participants monetary incentives more than doubled the response rate.
They identified other key strategies for improving response rate as: length of
questionnaire, follow-up and reminders, inclusion of a cover letter informing
participants of the potential benefits of the research to the society, assurance of
confidentiality, personalised questionnaires and the use of stamped envelopes
for the return of completed questionnaires (147). Although the review by
Edwards et al. provided evidence that monetary incentives double response
rates, this strategy could not be used in the current project because of its
controversial ethical implications (80). Similarly, it was not possible to use
personalised questionnaires because of the ethical requirement for the
anonymity of respondents. Other recommendations of Edwards et al. were
rigorously applied in the current project (see section 3.4).
3.10.3.6 Biases
Sackett catalogued 35 different types of bias associated with sampling and
measurement procedures in analytical research (148). Although many of these
forms of bias are more relevant in experimental research designs, a few of them
are applicable to survey designs and will be discussed in the context of the
current project. Many other forms of bias in research are recorded in the
literature, including: non-response bias, recall bias and social desirability bias
(80,141). Despite the rigorous quality assurance strategies applied in the
development and administration of the current questionnaire, it was not possible
to completely eliminate all bias.
The low response rate may have resulted in bias, because only pharmacist
prescribers highly interested or involved in prescribing practice may have
responded to the questionnaire; such that the results could be biased by
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‘atypical’ experiences. This was compounded by ethical requirements for
anonymity which did not permit the identification of questionnaire respondents
for the purpose of analysing possible non-response bias. However, evidence of
a systematic review suggests that non-response bias may be less problematic
when studying members of the same professional group such as physicians,
compared to studies involving the general public (149). Whilst this review by
Kellerman and Herold was focused on physicians, a similar argument may hold
true for pharmacist prescribers. Respondents in the current questionnaire
survey, were similar in terms of demographic characteristics to the general
population of pharmacist prescribers, reported in the latest analysis of GPhC
registers (146). This similarity in the characteristics suggests that pharmacist
prescribers are a fairly homogenous professional group for whom non response
bias may not be a major issue of concern.
Questionnaire surveys are particularly prone to recall bias; some questions may
task the memory of respondents to the extent that the information they provide
is selective and biased. However, this was probably less of a concern in the
current project since respondents were only required to give data on actual
prescribing practice. Social desirability bias occurs when respondents give
particular answers to impress researchers. This can potentially be a matter of
concern, especially considering that the sponsoring University for the current
project is a major provider of pharmacist prescribing training, and may have
been the training institution for many of the respondents. However, the postal
mode of questionnaire delivery and the anonymity of returned questionnaires
eliminated face-to-face contact with respondents, to minimise possible social
desirability bias (see strengths above). Notwithstanding, the results of the
questionnaire survey should be interpreted with caution; these will be discussed
in the next section.
3.10.3.7 Discussion of key findings
The general aim in this research project was to investigate the structures and
processes of pharmacist prescribing in GB. According to Donabedian,
‘structures’ comprise those attributes of the environment in which healthcare is
delivered, including: facilities, equipment, financial and human resources and
the way they are organised to deliver health services. Similarly, ‘processes’
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describe the actual activities undertaken in the course of delivering health care.
These include: patients’ care seeking activities that lead to health practitioners’
activities such as diagnosing illness and prescribing treatment (150).
Whereas, Donabedian framework of ‘structures’, ‘processes’ and ‘outcomes’
were proposed in relation to the definition and evaluation of the quality of
healthcare, his conception of ‘structures’ and ‘processes’ will be applied in this
project to discuss the implementation of pharmacist prescribing practice in GB.
The structures of pharmacist prescribing will cover the environment in which
they practice, including: setting, facilities, resources and personnel. Identifying
and quantifying these structures in the current project give an indication of the
amount (extent) of prescribing activities undertaken by respondents. Similarly,
the processes of pharmacist prescribing cover the activities undertaken by
pharmacists in the delivery of prescribing services, including conditions they
manage, how they identify the patients to prescribe for, dispensing of their
prescriptions and their prescribing related CPD activities. These give a
description of the type (nature) of prescribing activities undertaken by
pharmacists in GB. The implication of these findings on the policy and practice
of pharmacist prescribing will be presented in the next section.
A. Structures of pharmacist prescribing practice
i. Pharmacy practice setting
Results of the survey revealed that a majority of respondents had implemented
prescribing practice (i.e. they had prescribed for patients). Pharmacist
prescribers in the survey were already delivering prescribing services in various
settings, including: hospitals, GP practices, community pharmacies, prison
health centres, hospices, out-of-hour centres and substance misuse services.
‘Pharmacy practice setting’ was the only demographic characteristic of
respondents that significantly predicted their prescribing practice. This is the
setting in which respondents practise primarily as pharmacists. Non-parametric
analysis revealed statistically significant association between pharmacy practice
setting, and whether or not respondents had written prescriptions. Respondents
in hospitals and general medical practices were more likely to have written
prescriptions than their colleagues based in community pharmacies; they may
or may not be prescribing in the same setting as their primary pharmacy
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practice. Differences in the prescribing practice of pharmacists according to the
setting in which they are based has been reported in the literature.
A cross-sectional questionnaire survey to investigate early SP experiences of
pharmacists in GB, involved all registered prescribers at the time (n= 488
excluding the 30 who participated in the pilot). The study which achieved a
response rate of 82.2%, found that nearly half of the respondents were
practicing SP (60). The authors also found that 58.4% and 29.9% of the first
prescriptions written by pharmacists came from those in general medical
practice and hospital settings respectively. Thus they established that SP
practice was less likely in community pharmacies than in hospital and general
medical practice settings. Interestingly, even the hospital and general medical
practice settings had been associated with differences in SP implementation for
pharmacists. A survey of SCT chief pharmacists and individuals responsible for
SP implementation in PCTs across England showed that nearly equal
proportion of respondents (57% and 56% respectively) in the two settings,
planned to fully implement SP by 2005 (47). However, the authors perceived
that SP implementation barriers were more in general medical practices
because pharmacists were initiating novel roles and services, unlike SP in the
hospital setting which in most cases formalised existing practices.
The two studies cited above were undertaken when pharmacist prescribing was
in its infancy in GB, and only the SP model was operational (60) (47). This
represents a key difference with the current survey in terms of the study
populations. It was envisaged that the eventual implementation of IP was likely
to be more useful for pharmacists in different settings for different reasons.
Reporting on the risks and concerns about SP (a different aspect of the Hobson
and Sewell survey data cited above), Hobson and Sewell observed that SP was
better suited for chronic disease management; which made that model less
useful in hospital settings managing acute illnesses; hence IP was going to be
more useful. On the contrary, they argued that SP was less suitable for
community pharmacists because of the location of their premises outside GP
surgeries. Hence, IP was going to be more useful for managing minor ailments
(56). Despite the earlier optimism on the potential utility of IP in all settings, the
current study, conducted after several years of IP experience, shows that the
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‘structures’ for implementing pharmacist prescribing have not developed
equally in all settings. The level of prescribing undertaken in hospitals and
general medical practices, compared to community pharmacies, suggests that
the community pharmacy sector is least favourable for pharmacist prescribing
practice. This holds several implications for the policy and practice of
pharmacist prescribing in GB.
The low proportion of community pharmacists among respondents in
comparison to hospitals and general medical practices reflects the demographic
pattern in the GPhC register; which has less than one-quarter of prescribers
based in the community setting, despite nearly three-quarters of all registered
pharmacists in GB working in community pharmacies (146). This does not align
with the Government’s plan to deliver health services to the British public
through community pharmacies, as outlined in various policy documents
(17,151-153). Moreover, the ‘Crown’ report which recommended the
implementation of NMP listed enhancing patients’ access to medicines and
making best use of health professionals’ (pharmacists’) clinical skills, among the
goals for introducing the service (16). Therefore, the current survey results cast
doubts on whether the goals of implementing NMP for pharmacists are
attainable, given the current level of prescribing practice in community
pharmacies. The community pharmacy setting is best positioned to achieve the
objectives of increasing access of patients to medicines and making the best
use of pharmacists’ skills, largely attributed to the number of pharmacists
working in that sector and the size of the population it serves (154-156). It is
particularly relevant that more than 90% of the British population visit
community pharmacies annually, either as patients or healthy clients (155),
making this the pharmacy practice setting with the greatest potential to create
an impact through pharmacists’ prescribing activities. Therefore, it could be
argued that the overall success of pharmacists prescribing depends to a very
large extent on successful prescribing practice in community pharmacies.
ii. Facilities for pharmacist prescribing
Factor analysis of attitudinal responses to prescribing related statements in the
questionnaire identified three ‘factors’ associated with the practice of
pharmacists as prescribers. These were: ‘administrative structures and
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processes’; ‘perception of pharmacists’ prescribing role’; and the ‘facilities for
pharmacist prescribing’. Differences in the practice setting of respondents
(discussed above) were found to have arisen mainly in terms of the ‘facilities for
pharmacist prescribing’. This encompassed individual statements covering:
access of pharmacist prescribers to patients’ medical records; access to IT
facilities; communication with doctors; convenience of community pharmacies;
and the IP model as a facilitator of pharmacist prescribing practice. Availability
of adequate facilities appears to be a consistent factor involved with the delivery
of non-dispensing, cognitive roles in community pharmacies both in the UK and
internationally.
A systematic review of the literature conducted by Bond et al. to understand
community pharmacists’ response to the challenge of delivering enhanced
cognitive roles within the NHS, confirmed the key role of facilities in NHS
service delivery. The authors identified 50 research papers published within and
outside the UK, related to the involvement of community pharmacists in the
provision of health care services. They found consensus among pharmacists
that lack of facilities for access to patients’ medical records, severely limited
expansion of community pharmacists’ roles from technical dispensing, to patient
oriented clinical services (157). Similarly, Blenkinsopp and Celino reviewed
published evidence, and practice examples of the contribution of community
pharmacists to the management of patients with long-term medical conditions,
and found that inadequate IT links hindered remote access to patients’ medical
records from community pharmacies. This in turn imposed a major limitation on
their capacity to contribute optimally to the management of chronic diseases in
the UK (158).
Although the reviews cited above did not focus solely on pharmacist prescribing
practice, they are equally relevant for all patient oriented pharmacy services,
including prescribing. Capitalising on the open comments of survey respondents
and the individual statements that were grouped together by factor analysis,
show that facilities for prescribing is comprised of issues including: IT links for
access to patients’ medical records; space for patient consultation; availability
and adequacy of qualified support staff; and the financial resources needed to
commission and sustain services. The extent of pharmacists prescribing
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practice identified among study respondents based in hospitals and GP practice
settings may indicate taking advantage of the facilities already in place for
medical prescribers. This is particularly relevant to the NHS plans for
modernising services, which emphasises multi-disciplinary delivery of
healthcare (159). This underscores the challenges faced by prescribers in
community pharmacies in terms of the location of their premises, and the lack of
facilities for integration with the other members of the health team.
Data from observational studies indicate that community pharmacies within and
outside the UK have unique advantages, which have been applied to increase
access of the public to health services such as vaccination of at-risk individuals
(160); and improved smoking cessation rates in NHS patients with attendant
cost savings (161). However, challenges resulting from inadequate facilities
may hinder full exploitation of the potential available in the community pharmacy
sector. The observed limitations in the practice of prescribing by respondents in
the community pharmacy setting appear to nullify their advantage of easy
accessibility on the high street and longer opening hours (158). Therefore it is
important that this issue is explored further to gain in-depth understanding on
the setting and facilities (structures) of pharmacist prescribing practice. This will
be explored further in the qualitative phase of the project, drawing upon the
successful implementation of prescribing by pharmacists in hospitals and GP
practices (see Chapter 4).
B. The processes of pharmacist prescribing
i. Current prescribing practice of pharmacists
The processes of prescribing in the current study are denoted by routine
activities undertaken by pharmacists in prescribing for patients. Analysis of the
prescribing procedures used by respondents in primary care highlighted several
issues. Firstly, the most common conditions managed by pharmacist
prescribers were cardiovascular, respiratory and endocrine systems. Secondly,
a majority of questionnaire respondents personally identified or recruited
patients into their prescribing services; and thirdly, there is at present no clear
national guidance for the specific procedures adopted by pharmacist
prescribers in delivering prescribing services. Many of these issues have been
reported in previous studies. George et al. found that training in cardiovascular
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conditions during the PLP was a major predictor of pharmacists’ eventual
practice of SP. In addition, the authors found that 27.2% of their respondents,
experienced challenges with the referral process, for identifying suitable
patients for SP (48).
Despite similarities in the results of the study by George et al. and the current
survey, the difference between them should be noted. The current study, unlike
the one conducted by George et al. covers a period of relatively widespread
implementation of SP, and subsequent transition from SP to IP. It is perhaps of
concern that the same issues seemed to have persisted; and may have serious
Implications on the development of pharmacists’ prescribing practice. This is
even more apparent when viewed against the original context of the policy that
introduced NMP, which was to increase the access of patients to medicines and
decrease the workload of doctors; freeing them to take on the management of
more complex patients (16). The current survey results show that pharmacist
prescribing practice is mostly confined to the management of a few conditions,
for a few patients mostly identified by pharmacist prescribers themselves. It
could be argued that such ‘piecemeal’ approach to pharmacist prescribing
practice is incapable of decreasing doctors’ workload or making the best use of
pharmacists’ skills. Since a large proportion of the patients who could easily be
managed by pharmacist prescribers are still being managed by doctors, and a
wide range of conditions that could benefit from pharmacists’ expertise has not
become the key focus of activities. It is perhaps more worrisome that after
nearly 10 years of pharmacist prescribing implementation there is no national
strategy to match the areas of practice of pharmacist prescribers, to the needs
of the population. This notwithstanding, it is significant that the most common
condition of pharmacist prescribing is in the cardiovascular system. This has a
huge potential impact on the health of the British population considering that,
cardiovascular diseases are the most common impediments to good quality of
life and remain the highest cause of mortality in the UK (162).
Other processes of pharmacist prescribing identified in the current study show
that respondents were applying a variety of quality assurance steps in their
prescribing practice to ensure patient safety. Most of them had completed more
than 30 hours of CPD activities within the preceding year; and they self-audited
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their practice by getting feedback from patients and other health professionals.
Pharmacists were particularly cautious when dispensing their own prescriptions.
Some of them faxed their prescriptions to colleagues in other community
pharmacies for double-checking, before such prescriptions were dispensed.
These elaborate quality assurance steps stress the emphasis pharmacist
prescribers place on patient safety and the quality of their prescribing practice.
This has been confirmed in recent reports. A survey of nearly 300 pharmacist
independent prescribers in England incorporated a second phase, which also
involved the secondary analysis of national datasets of safety incidents relating
to prescribing, to determine the safety and clinical appropriateness of
pharmacist prescribers’ consultations, using the medicines appropriateness
index. The authors found that pharmacist IP was safe and clinically appropriate,
and that most patients were satisfied with the level of medicine information
provided by the pharmacist prescribers (139). Although the current project did
not specifically aim to establish the safety, or clinical appropriateness of
pharmacist prescribing, it is known that the right processes are essential
prerequisites to good outcome of healthcare (150). Therefore, determining the
procedures utilised by pharmacist prescribers in the current project is important.
It is reassuring that respondents in this study approached prescribing practice
with caution. This is particularly relevant in view of the initial concerns raised by
some doctors, that non-medical prescribing was going to compromise patient
safety (163). However, as pharmacist prescribing practice continues to develop
in GB, it may perhaps become necessary to re-examine the procedures
adopted by practitioners in the implementation of the policy. Hobson and Sewell
(discussed previously) argued that SP was likely to develop in an ad-hoc
fashion due to lack of national strategy to guide on the therapeutic areas of
pharmacists SP, and the type of expertise to be developed by pharmacist
prescribers (47). The current findings reiterate the necessity of providing such
national guidelines on specific activities like: therapeutic areas of practice,
patient recruitment and referral procedures and combined prescribing and
dispensing roles, especially in community pharmacies where the same
individual may be responsible for both functions. This would clarify, and
possibly enhance, prescribing practice of pharmacists towards achieving the
goals of increased access to medicines and decreasing doctors’ workload. The
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prescribing processes, described in the current study, could inform such policy
review. Thus, the qualitative phase of the project will attempt to gain a more in-
depth understanding of the processes that either work well or do not work well
for pharmacist prescribers.
ii. Change and development of pharmacist prescribing practice
Results of the current survey suggest that little has changed in the
implementation of pharmacist prescribing. Despite half of the respondents
reporting that they had increased the number of patients they were prescribing
for, the median number patients benefiting from pharmacist prescribing per
week was 10 (inter-quartile range 6-20). Similar results have been reported in a
survey of pharmacist IP in England (discussed previously) (139). The survey
which involved all pharmacist IP in England (n= 388) showed that 80% of all
qualified pharmacist prescribers were prescribing for patients, and almost 40%
of them managed less than 10 patients per week. Similarly, reports have shown
that the volume of items prescribed by pharmacists and the net ingredient cost
of the items they prescribed only increased slightly; in contrast with the volume
and cost of items prescribed by nurse prescribers in England between 2004 and
2007 (140). This implies that pharmacist prescribing, contributes only a small
fraction to the total number and cost of items prescribed in the NHS. It appears
doubtful if the current level of prescribing implemented in GB can achieve the
overall aim of decreasing the workload of doctors, in order to allow them to
concentrate on complicated patients. Perhaps increasing the number of
pharmacist prescribers, could mitigate this problem. Incorporating prescribing
training in the pharmacy undergraduate programme may be one path to
increasing the number of pharmacist prescribers; this way, pharmacists could
graduate from university qualified to prescribe.
A majority of respondents in the present study opposed the idea of pharmacy
students, graduating from the undergraduate programme, qualified to prescribe.
Instead, they felt that pharmacists need to gain practice experience before they
could become safe prescribers. However, there seems to be a reluctance of
experienced pharmacists participating in prescribing training. A cross-sectional
questionnaire survey of 4300 British pharmacists’ planned participation in SP
training, and their attitudes towards SP achieved a response rate of 55.1%. The
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authors found that almost all respondents were aware of pharmacist SP, but
only a minority were contemplating participation in SP training. The majority had
not thought about participating in SP, including those who considered
themselves as ‘venturesome’ and early ‘adopters’ of innovations (63). The study
by Stewart et al. sampled pharmacists that had not yet applied for prescribing
training, in contrast to the current study which studied pharmacists who were
already qualified as prescribers. However, respondents in the current study
seemed to have a consensus of opinion that the taught elements of the
prescribing course could be introduced in the undergraduate programme,
leaving the PLP to be undertaken post qualification.
This may present a less cumbersome way of training pharmacists for
prescribing in the future. Any change in the way pharmacists are prepared for
prescribing, may have far reaching implications on the policy and practice of
pharmacist prescribing in GB and internationally. Many developed countries
now make significant reference to events in GB, as they plan and implement
initiatives to extend the role of pharmacists in healthcare (18,164). Hence, the
issue of training pharmacy undergraduates for prescribing will be explored
further in the qualitative phase of the project.
C. Barriers to pharmacist prescribing
A significant proportion of respondents in this study had not prescribed. Again,
the pharmacy practice setting was the main difference in terms of demographic
characteristic, between respondents who had prescribed and those that had
not. Respondents based in community pharmacies were less likely to have
prescribed compared with their colleagues who were based in hospitals or
general medical practices. Non-prescribing respondents indicated lack of
opportunity as the main barrier that prevented them from applying their
prescribing qualification in practice; this resulted from such other reasons as:
administrative procedures, resource limitations and the lack of defined
prescribing roles for pharmacists.
Similar issues have been identified as challenges to the practice of pharmacists
as prescribers. George et al. found that lack of organisational recognition, lack
of funding, administrative delays resulting in the non-availability of prescription
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booklets and change of jobs by pharmacists were the main reasons why some
respondents were not prescribing (48). More recently, a cross-sectional
questionnaire survey of 179 pharmacist prescribers in the north-east of England
achieved a response rate of 54.7% (98/179). The authors found that 37
respondents were not prescribing at the time of data collection. Of the
respondents not prescribing, 24 had never prescribed mainly because of the
lack of defined prescribing role in their organisations; and 13 pharmacists were
no longer prescribing because they had changed jobs (165).
Although the studies cited above differ from the current study in terms of the
study population and sample size, the current findings indicate that little
progress has been achieved in terms of resolving the initial barriers and
challenges to pharmacist prescribing practice. There is presently no national
strategy for implementation of prescribing practice; hence pharmacist
prescribing seems to depend largely on the efforts of individual practitioners.
Baqir et al. commenting on their article cited above, argued that pharmacist
prescribing being ‘person-dependent’ stood the risk of collapsing in the event
that pharmacist prescribers experienced changes in their personal
circumstances (166). A questionnaire survey of 1992 random sample of nurse
prescribers (25% of all nurse prescribers) in the UK, achieved a response of
70%. The study found that the main barrier to nurse independent prescribing
practice was as a result of problems caused by local arrangements in their
organisations (167). While key differences between nurse and pharmacist
prescribing are acknowledged, the findings make apparent the need for a
national strategy to guide NMP practice.
For pharmacist prescribing, such guidance may include a clarification of how
the prescribing role of pharmacists should function in the multi-disciplinary
health team. It should be noted that despite identified barriers to pharmacists’
prescribing practice, a majority of the current study respondents had
successfully prescribed, especially in hospitals and general medical practices.
The apparent success of prescribing in these settings may provide some insight
into enhancing the prescribing practice in the community setting. Therefore the
issues that have either worked well, or not worked well, in the prescribing
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practice of pharmacists will be explored further, using qualitative methods in
Phase 2 of the project.
3.10.4 Summary and conclusion
In this quantitative phase of the research project, a cross-sectional
questionnaire survey identified the pharmacy practice setting of respondents, as
the main predictor of whether or not they applied their prescribing qualification
in practice. In addition, ‘facilities for prescribing’ comprising IT infrastructure for
access to patients’ medical records and electronic prescribing, were found to be
more readily available in hospitals and general medical practices, than in
community pharmacies. Thus, the extent of pharmacist prescribing
implemented in these settings was significantly more than community
pharmacies. The limitations of pharmacist prescribing practice in the community
setting have potentially negative implications. This may hinder the achievement
of enhanced patients’ access to medicines, and may neither make the best use
of pharmacists’ skills nor reduce doctors’ workloads which were the overarching
objectives of implanting NMP in the first instance. The quantitative phase also
provided a description of the processes by which respondents delivered
prescribing services in the primary care setting. This has highlighted several
issues in the prescribing practice of respondents. Thus further qualitative
studies would be required to provide a more comprehensive understanding of
the research project.
3.10.5 Reflections for further work
Facilitators and barriers to pharmacist prescribing practice have been identified.
However, it was not possible, using the survey approach, to gain in-depth
explanations of all the issues involved. How some respondents were able to
prescribe despite the challenges, shows that much can be learnt from exploring
the experiences of pharmacist prescribers. Findings in the quantitative phase
about prescribing role of pharmacists being unclear or misunderstood implied
that progress in the development of pharmacist prescribing may require some
clarification of the functions and operations of pharmacists as prescribers. Thus,
it would be useful to explore pharmacist prescribers’ views and perceptions of
the ‘ideal’ role for them in the care of patients. These issues can best be
addressed by qualitative methods, which was the rationale for designing a
Chapter 3- Cross-sectional questionnaire survey
130
mixed methods project to lead into a second phase of data collection. Using the
‘sequential mixed methods strategy discussed in Chapter 2, it is now possible to
extrapolate on the quantitative results, with in-depth qualitative investigation of
the factors that facilitate or inhibit successful implementation of pharmacists
prescribing in GB. In the next phase, the views and perceptions of pharmacist
prescribers regarding identified barriers and ways of advancing the
implementation of pharmacists prescribing practice will be explored in Chapter 4
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Chapter Four: Qualitative Interviews
This chapter presents Phase 2, the in-depth qualitative telephone interviews.
The chapter begins with a recap of the key findings of the quantitative phase,
and then outlines the aims and specific objectives of the qualitative phase. A
description of the methods applied in data generation and analysis are then
presented, before rounding up with findings and discussion of the qualitative
interviews.
4.1 Quantitative findings that informed the conduct of phase two
The results presented in Chapter 3 were derived through a quantitative cross-
sectional questionnaire survey, and it was established that a majority of
respondents were already practising as prescribers in GB. Working in general
medical practices or hospitals was significantly associated with respondents’
tendency to engage in prescribing practice. The main difference among the
practice settings was identified in terms of the facilities and infrastructure
available to support prescribing practice of respondents. In addition,
respondents enumerated a number of facilitators and challenges to their
prescribing practice including a lack of a clearly-defined prescribing role. It was
not possible using the quantitative method to explore these findings further; for
example, how the identified barriers and facilitators impeded or aided the
prescribing practice of respondents. Restricting respondents in the quantitative
phase to a few answer categories in the questionnaire did allow them to fully
express their views, perceptions and experiences of prescribing practice. In
contrast, qualitative methods have the advantage of eliciting rich data from the
perspective of research participants as discussed in chapter two. Therefore, this
phase of the project complements the quantitative phase by providing depth
and more rounded explanations of the issues involved in pharmacist prescribing
in GB.
4.2 Reflection on the focus of the project informed by findings of
the quantitative phase
The original aim of the project, as described in Chapter 1, was to explore
developments in SP and IP since implementation; focusing on an investigation
of the structures and processes of prescribing practice by pharmacists in the
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‘primary care’ settings of Great Britain. The project was planned to be executed
in two phases; in Phase 1, demographic characteristics of all pharmacist
prescribers were collected in a questionnaire survey which used filter questions
to focus the study on respondents based in the primary care setting. This
practice setting comprised of community pharmacies and general medical
practices as described in Chapter 3. The community pharmacy sector alone
employs more than seventy percent of all pharmacists registered in GB (146).
Moreover the latest pharmacy workforce census revealed that one quarter of
pharmacists worked in more than one setting in GB, combining roles in
community pharmacy and general medical practices (154). This informed the
original proposal to conduct the study in the primary care setting; and on this
basis Community Pharmacy Scotland provided funding for the project.
However, results in Phase 1 had shown that only a minority (less than 25%) of
pharmacist prescribers were based in the community pharmacy setting; with
even fewer (less than 8%) engaged in actual prescribing within this setting. In
addition, the quantitative phase identified significant associations between the
practice setting of respondents and their tendency to engage in actual
prescribing practice. These findings signified that practice setting may be
exerting a significant influence on the implementation of prescribing by
pharmacists. That being the case, it would be possible to extrapolate from
experiences in one setting and apply same to practice in other settings, for
example, it may be possible to draw lessons from successful prescribing
hospitals and apply them in a community pharmacy setting or vice-versa.
Therefore, the results of Phase 1 constituted grounds for expanding the focus of
the research to also include secondary care. The mixed methods strategy
adopted for this project (described in chapter two) supports this expansion
through an iterative process in which results of the quantitative phase informed
and guided the design of the subsequent qualitative phase (86). Consequently,
in this second phase of the project, respondents based in the hospitals will be
included in the sample to be interviewed. The research governance and ethical
issues raised by this inclusion, and the steps taken to address them, will be
explained in section 4.3.1
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4.3 Aims and objectives
The aim of the telephone interview phase was to explore in-depth key findings
of the quantitative phase, applying qualitative methods to probe the views,
perceptions, and experiences of respondents regarding prescribing practice.
The intention was to provide a deeper explanation of the issues involved in the
implementation, and possible developments, of pharmacist prescribing practice
and policy.
The specific objectives were:
1. To clarify from the perspective of pharmacist prescribers why and how
factors identified from the quantitative phase enhanced, or impeded their
prescribing practice.
2. To describe measures already adopted by individual pharmacist
prescribers, and their views of the strategies needed for successful
implementation of pharmacist prescribing practice.
3. To define and clarify the pharmacist’s prescribing role from the
perspective of pharmacist prescribers themselves; and to explore their
perceptions of developments in the pharmacist’s prescribing role.
4.4 Methods
The rationale for the choice of qualitative methods for this phase of the project
was described in Chapter 2. In particular, the advantage of qualitative methods
for eliciting rich data about the real world experiences, views and perceptions of
research participants was highlighted (96). This advantage has increased the
prominence of qualitative methods in addressing research objectives as the
ones outlined in section 4.3, which relate to the development of effective health
services (91). In addition, the relatively low cost and high efficiency of
telephone interviews compared with face-to-face interviews was considered in
Chapter 2; despite generating data of similar quality (116,119). These
considerations justified the application of in-depth, semi-structured, telephone
interviews for data generation in the qualitative phase of the project. The
specific steps and procedures of data generation and analyses are explained in
the sections following.
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4.4.1 Ethical considerations
In Phase 1, the North of Scotland Research Ethics Committee (NoSREC)
advised that the project did not require a full ethics review (appendix 3). This
advice was partly based on the understanding that NHS-employed pharmacist
prescribers were not going to be involved in the research, as explained in
Chapter 3. However, expansion in the scope of the project discussed in
sections 4.2 necessitated the inclusion of hospital pharmacists in the interview
sample. In addition, the research student and the project supervisory team
considered the project in its expanded form more as service evaluation, than
research (168,169). Therefore, the NoSREC was approached again for
guidance and advice on Phase 2 of the project. The NoSREC concurred with
the categorisation of the project as service evaluation (appendix 10), which did
not require a full ethics application (170).
Phase 2 of the project was planned in compliance with the ethics and research
governance policy of Robert Gordon University (129) described in Chapter 3.
Project information (appendix 11) was sent to prospective interview participants
by electronic mail. Information provided included: background to the project;
objectives of the study; criteria for choosing them as participants; and their
freedom to participate or withdraw from participating. In addition, prospective
participants were informed of the project sponsors, potential benefits of the
project, and what would happen to results of the study. They were assured of
the confidentiality of their responses, and that any data they supplied would be
processed and stored in accordance with the Data Protection Act 1998 (130).
All project records, including interview audio clips and transcripts, will be
destroyed on completion of data dissemination at the end of the study.
4.4.2 Initial development of the interview guide
An initial draft of the interview guide was developed around some key findings
of the quantitative phase that needed deeper explanations. Questions were
organised into sections to reflect the objectives outlined in section 4.3. This draft
was reviewed by members of the project supervisory team with diverse
academic and professional backgrounds, who were also experienced in
pharmacy practice research using qualitative methods. The review by the
supervisory team served to highlight potential pitfalls in the interview schedule.
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For example, they observed that some questions were too structured, and were
worded almost as in a questionnaire. This reflected the research student’s prior
background and training as a pharmacist with more experience in quantitative
than qualitative methods. Therefore the supervisory team offered advice on
restructuring and re-wording questions in the interview schedule. Table 4.1 is a
summary of the main points covered in the initial draft, before review by the
supervisory team.
Table 4.1 initial draft of the interview guide
Areas covered by the interview
Introduction and preliminary activities
 Greetings and self introduction to respondent
 Remind respondent of the project background and aims
 Assurance to keep to agreed time
 Confirm that respondent has accessed and accepted the online consent form
 Seek permission to audio-record interview
 Guarantee confidentiality; assure interviewee of responsible handling and storage of data
during transcription, analysis and reporting
Demographics
 Background information about respondent
 Information on prescribing practice
Section1 Clarify why and how facilitators enhance and barriers impede the
prescribing practice of pharmacists.
 Facilitators of prescribing implementation
 Barriers of prescribing implementation
Section 2 Clarify their perception and understanding of the pharmacist prescribing role
and possible developments of the role in future
 Describe their experience of prescribing implementation
 Define ideal prescribing role
 Describe ideal prescribing scenario
 What would they do differently in terms of prescribing implementation
Section 3 Development of prescribing
 Views on key developments in future
 Views in relation to the future training of pharmacists as prescribers
 Diagnosis, prescribing and dispensing
 Any general issues
The interview guide was re-drafted and reviewed several times, and this
resulted in redundant, leading or ambiguous questions being removed. A few
questions were added to clarify the prescribing role of pharmacists as specified
in Objective 3 (section 4.3). Development of the interview guide was iterative,
and was constantly evolving throughout the interviews. The loose structure of
the interview guide was used to direct conversations, but at the same time, the
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research student paid attention to participants’ accounts and modified questions
in subsequent interviews as appropriate. Issues raised by respondents were
followed up and clarified in subsequent interviews. Therefore, the interview
guide served as a flexible tool for moderating each interaction between the
interviewer and interviewee in line with best practice of investigating health
services issues (80,96).
The re-drafted interview guide had four main sections which covered the
following general headings:
1. Section 1: Introduction and additional demographic questions
2. Section 2: Questions to clarify why and how specific factors facilitate
and/or hinder implementation of prescribing by pharmacists.
3. Section 3: Questions to clarify pharmacist prescribers’ perceptions of
their roles as individual prescribers, including their desires and
expectations.
4. Section 4: Questions to explore respondents’ views regarding
development of pharmacist prescribing in general, and other issues they
considered relevant in the implementation of prescribing by pharmacists.
Table 4.2 gives a summary of the redrafted interview guide (details provided in
appendix 12).
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Table 4.2 Draft interview guide after review by supervisory team
General areas covered in each interview
Section 1 Additional demographic characteristics
1. How long they have been registered as a pharmacist
2. When they registered as a prescriber
3. Age
4. Main practice setting as a pharmacist
5. Prescribing setting if different from 4
6. Approximate number of hours spent prescribing in a week
7. Approximately number of patients prescribing for in a week
8. Patient groups managed as a prescriber
Section 2 Facilitator and barriers of prescribing implementation
1. What works or does not work very well in their prescribing practice
2. How do they monitor what works well
3. What changes have occurred in their prescribing practice
4. How difficulties have been resolved
5. If difficulties not resolved how they work around the challenges
Section 3 Perception of prescribing
1. What they consider ideal prescribing role in their practice as individuals
2. What they would change or do differently in prescribing if they had the opportunity
3. Key advice a new pharmacist prescriber
4. Developments they would want to see in their individual prescribing practice
Section 4 General development of pharmacist prescribing
1. Their views on development of prescribing within the profession of pharmacy
2. Views on the training of future pharmacist prescribers
3. Any other developments they consider relevant
After developing the interview guide, the research student’s interviewing skills
and techniques were tested in a mock telephone interview with a colleague. The
mock interview provided the research student with an opportunity to assess his
preparedness for performing multiple tasks during the interviews. These tasks
included technical handling of the telephone and recording equipment,
monitoring recording sound level, volume, pitch, and also keeping track of time.
With this preparation completed, the quality of the draft interview guide was to
be tested further in pilot interviews.
4.4.3 Pilot interviews
The draft interview guide was used in pilot interviews with two pharmacist
prescribers. The two interviews were recorded and transcribed verbatim, by the
research student. Transcripts of the interviews, together with digital audio
recordings, were reviewed for accuracy of transcription by the project
supervisory team members. This provided an opportunity to check the structure,
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flow and clarity of questions. The check involved assessment of the responses
provided against the questions put to respondents, to detect any
misunderstanding of questions. Review of the pilot interviews also considered
how the research student engaged respondents in conversation, using
appropriate prompts to elicit responses. In addition, approximate length of
interviews conducted with the draft guide was assessed. The supervisory team
did not consider any major change necessary in the interview guide or interview
techniques adopted by the research student. Therefore, data from the two pilot
interviews were included in the final sample for analysis.
4.4.4 Interview participants
Prospective participants for the telephone interview were selected from a list of
respondents who accepted the invitation that accompanied questionnaires in
the quantitative phase. Details of pharmacist prescribers (n=165) who
completed and returned the reply card from Phase 1 of the project were entered
into a database, to serve as the sampling frame for phase two. Reply cards
allowed respondents to provide email contact details, through which they were
sent invitations for the interviews phase. An invitation email containing a
portable document format (pdf) attachment of the project information sheet
(appendix 11) was sent to all pharmacist prescribers in the sampling frame. The
invitation email also contained a link to an online project web page, hosted by
Robert Gordon University. The web page provided additional information, and
contained a consent and copyright form (appendix 13). Prospective participants
had to read and agree to the copyright and consent form, before being included
in the interview sample. Copyright consent granted the research student
permission to use anonymised data from the interviews, including verbatim
quotes, in any resultant publications. The project webpage also made
provisions for participants to provide details of their telephone number(s), and
preferred day(s) and time(s) during which the interviews could be conducted.
These arrangements were necessary to minimise any disruptions or
inconveniences to interviewee’s schedules.
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4.4.5 Sampling strategy and sample size
Qualitative sampling strategies used in health services research were described
in chapter two (section 2.5.4). Selection of research participants to fulfil
predetermined criteria (purposive sampling) was described as the main
sampling strategy in qualitative research; and many of the other qualitative
sampling strategies are variants of purposive sampling (105). The pre-
determined criterion for the qualitative phase of the current project was to
selectively recruit interview participants with the purpose of achieving
maximum variability in terms of demographic characteristics. The sample so
recruited would capture a wide range of respondents’ perspectives in the
interviews. It was specifically desirable to obtain an interview sample that
covered the main pharmacy practice settings. This was particularly important
because the pharmacy practice setting had been identified as an important
predictor of prescribing practice in the quantitative phase. Moreover, the
expansion in scope of the project explained in section 4.2 meant that
pharmacist prescribers based in hospitals were now to be included in the
interview sample. This was to be achieved by deliberately selecting interview
participants from the sampling frame, who met those criteria. However,
response to emails inviting pharmacist prescribers for the interviews was very
low. It became expedient to adopt a convenience sampling strategy, to recruit
the most ‘readily-available’ participants, as described in Chapter 2. In this
process, pharmacist prescribers were recruited consecutively into the interview
sample as they accepted the invitation to participate.
In terms of the sample size, there are no guidelines in the literature regarding
the appropriate number of interviews to achieve data saturation. However,
pharmacy practice researchers have typically interviewed between 15 and 50
participants (169). In the current project, sample selection was planned to
continue up to a maximum of thirty. It was anticipated that thirty interviews were
sufficient to cover the issues being investigated and achieve data saturation,
without being too unwieldy to manage. This assumption tallied with the
recommendation of various authors that between 5 and 50 interviews were
sufficient. Moreover, Guest et al conducted an experiment involving 60
interviews, and reported that data saturation occurred after about 12 interviews
(171). Therefore, when a total of thirty-four pharmacist prescribers agreed to be
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interviewed, it was decided to include all of them; since this falls within the 15 to
50 range, typically interviewed in pharmacy practice research (169). Despite
adopting a convenience sampling strategy, the final interview sample displayed
maximum variability in terms of the characteristics of participants, similar to
what would have been achieved by purposive sampling.
4.4.6 Data generation
All 165 pharmacist prescribers on the sampling frame individually received a
generic invitation by email to participate in the telephone interviews. Emails
were sent using the blind carbon copy (Bcc) function, so that the email
addresses of other recipients were concealed. Whenever a pharmacist
respondent accepted the invitation, the completed consent and copyright form
was automatically transmitted to the researcher’s e-mail box. The pharmacist
prescriber provided a preferred telephone number, specific day(s), date(s) and
time(s) convenient for them to grant the interviews. The researcher then sent
individual emails to such respondents confirming details of the interview
appointment. This was followed later by another email 24 hours before the
actual interview to confirm that interviewees’ schedules had not changed. On
the appointed date and time the interviewee was telephoned using a conference
call facility, and the conversations were audio recorded using a Marantz® digital
audio recorder. Recruitment emails were sent to the first 85 pharmacist
prescribers on the sampling frame for Phase 2, followed by two reminders at
two weekly intervals. The process was repeated for the second batch of 80
pharmacist prescribers eight weeks after the first.
Interviews were to be of short duration, lasting between 15 and 20 minutes, in
order to keep respondents interested. Interview participants were also aware
that they could stop the interview at any time without having to explain their
reasons. This ensured that the interviews did not last longer than was
convenient for the participant. However some participants who wanted to talk
for longer had the chance to direct the conversations beyond 20 minutes.
Interviews were arranged and conducted sequentially until all participants who
accepted the invitation had been interviewed. Digital audio recordings of the
interviews were replayed and listened to several times, before they were
transcribed verbatim into Microsoft® word documents by the research student.
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The transcript of each interview was read by the research student, while
simultaneously listening to the digital audio recording to check for accuracy of
transcription. This was confirmed by members of the project supervisory team
who also read interview transcripts and listened to digital recordings at the
same time. They did not find any major errors of transcription; hence data was
ready for analysis.
4.4.7 Data analysis
Transcripts of telephone interviews were analysed with the aid of Nvivo® 8
software, a computer programme for managing qualitative data. The framework
approach for qualitative data analysis was used to organise and categorise
interview transcripts into emerging themes and sub-themes in a hierarchical
order. This approach was developed for applied policy research and involves
five inter-related stages as described by Ritchie and Spencer. The stages are
familiarisation, identifying a thematic framework, indexing, charting, mapping
and interpretation (101). These steps were made operational in this project as
follows:
 Familiarisation began with taking notes as issues were raised by
participants during each interview. Key concepts were marked as
potential themes to be used in the coding of interview data. Additionally,
interview transcripts were read repeatedly, while listening to the digital
audio recordings, to get a good grasp of the full range of issues
discussed by research participants.
 Identifying a thematic frame work was achieved by reviewing the
potential themes noted during the interviews, along with any ideas or
concepts identified from the repeated reading of the interview transcripts.
The research objectives were used to derive some thematic codes
apriori; as some questions were automatically categorised into pre-
determined codes. However, emerging themes were identified from
issues that were recurrent in the narratives of pharmacist prescribers.
 Nvivo® facilitated the labelling of all interview transcripts according to the
identified codes during the indexing stage of data analysis.
 Charting categorised the indexed data according to how they related to
each other. This process involved moving chunks of data, and re-
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arranging them under main themes or sub themes depending on the
central idea they contained. In the process some themes were merged,
and others broken down, while some passages of the data were charted
into more than one category.
 The mapping and interpretation stage evaluated central ideas embedded
in the themes and subthemes to provide explanations of the data. This
involved the use of verbatim quotes to illustrate themes or subthemes.
The selection of quotes considered opposing views, contradistinctions
and exceptions to further explain the data, in line with research
objectives.
The supervisory team read transcripts of interviews and listened to digital audio
recordings to devise thematic coding categories which were used to check the
robustness of the themes and sub-themes developed by the research student.
They also reviewed how the coding categories were applied in analysing the
data and found no major concerns; thereby attesting to the validity of the
analytical process. Findings from this exercise are reported in the next section.
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4.5 Findings from the qualitative interviews
This section presents findings from analysis of the in-depth telephone interview
transcripts. It begins with a description of demographic characteristics of
interview participants, followed by narratives explaining the themes and sub-
themes that emerged from the interviews. Verbatim quotes have been used to
illustrate themes and to aid interpretation of the data. Findings were structured
around objectives of the telephone interview phase as follows: factors
associated with the implementation of prescribing by pharmacists; factors
clarifying the prescribing roles of pharmacists; and exploring developments, and
the future of prescribing implementation by pharmacists.
4.5.1 Characteristics of interview participants
In Phase 1 of the project 165 pharmacist prescribers completed and returned
reply cards agreeing to participate in the telephone interview phase. They each
received an email invitation for the purpose of recruiting the interview sample.
Email delivery failure was reported for 53 respondents, because of illegible
hand writing, which resulted in the wrong email addresses being used.
Selection of the interview sample from the remaining 112 addresses is
summarised in Figure 4.1.
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Figure 4.1 Selection process of interview sample
Chapter 4- Qualitative interviews
145
Thirty-four pharmacist prescribers (twenty based in England and fourteen based
in Scotland and none were based in Wales) participated in the interviews
conducted one-to-one over the telephone. Interviews had an average duration
of 20 minutes, and ranged from fifteen to forty minutes. Twenty-four female and
10 male participants reflecting a similar pattern on the GPhC registers (146).
The composition of pharmacist prescribers interviewed provided diverse
professional and personal characteristics, representing a wide range of views
and opinions. Participants had between 8 and 46 years experience of working
as pharmacists, mostly in GP surgeries and hospitals with a few in community
pharmacies. There was at least one participant from settings such as Primary
Care Trusts (PCT) or Health Boards, prisons, drug misuse clinics and those
who split their work between two settings.
Whereas differences in the delivery of health services between England and
Scotland are acknowledged, which may deter from direct extrapolation of
participants’ experiences across the two jurisdictions, the experiences narrated
by interview participants were mainly similar in the two countries. Therefore, the
practice setting and country in which participants are based have been provided
along with the quotes, so that these can be read in context. Table 4.3 gives a
summary of the personal, professional and prescribing characteristics of
interview participants. Twenty-nine participants had commenced prescribing
managing a wide range of conditions (mainly cardiovascular and respiratory)
across different settings (mainly general medical practices and hospital).
Table 4.3 Personal characteristics of interview participants
Characteristics Number of participants
Age group (years)
30-39 14
40-49 11
50-59 7
≥ 60 2
Sex
Female 24
Male 10
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Table 4.4 Professional characteristics of interview participants
Table 4.5 Prescribing characteristics of interview participants
Characteristics Number of participants
Year(s) of experience as a pharmacist
5-10 4
11-15 9
16-20 3
21-25 9
26-30 4
≥ 31 5
Practice setting as pharmacist
GP practice 13
Hospital 8
Community pharmacy 5
Other settings ( settings listed in the text) 8
Country of participants’ practice as pharmacist
England 20
Scotland 14
Wales Nil
Characteristics Number of participants
Year(s) of experience as a prescriber
1 6
2 6
3 17
4 4
5 1
Time in hours/ week spent prescribing
Not prescribing 5
1-4 9
5-8 11
9-12 6
Above 13 3
Patient load/week
Not prescribing 5
1-10 11
11-20 11
21-30 4
Above 30 3
Therapeutic group(s) managed by pharmacist prescribers
Cardiovascular 18
Respiratory 8
Central nervous system 5
Endocrine 3
Others 7
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4.5.2 Factors associated with the implementation of pharmacist
prescribing
In Phase 1 of the research, analysis of questionnaire responses, identified and
quantified factors associated with the implementation of prescribing by
pharmacists. These factors, as observed in Chapter 3 were often antonymic, in
the sense that the same factor influenced prescribing implementation both as a
facilitator or barrier, depending on the circumstances in which the factor
operated. Data from the interviews provided further insight into the interaction
of these factors to facilitate or challenge prescribing implementation. Interview
participants described their perceptions and experiences of prescribing practice.
The following sections provide details on the key themes and subthemes that
emerged from the interviews, but first a summary is presented in Table 4.6
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Table 4.6 Summary of key themes and sub-themes from the analysis of telephone interviews
Objective categories Themes subthemes
4.5.2 Factor
associated with
pharmacist
prescribing practice
4.5.2.1 Support for pharmacists implementing prescribing A. Clinical support
B. Administrative support
C. Organisational support
4.5.2.2 Consistent patient contact for prescribing activities
4.5..2.3 Regulatory issues
4.5.2.4 Lack of clarity about pharmacists’ prescribing role A. Lack of clarity among pharmacist prescribers
B. Lack of clarity among other health care professionals
C. Lack of clarity among patients and the general public
4.5.3 Strategies for
successful
prescribing practice
4.5.3.1 Identify or create niche areas for pharmacist prescribing
4.5.3.2 Promote pharmacist prescribing activities
4.5.3.3 Increased uptake of prescribing by pharmacists
4.5.3.4 Agreed formal prescribing roles and boundaries
4.5.4 Clarifying the
role of pharmacists
and developments in
prescribing practice
4.5.4.1 Ideal structures for pharmacist prescribing
4.5.4.2 Ideal prescribing roles of pharmacists
4.5.4.3 developments in pharmacist prescribing practice
A. Training i. Issues with the current training of pharmacist prescribers
ii. Training pharmacy undergraduates for prescribing
B. Practice priority for pharmacist prescribers
C. Benefits of pharmacist prescribing i. Patient related benefits
ii. Professional benefits
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4.5.2.1 Support for pharmacists implementing prescribing
Interview participants narrated various experiences that enhanced or diminished
support, and the outcome of that support in their prescribing practice.
Pharmacist prescribers described support for implementing prescribing as
clinical, administrative and organisational support. Where available, participants
considered adequate support a key facilitator, and inadequate support a
challenge to the implementation of prescribing practice.
A. Clinical support
Clinical support was described by interview participants in terms of the feedback
or advice they received from doctors regarding specific issues about the
management of patients. They perceived that clinical support facilitated their
prescribing practice through the enhanced confidence they gained after dealing
with difficult cases. Interaction with, and feedback from other clinicians created
the atmosphere for them to reflect on their prescribing decisions. Clinical
support was particularly valued in the early days of pharmacists implementing
prescribing; then as their confidence improved with time, so did their
competence in prescribing.
“... but you need somebody to talk your cases over with, and
challenge you to think about how you are practising. So I think
clinically you need to have somebody to support the work you do
and be able to talk about particular patients ...”
(Interviewee 2- Male, nineteen years experience as a pharmacist in England, prescribing
for drug dependence in a drugs misuse clinic over three years)
“... I think if you don’t have the support of certainly the doctors
involved in the care or management of the patient you are seeing, it
makes it very difficult to prescribe with confidence ... and then
generally if you are not prescribing in a supportive environment
then that makes it quite difficult for a newly established profession
in terms of prescribing to flourish. I think it has to have at least
some support from key professionals dealing with that area be it
primary care or secondary care.”
(Interviewee 17- Male, sixteen years experience as pharmacist in England, prescribing in
hospital chronic renal failure over one year)
Participants based in hospitals or GP practice settings for their primary role as
pharmacists, perceived that they had adequate clinical support because of the
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pre-existing good working relationship they already enjoyed with other health
care professionals who worked in the same setting. Similarly, those based in
the community pharmacy setting, narrated their experiences of clinical support if
they prescribed in general medical practices. Some, who prescribed in both GP
practice and community pharmacy settings, confirmed that prescribing was
easier in the GP practices, because of clinical support among other reasons.
Cordial working relationships and good communication with other health care
professionals minimised inter-professional conflicts, and antagonism to the new
role of pharmacists in prescribing. It was the view of participants that clinical
support ensured all members of the health care team pursued common goals in
the best interest of patients. In this regard, patients were referred among
different health care professions based on which profession had the most
appropriate skills to intervene.
“Team working gives you much more information about the patient,
and it gives you much more support if you need it; and I have a
good working relationship with the GPs ... I have referrals from the
practice nurse; I have referrals from the doctor...So I think the close
working relationship in the team is the best part”
(Interviewee 23- Female, twenty-nine years experience as a pharmacist in Scotland,
prescribing for asthma/COPD in a GP practice)
B. Administrative support
Interview participants recognised the supportive role of administrative and
managerial staff that provided the necessary logistic arrangements for the
smooth running of pharmacists’ prescribing activities. Administrative support
was frequently described by interview participants in terms of the logistics of
actually setting up and running prescribing services.They perceived that
administrative support enhanced the efficiency of prescribing, and freed
pharmacist prescribers to concentrate on clinical roles including the prescribing
of medicines.
“... I also think the practice staff, the reception team is very
supportive of prescribing and my role in it so …”
(Interviewee 8- Female, eleven years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over four years)
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Initial logistic difficulties for some interview participants included the lack of
dedicated space for patient consultation and insufficient time for prescribing
activities. Similarly, limited access to patient medical records and information
technology (IT) facilities were considered major hindrances for pharmacists
delivering prescribing services. On the other hand, interview participants who
succeeded in implementing prescribing were those who worked in environments
with a minimum of such logistic challenges.
“I do think that the GP setting at the moment is the best for non
medical prescribing because you have all the information and
patient details in front of you and you are not going to miss
anything.... outside GP clinics, I can see a setting in health centres
because it is quite likely, that records would be available there as
well...”
(Interviewee 29- Male, thirty-nine years experience as a pharmacist in England,
prescribing for hypertension and hyper-lipidemia in a GP practice over one year)
Administrative support in terms of organising the logistics of prescribing
services was mentioned more by interview participants based in hospitals and
general medical practices. They perceived that it was less likely to obtain the
same level of support in community pharmacies. Some of them even suggested
that prescribing was only possible for pharmacists based in GP practices and
hospitals.
“... if pharmacists want to be prescribers at the moment, they would
have to base themselves in GP practices and not in the community
pharmacy ... I know one pharmacist who renders review services,
and consultation for COPD within a pharmacy, but her problem is
that she has to go to the GP practice to get patient notes and other
necessary logistic support ... whether that can work I don’t know”
(Interview 14- Male, twenty one years experience as a pharmacist, prescribing for
hypertension in a GP practice over four years)
“I would prefer to see pharmacists prescribe in a GP setting
because then you have access to the computer, you have access
to paper notes, you have access to nurses, GP colleagues etc, I
would find doing my job very difficult in the community pharmacy.”
(Interviewee 1- Female, twenty-two years experience as a pharmacist in Scotland,
prescribing for hypertension in a GP practice, over one year)
Indeed, respondents who prescribed in both GP practice and community
pharmacy settings affirmed that the logistics were easier in the GP setting.
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Practice staff and receptionists handled the administrative tasks in the GP
setting, whereas they had to deal with those tasks themselves in the community
pharmacy.
“... where possible it will be good to have these things [prescribing
services] in the community pharmacy ... I think there is a lot of
benefit to having them in there, but of course there are practical
elements and logistics which means that it does become a problem
working within the community”.
(Interviewee 7- Male, nine years experience as a pharmacist in Scotland, prescribing in a
GP surgery and running a smoking cessation service in community pharmacy over four
years)
Interview participants based in community pharmacies also mentioned the
challenge of physical distance from other health professionals, who were often
located in GP practices. Such distance, they perceived, lead to communication
difficulties between them and the GP practices. Some described their frustration
at being isolated and detached from the supportive environment of a multi-
disciplinary health care team.
“Yes the admin side was a nightmare, we have no IT connections
with the surgeries, so you have to see the patients in the shop,
gather all your information, walk up to the surgery, put it all in the
computer. That all takes time, so that limits you to where you can
go…, I do actually run a couple of clinics in the surgeries and that is
so much easier because, you have the computer up in front of you,
you have all the records of the patient so you put it straight on to
the computer, it makes life so much easier.”
(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
It appeared from the interviews that administrative and logistic problems which
were present at the inception of pharmacist prescribing had not been solved
after so many years of implementing prescribing by pharmacists.
“I hope we can have IT links with the surgeries, but until that
happens, and we have been talking about this for how long? Ten
years at least to my knowledge, maybe a bit longer, and every year
they keep saying it will be up and running and here we are, we are
still ... so it is just an absolute nightmare and I think it is extremely
difficult to expand the service in any meaningful way unless we
have IT connection ...”
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(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
The sort of administrative problems that have persisted seemed to be those
related to policy and strategies initiated at the organisational level for
implementation of pharmacist prescribing. Hence, interview participants
considered organisational support a key factor in their implementation of
prescribing practice.
C. Organisational support
Strategic policies and priorities of NHS Trusts, Health Boards and GP practices
were described by interviewees as having direct bearings on the administration
and logistics of pharmacist prescribing services. Interview participants
emphasised the issue of funding the prescribing activities of pharmacists.
Some expressed concern about the workability of prescribing in community
pharmacies, considering the apparent lack of budgetary provisions in that
sector.
“… well it is not my problem but I really wonder and worry how
pharmacists who are trying to do prescribing in a community
pharmacy setting manage, because they don’t have a budget I
mean I worked in the community pharmacy myself and I can’t see
how it would work, you would have to have amazing set up with
PCTs or surgeries or something that you would be allowed to
prescribe for people”
(Interviewee 20 - Female, thirty-five years experience as a pharmacist, prescribing for
chronic kidney disease in a GP practice over three years)
In addition, those in the community pharmacy setting felt that existing funding
mechanisms for prescribing services did not include any financial benefits to
community pharmacy businesses.
“I think the funding stream is still a bit of a problem; you know we
don’t really get anything to drive pharmacy businesses to do it ...
Very often, pharmacist prescribers would be doing stuff in the
doctor’s surgery which makes QOF points for the surgery and
extend remuneration for that surgery; but the only way of getting
that remuneration for our own businesses is to try and negotiate
with the surgeries ... so I think some sort of directive that when a
pharmacist is into partnership with a surgery then there is some sort
of sharing of the funding that the partnership generates ...”
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(Interviewee 7- Male, nine years experience as a pharmacist in Scotland, prescribing in a
GP surgery and running a smoking cessation service in community pharmacy over four
years)
Funding and budgetary issues were not however, restricted to the community
pharmacy setting. Interview participants from all practice settings narrated
experiences of funding limitations in their organisations. Funding problems were
described in relation to administrative and logistic problems as explained above.
On a personal note, pharmacist prescribers felt strongly that they were not
adequately compensated financially, despite having to deal with increased costs
of indemnity insurance and registration with the professional regulatory body.
“...basically we need additional funding from the GP practice or
within the NHS department to fund that extra, because I am not
going to come for half a day and have to pay child care etcetera
with no payment. Unfortunately we have to be practical.”
(Interviewee 21- Female, twelve years experience as a pharmacist in England,
prescribing for cardiovascular conditions in a GP practice over three years)
“... if the organisation, the NHS were willing to pay the indemnity
insurance to support people to take on the extra role, then
obviously I would be happy to take on prescribing independently;
but because you would actually get worse off having to pay more
insurance, then it is not worth my personal while to do that ...”
(Interviewee 6- Female, ten years experience as a pharmacist in Scotland, prescribes for
hypertension in a GP practice over three years)
Interview participants also perceived that organisations could support
implementation of prescribing by formulating clear frameworks of career
progression for pharmacist prescribers. For example, respondents based in
hospitals and GP practices suggested a banded structure for pharmacist
prescribers, depending on their skills and experience, up to the consultant
grade.
“I suppose it is the pay structure really, I don’t think it is particularly
clear. I would probably go through all that training and not actually
see any benefits, I mean we are not just doing it for money but it
would be quite nice to think that you are sort of being paid
according to skills … Well, yeah just sort of being able to say you
expect to be a grade whatever as supplementary then, I mean
similar to those of the GP system … just to have like a ladder where
you are sort of aiming, and you are ultimately paid according to
your expertise and obviously the extra work you have to put in to
get there really.”
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(Interviewee 31 - Female, twenty-four years experience as a pharmacist, prescribing for
neurology and cardiovascular conditions in hospital and GP practice settings over three
years)
Although administrative and logistic difficulties were described by pharmacist
prescribers in all settings, they frequently noted many of the issues were
surmounted as more pharmacists engaged in prescribing practice. Consistent
engagement in prescribing practice was therefore mentioned as one of the key
factors associated with the implementation of prescribing.
4.5.2.2 Frequent patient contact for prescribing activities
Frequent patient contact was regarded by interview participants as essential in
developing prescribing competence and confidence. Respondents frequently
alluded to the idea that ‘practice makes perfect’. Therefore, they identified
space for patient consultation as one of the essential structures that facilitated
prescribing practice.
“The fact that the clinic is running regularly, I think has made the
thing sort of successful. I do know of colleagues who had problems
getting rooms, had problems getting space you know, had problems
with support and all the rest of it …”
(Interviewee 31 - Female, twenty-four years experience as a pharmacist, prescribing for
neurology and cardiovascular conditions in hospital and GP practice settings over three
years)
Availability of dedicated space and regular scheduled times for patient
consultation facilitated continuity of care in pharmacist prescribing. In those
circumstances, pharmacist prescribers follow up patients in the long term; and
regular contact with the same group of patients allows them to develop
competence, before gradually expanding the role.
“... if you are not examining patients on a regular basis you quickly
lose the skills, you lose your confidence. It is better to focus on a
small suite care and do a lot of it regularly and gradually expand the
role”
(Interviewee 17- Male, sixteen years experience as pharmacist in England, prescribing in
hospital chronic renal failure over one year)
Some participants contrasted regular prescribing sessions with their
experiences in the early periods of prescribing practice, which they described as
‘ad hoc’. Prescribing services were said to be organised, and managed in a
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manner that did not permit appropriate follow-up of patients. Appointments
were often inconvenient for patients, who had to make multiple visits to different
prescribers. Similarly, those participants who worked part-time, or who were in
rotational posts, perceived that irregular working practices had negative impact
on their prescribing practices. Prescribing sessions had to be arranged around
the prescribers’ schedules which were not always convenient for patients, and
that often caused them to miss appointments.
“… The referrals to the clinic initially were a bit inappropriate, so
that was an issue with the clinic set up, and patients were not that
keen to come, certainly in the early days not keen to come to an
additional clinic.”
(Interviewee 17- Male, sixteen years experience as pharmacist in England, prescribing in
hospital chronic renal failure over one year)
“... the negative side of things is that patients get frustrated that
they have to see the doctor for one issue, then they have to see me
for the review and they have to see the nurse for the bloods so you
do get occasional patients who are frustrated that they have to
attend three things rather than one but that is more of an admin
issue rather than you know …”
(Interviewee 14- Male, twenty-one years experience as a pharmacist in England,
prescribing for hypertension in a GP practice over four years)
The importance of a practice environment that is conducive for consistent
patient contact was highlighted by a participant that prescribed within the prison
setting. This participant attributed success in prescribing practice to the fact that
all the necessary support structures were accessible, and that patients always
turned up to the prescribing sessions.
“Well because it is a prison, the patients always turn up, they are
here, so they are just brought across by the officer and the doctors
are here, the medical notes are here, everything is here and I can
get access to everything I want. I can get a room to hold the clinic
in..., there is nothing really that I need because everything is here at
the moment, so this is perfect ...”
(Interviewee 11- Female, twenty-one years experience as a pharmacist in Scotland,
prescribing for asthma in a prison setting over one year)
4.5.2.3 Regulatory issues
The requirement for using clinical management plan (CMP) in supplementary
prescribing was frequently mentioned as a critical factor associated with the
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implementation of prescribing. The CMP which is meant to provide a safeguard
for non medical prescribers requires that the pharmacist obtains written
agreements for a named patient, and include disease conditions and rugs to be
used in managing the condition (see Chapter 1). Some participants were of the
view that CMPs were impractical and cumbersome, particularly for managing
categories of patients like those admitted in acute hospital settings. In particular
there were issues raised about getting the required agreement from all parties.
Such statutory requirements for the CMP often lead to delays in the process of
prescribing and drug administration.
“The biggest barrier, the biggest problem I have with the work that I
do is still with controlled drugs (CDs), how I can only prescribe them
through supplementary prescribing arrangement. I am confident
and competent to deal with controlled drugs, but I still have to go
through the process of being a supplementary prescriber ... I
suppose one of the issues raised is that it makes the response time
between seeing a patient and getting his methadone prescription
longer. If I didn’t have to do that..., I am supposed to get the guy or
the girl the treatment a lot quicker than I can at the moment,
because it necessitates me having a discussion with my clinical
supervisor and agreeing on the CMP”
(Interviewee 2- Male, nineteen years experience as a pharmacist in England, prescribing
for drug dependence in a drugs misuse clinic over three years)
Although independent prescribing does not require the use of CMPs, the
prescribing of controlled drugs (CDs) by pharmacists still has to be done using
CMPs as described in Chapter 1 under supplementary prescribing. CMPs entail
pharmacist prescribers agreeing with doctors and patients in writing, individual
therapeutic plans covering specific disease conditions and the drugs or classes
of drugs to be used (16). Consequently, pharmacists whose practice involved
the prescription of CDs, including those using CDs for the management of pain,
regretted the limitations imposed on their practice as a result of these regulatory
issues.
“It is difficult getting clinical management plans individually signed
off for the patients; and it is also hard to explain to a patient and the
medics, that yes I can prescribe this, this and this; but I am afraid
those (controlled drugs) can only be prescribed by yourself, or we
have to have a clinical management plan ...”
(Interviewee 26- Female, fourteen years experience as a pharmacist in England,
prescribing for cardiovascular conditions and elderly care review in a GP practice over
three years)
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Many participants were, however, optimistic that restrictions on independent
prescribing of controlled drugs would soon be removed. They also expressed
the opinion that it was more appropriate for CDs to be prescribed by
pharmacists, because their professional training gives them better knowledge
about drugs than nurses. Some described past experiences in which their
expertise was applied successfully to manage patients with CDs.
“... four years ago I ran a benzodiazepine reduction clinic where I
saw patients and got them off mainly nitrazepam, temazepam and
lorazepam; doing all the prescribing and seeing the patients on a
monthly basis and gradually weaning them off. The patients had
nearly 50% success rate which is excellent …”
(Interviewee 29- Male, thirty-nine years experience as a pharmacist in England,
prescribing for hypertension and hyper-lipidemia in a GP practice over one year)
Apart from regulatory issues, interview participants narrated challenges related
to an apparent lack of clarity in the prescribing role of pharmacists.
4.5.2.4 Lack of clarity in the pharmacist prescribing role
It was apparent throughout the interviews that some features of pharmacist
prescribing were unclear to different stakeholders in the prescribing process.
Interview participants perceived that lack of clarity resulted in confusion that
undermined the smooth running of pharmacist prescribing services.
A. Lack of clarity among pharmacist prescribers
Some interview participants appeared not to be very clear about their own
prescribing roles. This was conveyed in the way they described their prescribing
roles relative to that of nurses. They frequently narrated experiences of
competition between practitioners of the two professions, resulting from a lack
of clear distinction in their roles. Pharmacist prescribers felt they lost out on
many prescribing opportunities because nurses provided the same services at
cheaper rates.
“I did have issues with one particular nurse in one particular
practice who made things very difficult because she had never
heard of the concept of pharmacists coming in to prescribe, and
she saw it as a threat and this really made it difficult ...”
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(Interviewee 31 - Female, twenty-four years experience as a pharmacist, prescribing for
neurology and cardiovascular conditions in hospital and GP practice settings over three
years)
Some respondents compared their consultation styles with those of nurses and
GPs in a sense that portrayed each of the health professions had the same
objectives in prescribing.
“...the practice that I work in has three nurses to deliver a range of
clinics; hypertension clinics, diabetic clinics things like that so it is
important that I don’t duplicate their work but that I work in
conjunction with them so it took a little time to work out what was
the best role for me...”
(Interviewee 9- Female, twelve years experience as a pharmacist in Scotland, prescribing
for cardiovascular conditions in a GP setting and runs a pilot project managing minor
infections in a community pharmacy, over three years as a prescriber)
“Effectively, we could do what nurses are doing, run asthma clinics
for GPs, run diabetes clinics for them, run pain clinics and
hypertension clinics, COPD clinics..., so yes I think pharmacist and
nurse prescribers are interchangeable. For those pharmacists who
have actually made the attempt to go and do the extra courses I
think they are interchangeable...”
(Interviewee 16- Female, twenty five-years experience as a pharmacist in England,
qualified as a prescriber in diabetes over two years, practised in community pharmacy
and academia but not prescribing)
Similarly, interview participants based in the hospital setting, introduced the
argument that the prescribing role of pharmacists could potentially deskill junior
doctors. What emerged from this argument seemed to suggest that pharmacist
prescribers and the junior doctors performed the same roles in the prescribing
of medicines.
“We were very aware on the in-patient side in the ward that the
junior doctors might then say oh we have got pharmacists
prescribers we don’t have to do certain things...”
(Interview 12- Female, twenty four years experience as a pharmacist prescribing for HIV
in a hospital over three years)
“I think the only negative is that junior doctors become a bit
deskilled; and because we don’t provide a service seven days a
week, so when they are left to themselves at the weekend I think
they become…, it creates a bit of a risk … and in future that might
become even more difficult for them”
(Interviewee 3- Female, Twenty-six years experience as a pharmacist in England,
prescribing in renal impairment in a hospital over three years)
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The apparent confusion around the prescribing role of pharmacists manifested
in the divergent views about the scope of conditions they can manage. The
predominant view among interview participants was that pharmacist prescribers’
main expertise related to the management of multiple co-morbidities.
Participants with this view suggested that pharmacist prescribers had no useful
role in the management of ‘simple’ and ‘straight forward’ conditions. They
preferred instead, that nurses were left to handle those simple conditions; and
pharmacists could then apply their expertise and skills in managing patients
who need multiple drugs for co-morbidities.
“I don’t think we necessarily have a role to play, prescribing in mono
disease areas for example asthma, infections, family planning and
that kind of thing. I think those are the kind of things a nurse
prescriber can deal with. I think the only areas within general
practices that the pharmacist has the advantage is in long-term
conditions and multiple co-morbidities. Cardiovascular disease is
the most common one, a lot of the cardiovascular diseases overlap,
and what you need is quite a good pharmacological knowledge of
different agents in terms of their interactions and certainly adverse
reactions will occur if you are prescribing multiple agents for
different conditions. I think that goes well beyond what a nurse can
manage in a prescribing clinic.”
(Interviewee 18- Male, thirteen years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over three years)
On the contrary, others felt the complexities of co-morbidities presented a
challenge to pharmacist independent prescribers. This category of respondents
preferred that pharmacists managed what they described as ‘simple’ and
‘uncomplicated’ cases.
“I mean I have never gone through independent because I have
problems with the issues of co-morbidities, and I think people did
and did not feel confident prescribing for co-morbidities ...”
(Interviewee 5- Female thirty-three years experience as a pharmacist in Scotland, PCT
prescribing advisor, registered as prescriber over five years, prescribed for a while in a
GP practice but had to stop)
B. Lack of clarity among other health professionals
Interview participants described lack of understanding and clarity of
pharmacists’ prescribing role among other health care professionals, especially
doctors and nurses. They perceived that lack of understanding lead to
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antagonism and resistance to pharmacists implementing prescribing. Some
narrated experiences where doctors or nurses felt threatened by pharmacists
prescribing. One participant, who was not using the prescribing qualification,
explained that it was because her GP colleagues were not happy about the
prescribing role of pharmacists. This participant reported that some GPs
regarded pharmacist prescribers as ‘half-baked doctors’. Indeed, other
participants repeatedly mentioned that some doctors perceived pharmacist
prescribers as ‘second grade’ alternatives to themselves. Some interview
participants narrated stories of personal encounters with doctors, in which the
doctors expressed the view that pharmacist prescribing, had an underlying
Government agenda to replace GPs with pharmacist prescribers as cheaper
alternatives.
“... biggest problem the biggest barrier we have is a lack of
understanding of what role the pharmacist would play when they
prescribe. There is very little clarity on the part of GPs’
understanding ... There is a lot of myth and untruths about what
pharmacist prescribing is all about because they think there is an
underlying government agenda … one GP said to me ‘there is an
underlying government agenda to take our work from us so that
they can cut down on the number of GPs ...”
(Interviewee 16- Female, twenty five-years experience as a pharmacist in England,
qualified as a prescriber in diabetes over two years, practised in community pharmacy
and academia but not prescribing)
Some interview participants described how institutions implemented pharmacist
prescribing policy, portraying lack of understanding on the part of managers and
administrators. Some hospital administrators applied the same criteria for
implementing nurse and pharmacist prescribing, without considering the
peculiarities of the two professions.
“... The way that hospitals have implemented non medical
prescribing (NMP) for nurses is to come up with a personal
formulary, and they can only prescribe from that list of medicines.
Hospitals try to implement pharmacist prescribing in the same way.
If you look at the way nurse prescribing is implemented, they
usually work within a specialty, so it might be a diabetic nurse, for
example, or heart failure nurse; they are going to be quite specific
about the list of medicines they want to prescribe for their patients.
However, if you look at that role of pharmacist prescribing the
patient’s usual medicines on admission, that is quite a wide range
of medicines that could be prescribed; so it would be difficult to
come up with a personal formulary that would allow you to do that.”
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(Interviewee 34- Male, ten years experience as a pharmacist in England, qualified as
prescriber in a hospital for more than one year but was not prescribing)
C. Lack of clarity among patients and the general public
Interview participants emphasised the importance of patients’ awareness and
understanding of the prescribing role of pharmacists. Some were of the view
that patient confidence in the prescribing process increased when they
understood the role of the pharmacist prescriber. They even perceived that
such awareness and understanding could translate into patient acceptance of,
and adherence to, their medication. However, interview participants described
their experiences of patients being surprised and having no expectations of
being referred to a pharmacist prescriber. Some reported instances of patients
initially being reluctant to discuss their medical issues. Some patients
demonstrated confusion, referring to pharmacist prescribers as doctors.
“I think what has not worked well is that … you know some medical
practices you have to find where you fit in within the health care
team and sometimes patients can’t understand why I should be
discussing medical stuff with them ... They didn’t understand why
they should be talking to me, and some patients didn’t want to
discuss their issues with me because I am not a doctor ...”
(Interviewee 14- Male, twenty-one years experience as a pharmacist in England,
prescribing for hypertension in a GP practice over four years)
Some of the confusion appeared to be the consequence of the apparent
inadequate understanding among other health care professionals of the
pharmacist’s prescribing role. Some interview participants narrated their
experiences of other health care professionals inappropriately referring patients
to them, even when the interventions needed were not those of a pharmacist.
“... we were involved with some of the prescribing around things like
long acting reversible contraceptives, and these sort of jobs which
were given to me by the surgery probably don’t really sit well in the
true spirit of supplementary prescribing or independent prescribing
because I think they are almost minuscule tasks, or the clinic
tended to be more about information and not really about
prescribing”
(Interviewee 7- Male, nine years experience as a pharmacist in Scotland, prescribing in a
GP surgery and running a smoking cessation service in community pharmacy over four
years)
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The situation as described by some interview participants based in the hospital
setting was that such inappropriate use of pharmacist prescribers’ skills
devalued the role.
“We need to get more pharmacists doing it, and doing it
appropriately. I don’t think we want pharmacists just writing up drug
charts on the wards because you just end up working as a clerk”
(Interviewee 30- Male, twenty years experience as a pharmacist in England, prescribing
for rheumatology and dermatology in a hospital over three years)
On a positive note, it appeared that the lack of understanding of the prescribing
role of pharmacists among stakeholders was a short-term challenge during the
initial implementation of the pharmacist prescribing concept. Interview
participants perceived that most of the problems of lack of understanding had
been resolved with time and experience. In addition, pharmacist prescribers
described some of the strategies they had adopted to overcome other
challenges they faced in the implementation of prescribing.
“Yes initially it was lack of awareness from patients and the GPs.
There was suspicion about what it was going to be, now that seems
to have gone from my own practice because the GPs and the
patients I work with all know me well”
(Interviewee 23- Female, twenty-nine years experience as a pharmacist in Scotland,
prescribing for asthma/COPD in a GP practice)
4.5.3 Strategies for successful prescribing practice
Pharmacist prescribers narrated their experiences of implementing prescribing,
including steps taken to overcome some of the initial challenges. They
described some general strategies they had adopted in their individual
practices. For example, many of them said they capitalised on and maximised
relevant stakeholder support for pharmacist prescribing. In addition, they had
utilised every opportunity for consistent patient contact to improve their
confidence. In other words, interview participants were of the opinion that
overcoming the challenges of prescribing implementation required the
systematic exploitation of the unique advantages of each practice environment.
Pharmacist prescribers expressed specific ideas, through the interviews, on
how to overcome the challenges of prescribing implementation.
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4.5.3.1 Identify or create niche areas for pharmacist prescribing
Identifying or creating niche areas was proffered by pharmacist prescribers as a
strategy for overcoming the challenges of prescribing implementation.
Essentially, they identified gaps in existing practices around the prescribing of
medicines, and presented pharmacist prescribing to fill such gaps. Practice
areas, such as travel medicine and supervised consumption of methadone,
were described by interview participants as under-developed or neglected. They
perceived that GPs had little interest in those areas hence pharmacists could
easily be supported to prescribe for those conditions.
“One of the reasons that I get some support in what I do at the
moment is the fact that a lot of the surgeries don’t really want to
have the drug users accessing the surgery as much as they do ...”
(Interviewee 10- Female, twenty-five years experience as a pharmacist in England,
running a supervised drugs consumption/travel clinic in a community pharmacy over two
years)
Beyond the neglected areas however, interview participants frequently identified
niche areas in mainstream patient care that related to pharmacists’ expertise in
medicines and medicines management. For example, many pharmacist
prescribers identified sub-optimal management of chronic conditions in
oncology and cardiovascular medicine, as potential gaps that could benefit from
their intervention. They said such opportunities enabled them to apply their
specialist knowledge of medicines to deal with complex medication issues.
“... Right across the board (Health Board) we have got people who
are saying why should we employ or train up a pharmacist
prescriber as opposed to a clinical nurse specialist? Well if you pick
up the right disease area then there is no reason why a pharmacist
shouldn’t be more comfortable with the complexity of the drugs that
are being prescribed well and beyond the nurse.”
(Interviewee 17- Male, sixteen years experience as pharmacist in England, prescribing in
hospital chronic renal failure over one year)
Identifying these gaps involved negotiating the pharmacist’s prescribing role
with key stakeholders concerned with the management of patients. Interview
participants noted that, finding niche areas fostered understanding among
health care professionals of the role of pharmacists in prescribing. Improved
understanding was achieved because prescribing services were established
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based on the local needs of the population, rather than the personal
preferences of pharmacist prescribers.
“It was by first of all whether there is worth for it? I chatted up the
lead consultant based on what I saw as the problem, these were
the possible solutions and then we worked from it, we asked the
other consultants and they said yeah, we see this as team work
where we fit in, and that was how we got a good team in place”
(Interview 30- Male, twenty years experience as a pharmacist, prescribing for
rheumatology and dermatology in a hospital over three years)
“If you run your small local pharmacy, there are certain services you
won’t offer because you can’t manage it or there is no need for that
service. You know, not everywhere has methadone consumption
because there may not be methadone addicts you know, so it is
really ...”
(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
It was the view of interview participants that identifying gaps in practice ensured
they channelled their training and skills appropriately. However, interview
participants felt that identifying gaps was not enough. They advocated active
promotion of pharmacist prescribing practice by individuals and organisations.
4.5.3.2 Promote pharmacist prescribing activities
Interview participants appeared critical of their own prescribing practices, noting
that they had not adequately promoted the service. They made comments
suggesting that health care professionals, patients and the general public were
not taking full advantage of pharmacist prescribing, mainly because they were
not aware that such services existed. Consequently, it emerged from the
interviews that a useful strategy to enhance pharmacist prescribing practice,
needed to involve programs targeted at creating awareness about the role.
Interview participants felt that individual pharmacists should advertise their
prescribing practice, by talking about it to health professionals and patients.
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“... make sure everybody knows that you are doing it, why you are
doing it and then you get lots of referrals so that you are getting to
be properly used in the right way and also let people know how you
are doing because I don’t think I am very good at that, I am just kind
of working away in my clinic, I am not kind of advertising it, but I
need to probably advertise that I am doing it more”
(Interviewee 11- Female, twenty-one years experience as a pharmacist in Scotland,
prescribing for asthma in a prison setting over one year)
Promoting pharmacist prescribing was described as pointing out the benefits
and unique advantages of pharmacists in managing patient medication. This
involved talking to relevant stakeholders, such as consultant physicians, GPs
and representatives of patient groups, producing a multiplier effect as the
stakeholders then promoted pharmacists prescribing services in their respective
organisations.
“I think this is the same issue that affects pharmacy in general; it is
about promoting what we are good at, and what benefits we bring
above and beyond other professionals and thereby showing that
pharmacists are safe prescribers. We are still probably not very
good at that in terms of promoting what we are good at.... I am as
guilty as any one in terms of promoting what we do and...we owe a
duty to ourselves to promote our practice and not just within
pharmacy circles I think we need to promote it wide…, yeah so as a
renal pharmacist I think we should promote it to nephrologists rather
than to pharmacy groups so that they get the message that it is a
good thing and then they are more inclined to go back and promote
it in their own centres.”
(Interviewee 17- Male, sixteen years experience as pharmacist in England, prescribing in
hospital chronic renal failure over one year)
Apart from individuals promoting their prescribing practices, interview
participants shared the view that a multilevel approach involving the
Government, PCTs, Health Boards and the Royal Pharmaceutical Society
(RPS) was required. The interviews emphasised the role of these organisations
in developing effective strategies to put pharmacist prescribing on top of the
health services agenda. Some were of the view that the government should
commission the evaluation of pharmacist prescribing in more sites, in order to
demonstrate the beneficial outcomes of implementation. Similarly, interview
participants felt that the new professional body for pharmacists (RPS) should
employ every available means at their disposal to make sure the patients and
the general public were made aware that pharmacists could prescribe. On the
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contrary, pharmacist prescribers perceived that the government, NHS trusts,
and the RPS had often not done enough to make the public aware of
pharmacist-led services, such as prescribing and the minor ailment scheme.
“The profession is not exactly advertising itself; for example the
minor ailment service started in Scotland five years ago; it was not
publicised whereas as a national contract all pharmacies are
providing it, therefore, everybody should be talking about this
change… therefore, it should be made well-known and well-
publicised by the Scottish Government, by the Scottish professional
board, by the new professional body that this is something that the
pharmacist can do”
(Interviewee 25- Female, thirteen years experience as a pharmacist in Scotland,
prescribing for diabetes in a GP practice over two years)
4.5.3.3 Increase uptake of prescribing by pharmacists
It emerged from the interviews that increasing the number of pharmacist
prescribers would enhance the implementation of prescribing services. Some
perceived that higher numbers of prescribing pharmacists would establish this
as a routine and expected role of pharmacists. Participants who held this view
believed that once pharmacist prescribing became common place, funding for
services would be more likely. They thought that pharmacists in all settings
needed to train as prescribers.
“We need to get more pharmacists doing it; if it becomes the norm
then it becomes part of the accepted job that if you are a
pharmacist you will be doing a certain amount of clinic work
including prescribing and things like that. That is just like once when
pharmacists were not accepted in the wards and now it is part of
the job for pharmacists to be in the wards
(Interviewee 30- Male, twenty years experience as a pharmacist in England, prescribing
for rheumatology and dermatology in a hospital over three years)
In addition, participants observed that increasing the number of pharmacist
prescribers was likely to counter the negative impact created by lack of
understanding, as more health care professionals experienced pharmacist
prescribing first hand. Interview participants narrated their own experiences
whereby sceptical GPs and other health care professionals gradually developed
confidence in pharmacists, once they demonstrated competence in prescribing.
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“I think doctors need to not be threatened by it (pharmacist
prescribing), I think if we roll out the prescribing and it is becoming
common practice, then those concerns by the medics will dissipate.
I know there were concerns in my area by medics about doing
prescribing as pharmacists but actually once it was in practice they
were happy to support it”
(Interviewee 13- Female, twenty-two years experience as a pharmacist in England,
prescribing for cancer in a hospital, more than three years as a prescriber)
Importantly, interview participants emphasised that increased number of
pharmacist prescribers also meant increased opportunities for networking and
peer support.
“I supposed it would be easier if there were more opportunities for
networking and finding other people who worked within some more
areas ... and possibly sharing the knowledge would be useful”
(Interviewee 9- Female, twelve years experience as a pharmacist in Scotland, prescribing
for cardiovascular conditions in a GP setting and runs a pilot project managing minor
infections in a community pharmacy, over three years as a prescriber)
However, interview participants also pointed out some possible negative
consequences of increasing the number of pharmacist prescribers. They made
reference to the high proportion of pharmacists who were qualified, but were not
using the qualification in practice.
“I think we have made the same mistakes that nurses made
originally because every one was allowed to train without
necessarily a prescribing role at the end of it so we have exactly the
same situation; we have a whole list of prescribers who aren’t
actually prescribing which I think is a real waste of resource, I think
that is a problem that we have got too many who aren’t working, so
they have probably paid for training without having anything at the
end of it ...”
(Interviewee 8- Female, eleven years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over four years)
4.5.3.4 Agree formal prescribing roles and boundaries
Definite agreements between pharmacist prescribers on one hand, and GP
practices or NHS trusts on the other about prescribing roles, was described as a
key element of successful prescribing practice. Interview participants felt that
such agreements set out in concrete terms boundaries and scope of prescribing
activities to be implemented by pharmacists. They emphasised the need for
pharmacists to develop clear plans for prescribing practice, prior to obtaining
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the prescribing qualification. Participants said that such plans should include
firm commitments from employers that they would use the prescribing skills of
pharmacists in their organisations.
“... Get an agreement with your Health Board or the GP surgery that
you can actually run the clinic and have a clinic up and running
once you are finished. I really do think you have to have a clear
plan of what they want to do at the end of it”
(Interview 32- Male, thirty years experience as a pharmacist prescribing anticoagulants in
community pharmacy over three years)
“I think it would be more a case of making sure there was a firm
agreement before they came into the course so that the mentor
who is training them is actually going to commit to using their
service. This is six months very hard course and if their skills are
not being used it is a lot of money being wasted and a lot of time
being wasted training up people that are not using their skills ...”
(Interview 16- Female, twenty-five years experience as a pharmacist, qualified as a
prescriber in diabetes over two years, practised in community pharmacy and academia
but not prescribing)
Interview participants perceived that agreeing formal roles and setting clear
boundaries enhanced the implementation of pharmacist prescribing by fostering
understanding of pharmacists’ contribution in the prescribing process. This they
said minimised unnecessary inter-professional tensions about role
encroachment. Similarly, participants thought it was necessary to agree how
pharmacists’ prescribing services were covered during holidays, and other
periods of absences. Some pharmacist prescribers used the idea of the CMP to
agree their prescribing roles and boundaries with their employers,
notwithstanding that they were independent prescribers. In their view, written
agreements provided them with a means of keeping prescribing audit trails.
“You have to have, whether you are independent or supplementary,
a clinical management plan. I know legally, you don’t need one, but
I think you are very foolish if you don’t have one because it sets out
what you are doing, what drugs you are going to be prescribing;
you know, I don’t put specific drugs I put the BNF chapters ... I just
have a generic CMP for each group of patients”
(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
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Interview participants proffered solutions to lack of clarity in the prescribing role
of pharmacists. They defined what they considered ideal prescribing role of
pharmacist prescribers in their individual practices; and for the pharmacy
profession in general. These descriptions are presented in the next section.
4.5.4 Clarifying the role of pharmacists and developments in prescribing
practice
It emerged from the interviews that a clear prescribing role was necessary for a
successful implementation of prescribing. Participants commonly described two
types of ideal as they attempted to define what they considered a clear
prescribing role of pharmacists. First, they described ideal structures for
implementation of prescribing. In this regard, they raised issues related to the
setting and facilities that supported optimal pharmacist prescribing practice.
Secondly, they described the ideal functions of pharmacist prescribers in
relation to those of other health care professionals involved in the prescribing
process, such as clinical examination, diagnosis and dispensing. The issues
raised appear to repeat the factors associated with prescribing (section 4.5.2).
However, in this case, participants described what they perceived as ideal and
not actual experiences of prescribing implementation.
4.5.4.1 Ideal structures for pharmacist prescribing
The environment, facilities and structural influences of different settings on the
implementation of prescribing were described by pharmacist prescribers. As a
result, many interview participants were of the opinion that the GP practice and
hospital settings were ideal for implementing pharmacist prescribing. This view
was corroborated largely by interview participants based in community
pharmacy setting, but who were prescribing in GP practices.
“If I could access patient records from the shop on my computer,
you know, a separate computer system; then life would just be a
breeze quite frankly ... So I want a computer in my consultation
room in the shop that I can just switch on and, up comes the
records and it would be just like prescribing in the surgery which is
what I do with some of the clinics, and it is just like being a doctor or
a nurse or whoever works in the surgery it is so much easier ...”
(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
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The perceived suitability of hospitals for implementing prescribing was
highlighted by the case of a pharmacist who had a clinical role, and was writing
prescriptions for doctors to sign (prescribing by proxy) before qualifying as a
prescriber. The same individual qualified as a prescriber, then moved to a
community pharmacy setting and never got the opportunity to prescribe.
Interestingly, some participants based in GP practices and hospitals perceived
their community pharmacy colleagues as less suitable prescribers, doubting
their clinical abilities. They also cited the pressure on community pharmacists’
time, which they perceived impeded their capacity to prescribe.
“I think at the moment community pharmacy is the place where we
would want to see pharmacist prescribing occurring. I don’t think
they have got the attitude to be able to reflect, I don’t think they
have got the time and sometimes I don’t think they have got the
clinical knowledge to be able to manage these patients so I think at
the moment prescribing can only be in secondary care. When I talk
about secondary care I am not talking about prescribing on the
wards I am talking about prescribing in outpatient clinics”
(Interviewee 18- Male, thirteen years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over three years)
It was recognised that even within the hospital setting, prescribing was more
suitable in out-patient clinics because of the nature of acute cases presented in
the wards. Also, the unique advantages of the community pharmacy setting
were highlighted in section 4.5.2. Therefore, it became obvious from the
interviews that no single approach was suitable for implementing pharmacist
prescribing in all settings.
4.5.4.2 Ideal prescribing roles of pharmacists
Pharmacist prescribers were almost unanimous in stating that their role was not
in diagnosis, even when they practised independent prescribing. Rather,
interview participants considered their ideal role in prescribing as one of
partnership with doctors. They thought that doctors should ideally concentrate
on diagnosis, while pharmacist prescribers handle prescribing. They noted that
pharmacist prescribers possess extensive professional expertise on medicines.
Hence, they held the view that pharmacists took a more holistic approach to the
management of patients’ use of medicines.
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“... doctors spend four, five, six, seven, eight, nine, ten years
learning to diagnose patients appropriately, we spend five years
learning how to use medications so GPs and doctors in general
have an expertise and a skill in that area and we have a skill in
actually prescribing medication ...”
(Interviewee 18- Male, thirteen years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over three years)
“I think that it should be the norm that doctors diagnose and
pharmacists prescribe..., we (pharmacists) are the experts in
medicines, and we do a really good job prescribing medicines,
knowing all about medicines I think that should be recognise., If we
are the experts in medicines then surely we are the experts that
would know what medicine is best to treat what particular condition”
(Interviewee 19- Female, eleven years experience as a pharmacist in Scotland,
prescribing for a smoking cessation service in a community pharmacy over three years)
Participants clarified the difference in roles of the health professions involved in
the prescribing process. This is in contrast to what was described earlier about
the perceived competition and role encroachment by health professionals in
prescribing. They emphasised that a prescribing role for pharmacists was not
about encroaching the boundaries of doctors or nurses. Instead, it was about
utilising the best potential of pharmacists. They pointed out the role of doctors
as supervisors of the health team, whose specialty was diagnosis. They noted
the clinical skills of nurses in physical examination, taking samples, providing
lifestyle advice, general treatment, and prescribing within protocols for single
disease states. Pharmacist prescribers’ skills were perceived as the
management of patients with chronic conditions and multiple co-morbidities
based on pharmacists’ extensive knowledge of pharmacology,
pharmacokinetics, drug interactions and adverse effects.
“Well every profession has its strengths isn’t it? So to me a GP
should be defining what is wrong with a patient and that should be
their main role; to assess the patient and say right: Mrs Smith
definitely has got this and Mrs Smith has definitely got that or
whatever and deal with more complicated patients. So I think the
doctor is dealing much more with the acute, seriously acute not
over-the-counter acute; and the nurses fit in there as well, because
they are far better at examination skills than we are, they are more
hands on so they are doing the treatments, the dressings, the
bloods all those sorts of things. Pharmacists are definitely better at
medication and prescribing and pharmacists are trained to deal with
medication.”
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(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
“Well, obviously we are not trained in our degree in diagnosis and
that is something where pharmacists’ competency may not be up to
scratch so I think that in the area that I work, the patients are
already diagnosed so it is really prescribing in a supportive care …
so I think the doctors are in the best position for diagnosis, the
pharmacist for prescribing and clinical examination either by the
doctor or the nurse.”
(Interviewee 13- Female, twenty-two years experience as a pharmacist in England,
prescribing for cancer in a hospital, more than three years as a prescriber)
Interview participants made comments to shed light on the frequent comparison
among GPs, pharmacist and nurse prescribers. They noted that differences in
pay scales meant that nurse prescribers would always be cheaper than
pharmacist prescribers. However, they emphasised the relative advantage of
each profession, and that it was potentially more cost effective to exploit the
strengths of the professions for some prescribing services more than others.
For example, hospital-based participants thought that the follow-up of patients
with chronic conditions in out-patient clinics was more cost effective if led by
pharmacist prescribers than registrars or consultants. Registrars and
consultants could concentrate on new cases while discharging chronic patients
to pharmacist care. Similarly, some noted that annual reviews of patients, which
mostly involved lifestyle recommendations and advice, was more cost effective
if performed by nurses than by pharmacists. In other words, interviewees were
of the opinion that each profession should recognise unique strengths and refer
patients appropriately.
“I think the ideal prescribing role for pharmacists is in managing
long term stable conditions. It seems to be waste of resources
having highly trained senior consultants do it, when pharmacists
can do it to help the financial situation. I also think there is a role for
pharmacists in patients that are not necessarily stable, but where
the problem is actually drug-related, or because it is a difficult drug
like anticoagulant clinics, or diabetic clinics where it is very drug-
focused. I think there is a real future for pharmacist prescribers
there.”
(Interviewee 12- Female, twenty-four years experience as a pharmacist in England,
prescribing for HIV in a hospital over three years)
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“...let us say we have a patient who has been on the same
antihypertensive treatment for a couple of years, the blood pressure
has always been round about let us say 130/80 and let us say there
is no change, this is cheaper to have the nurse do the six-monthly
reviews than for the pharmacist to do the six-monthly reviews
because of the differences in pay scale. If it is only a matter of
checking blood pressure, then a health care assistant can do it
cheaper than the nurse and then if they aren’t satisfied they refer up
from there to the next in line”
(Interviewee 29- Male, thirty-nine years experience as a pharmacist in England,
prescribing for hypertension and hyper-lipidemia in a GP practice over one year)
Interview participants identified roles in which pharmacist prescribers performed
functions related to, but distinct from, those of other health care professionals,
including non-prescribing pharmacists. They described such functions to
include acting within the multi-disciplinary health team as experts on the use of
medicines or “drug clinicians” as some of them put it.
“I think pharmacists have that side which is where I am going, that
is they become..., if you like drug clinicians ...”
(Interviewee 4- Female, eleven years experience as a pharmacist in Scotland, prescribing
for respiratory diseases in a GP surgery over three years)
Interview participants were of the opinion that these specialist roles should be
developed, and pharmacists could delegate routine dispensing to checking
technicians.
4.5.4.3 Developments in pharmacist prescribing
Prescribers discussed the future of prescribing in terms of their individual
priorities and expectations. They all expressed a desire to further develop
prescribing services. Many had undertaken further training post-prescribing
qualification and acquired additional skills to allow expansion of prescribing
services. Expansion for some, related to new therapeutic areas, while others
wanted to expand prescribing in the areas they were currently managing. All
participants emphasised different aspects of prescribing implementation that
they considered the most important, by prioritising what they felt as key advice
for new pharmacist prescribers. Issues perceived as crucial in the development
of pharmacist prescribing are presented in this section under the themes of
training, safety, and benefits of pharmacist prescribing.
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A. Training
The training of pharmacists to prescribe was explored as one of the key
developments likely to shape the implementation of prescribing by pharmacists
in GB. The main issues raised by interview participants related to the structure
and content of the prescribing course; and possible integration of the
prescribing course into the undergraduate pharmacy curriculum.
i. Issues with the current training of pharmacist prescribers
Many expressed reservations about the current training for pharmacist
prescribers; they observed that the training lacks sufficient diagnostic
components. This was despite them consistently holding that it was not the role
of the pharmacist prescriber to diagnose patients. They also conveyed in the
interviews perceptions that the course components relating to patient
assessment skills were inadequate and needed to be reviewed, with emphasis
on patient contact and hands-on experience.
“Well, I think perhaps a bit more in diagnosis would have been
useful, I think we did one face-to-face session at X (university) and
that was kind of it, although we may refer to the consultant or other
people for final diagnosis … I mean we are diagnosing aren’t we?
Even in community pharmacies and stuff, you are giving your
diagnosis on the features that are presented, so I think probably
diagnosis would have been a bit … not be an expert but at least to
have a bit more background information”
(Interviewee 31 - Female, twenty-four years experience as a pharmacist, prescribing for
neurology and cardiovascular conditions in hospital and GP practice settings over three
years)
“I am not particularly impressed by the training for independent or
the conversion for it that is why I have never done it because I don’t
think that it gives you the skills and the confidence in diagnosis.
That is why … I don’t feel that … I don’t want to be an independent
prescriber because ... I think you need a lot more experience and
you can get it on the job but that is not monitored. GPs are not paid
supervisors and therefore they don’t arrange any training, it is very
much a ‘hit and miss’ approach”
(Interviewee 5- Female thirty-three years experience as a pharmacist in Scotland, PCT
prescribing advisor, registered as prescriber over five years, prescribed for a while in a
GP practice but had to stop)
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An aspect to be reviewed was post-qualification training. They stressed that
there were no specific continuing professional development (CPD) programmes
targeting pharmacist prescribers. In addition, they felt that current procedures to
demonstrate competence through CPD required extensive documentation and
paperwork. This, they claimed, was cumbersome and failed to accurately
assess the prescribing competence of individuals.
“Pharmacist prescribing is strictly controlled with CPD and
maintaining it. Unfortunately, you have got to prove that you have
done it rather than just … well, before, I would just put down the
number of hours, but now you have to give more details … it is
going to make it harder as the years go by … when you have been
prescribing for a while, when you have been doing medication
reviews for ten years in a GP practice then I would be more
competent to prescribe, more than my competence actually reads.
If there were ways that you could show your competence other than
doing CPD, for example a system where you can have a GP mentor
who says yes or no to a particular skill rather than having to go
through the rigmarole of extending competence by producing paper
work”
(Interviewee 29- Male, thirty-nine years experience as a pharmacist in England,
prescribing for hypertension and hyper-lipidemia in a GP practice over one year)
Similarly, interview participants expressed divergent opinions on the issue of
incorporating prescribing training within the undergraduate curriculum, so that
pharmacists could graduate as prescribers.
ii. Training of pharmacist prescribers in the undergraduate curriculum
Participants who supported the qualification of undergraduate pharmacy
students as prescribers considered logistic benefits for pharmacists, especially
community pharmacists, to access and attend training. In addition, this
approach would resolve training funding issues, again particularly for
community pharmacists. Resources released could be channelled to other
areas of health care and prescribing provision. However, these participants
were unsure of aspects such as impact on training course content and duration.
There were also issues to consider around providing adequate patient contact
and experience. Suggestions included covering the prescribing curriculum only
during the undergraduate degree and undertaking the period of learning in
practice post graduation.
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“It would probably be better to do the prescribing training during the
undergraduate degree course; because it seems an awful waste of
all these people trained and not using it whereas if it was part of the
degree course it would not be, you know the money could be used
for other trainings...., Like I have done my undergraduate course
and I did not have it and it was extra to go and do it …”
(Interviewee 33- Female, twenty-one years experience as a pharmacist in Scotland,
initially prescribed for asthma in a prison as part of a contract arrangement between
community pharmacy employers and the prison service; but is no longer prescribing)
The alternate opinion centred on the need for pharmacists to gain experience
before venturing into prescribing. There were also those who felt training all
pharmacists for prescribing could be a waste of resources since there would be
those who would not or could not practise as prescribers.
“I think there should be some time, between qualifying and when
you are allowed to do the prescribing course. I wouldn’t like to see
prescribing become part of the undergraduate degree course. I
think you need experience as a pharmacist and experience in
applying clinical knowledge and having clinical judgement because
that is absolutely crucial when it comes to making prescribing
decisions. Everything is not black and white, everything is not text
book and fortunately we have a lot of guidance but still you need
clinical judgement and I don’t think when you come out of university
first of all as a pharmacist, you necessarily have that level of
judgement. You have a lot of knowledge but it is the ability to apply
that knowledge to a situation
(Interviewee 21- Female, twelve years experience as a pharmacist in England,
prescribing for cardiovascular conditions in a GP practice over three years)
Interview participants emphasised the importance of pharmacists gaining
practice experience for a few years, before they ever engage in actual
prescribing. This is irrespective of whether or not the prescribing training was
incorporated into the undergraduate curriculum.
“... I do think that it is a good idea to qualify, to do your pre-
registration year and may be getting some practice under your belt
before you rush off to do the prescribing ...”
(Interviewee 27- Female, thirty-two years experience as a pharmacist in Scotland,
prescribing for cardiovascular and respiratory conditions in community pharmacy and GP
practice over three years)
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B. practice priority for pharmacist prescribers
Prescribers identified safety and quality of prescribing as key priorities. They
emphasised a cautious approach to prescribing throughout the interviews. Many
commented on the considerable time and effort they expended on double
checking and confirming their decisions, especially when they were unsure
about such decisions. Safety considerations were top on the list of advice
participants had for new pharmacist prescribers. They reflected on the need for
new pharmacist prescribers to be aware of their own competences and
limitations. Some suggested supplementary prescribing as a starting point to
develop their skills and confidence, before progressing to independent
prescribing.
“Make sure that you know as much about the condition as possible,
and get as much training as possible from a consultant, sit in his
clinics, shadow him more ... I think it is very important that you are
able to justify everything that you do and if you can’t then that is the
point where you need to know whether you should be referring.”
(Interviewee 24- Male, forty-six years experience as a pharmacist in England, prescribing
for diabetes and respiratory conditions within a GP practice over two years)
Similarly, pharmacist prescribers emphasised the need for continuous
professional development (CPD) for safe and effective prescribing practice.
“I would like all pharmacists who are prescribing for patients to
make an effort to keep up to date with the latest guidelines in their
own area and the protocols for the practices they work with, and
also to take it slow to begin with, get comfortable and don’t be
afraid to chat to the other health care workers … Prescribing is not
something you can learn, it is not something you do one course and
that is you. If you are not going to go to any follow-up sessions or
peer review sessions things like that, then you should think twice
about it, you can’t just tick the box you have done prescribing
course and then carry on ...”
(Interviewee 23- Female, twenty-nine years experience as a pharmacist in Scotland,
prescribing for asthma/COPD in a GP practice)
The emphasis of interview participants on safety and quality assurance
measures appeared to relate their practice behaviours with perceived benefits
and outcomes of implementing pharmacist prescribing.
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C. Benefits of pharmacist prescribing
Participants repeatedly described perceived benefits of their prescribing
practice. Main benefits were categorised into patient benefits and professional
benefits.
i. Patient-related benefits
One key benefit was optimal medicines management. Participants throughout
commented that pharmacist prescribers applied in-depth knowledge and
expertise on medicines to achieve specific outcomes for patients. These ranged
from basic knowledge of appearance of medicines and medicine names, to
more specialised outcomes related to pharmacist skills in the application of
pharmacokinetics and pharmacodynamics.
“I mean if you look at most of the GPs doing a medication review,
often they will click the button was everything else on the clinical
system? Yes that is fine; medication review done? Yes, you know
click the buttons. Whereas, I think pharmacists we are going into
checking how they were taking it, any side-effects you know that
level of interrogation didn’t seem to go with most of the GPs that I
was with, but I think we do a lot more of in-depth of medication…,
well we do I am sure, medication questioning and…, you know I
have picked up people who would start on a statin, take it for a
month and then stop because they thought it was a one off course
in their specific ailment, you know, people taking simvastatin in the
morning and…, you know, really basic things that probably had
gone on for so long without somebody pointing it out….”
(Interviewee 31 - Female, twenty-four years experience as a pharmacist, prescribing for
neurology and cardiovascular conditions in hospital and GP practice settings over three
years)
Participants noted that implementing prescribing by pharmacists granted
patients quicker access to medicines. Participants based in the hospital setting,
compared pharmacist prescribing with previous practices when they could only
recommend and wait for doctors to prescribe. They perceived that in-patients
got access to medicines quicker, and were less likely to miss any doses on
admission.
“What happens at the moment is that patients would come in, they
will have the medical clerking and part of that is the drug history but
when pharmacists go to verify that, it is often wrong and that is not
just in my hospital, but it is widely documented throughout the UK.
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So what we would usually do is that we will confirm their usual list
medicines, write them in the notes then ask the doctor to prescribe
them. So why not take out that step and ask the pharmacists to
prescribe? You know they are competent, they want those
medicines to be prescribed; why not do it themselves? Plus they
are doing it quicker, they can deal with it more quickly and the
patient is less likely to miss many doses.”
(Interviewee 34- Male, ten years experience as a pharmacist in England, qualified as
prescriber in a hospital for more than one year but was not prescribing)
Community pharmacy and GP practice-based prescribers interviewed thought
also that patients gained quicker access to medicines, often without the need
for GP appointments. GP practice-based pharmacist prescribers typically
identified potential patients that could benefit from their prescribing. Community
pharmacy-based prescribers highlighted the advantage for patients in terms of
accessibility, particularly over the weekend.
“Normally patients are referred to me from nurses or doctors
themselves where for instance, somebody’s blood pressure is not
on target or there are complex medication issues involved. They
would like me to review those patients, and one or two patients
actually phoned the surgery to say that, they gained a lot from my
consultation, so they are seeing the value of pharmacists being part
of the medical practice and the advantages that has for them
because sometimes they have medication issues and rather than
deal with the pharmacist and refer to the local community
pharmacist they have got an expert on site.”
(Interviewee 14- Male, twenty-one years experience as a pharmacist in England,
prescribing for hypertension in a GP practice over four years)
Participants from all settings considered that pharmacist prescribing gave
patients more choice in terms of the professional they consulted.
ii. Professional benefits
Interviewees identified professional benefits of pharmacist prescribing. They
thought that pharmacist prescribing ensured that the most appropriate
professional prescribed, allowing pharmacists to deal with complex medication
issues and freeing other health care professionals to concentrate on their
specialised roles.
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“I suppose there would be a week where the GPs are seeing
patients in parts of other clinics or the practice nurse takes patients
as part of a chronic disease clinic you know like diabetic reviews,
and if they discover that their blood pressure is not controlled they
would refer them to me then I can take over the consultations and
prescribing until they are stable, their conditions managed then I
can discharge them back to the normal care with the GP; so it helps
free up some of their time and it also gives patients a bit more time
to go through their medication, and not just for the hypertension but
for all the other medications as well.”
(Interviewee 6- Female, ten years experience as a pharmacist in Scotland, prescribes for
hypertension in a GP practice over three years)
In addition, participants reported increased job satisfaction as prescribers,
taking responsibility for selecting appropriate drug regimens. Many participants
acknowledged that prescribing was difficult and involved a lot of hard work, but
they often concluded that it was personally rewarding for them.
“I enjoy seeing the patients from diagnosis right through to
managing their conditions, and being able to get their conditions
under control and by having the responsibility to do that, writing
prescriptions to control their conditions this gives me justification as
a professional pharmacist”
(Interviewee 15- Female, twenty-eight years experience as a pharmacist in England,
prescribing for hypertension in a GP practice, over two years)
Participants recognised the value of teamwork and collaboration with other
health care professionals.
“Within the practice that I work, nurses actually refer patients, where
there is a cardiovascular issue they refer them through to me for
assessment; then I have to manage them appropriately and
likewise I would refer patients to the nurses if I thought there was a
respiratory issue. Whereas, if I thought there were some other
issues for example smoking cessation where there are experts in
those areas that they would be referred appropriately …”
(Interviewee 18- Male, thirteen years experience as a pharmacist in England, prescribing
for cardiovascular conditions in a GP practice over three years)
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4.6 Summary of qualitative findings
This study established that funding and administrative support lead to better
logistic arrangements for pharmacist prescribing. In addition, clinical supervision
and feedback resulted in confident pharmacist prescribers, who were better
equipped to prescribe. Conversely, a perceived lack of clarity about the
prescribing role of pharmacists, problems with the use of CMPs in
supplementary prescribing, and regulatory restrictions on independent
prescribing of controlled drugs, all made prescribing by pharmacists difficult.
Participants in the study described various strategies they adopted in practice to
prescribe successfully. They identified niche areas, agreed formal prescribing
roles, and set clear boundaries for their prescribing activities. For the future
development of prescribing however, they advocated an increase in the number
of pharmacists taking on the prescribing role. They also suggested aggressive
advertisement and promotion, to raise awareness and understanding of
pharmacists’ prescribing role, among stakeholders in healthcare.
Interview participants advanced descriptions of what they considered the ideal
role of pharmacists in prescribing. From their descriptions, two ‘ideal’ types
relating to structures (facilities) and functions emerged. Other issues arose in
the interviews related to the current and future training of pharmacist
prescribers; also safety priorities and benefits of having pharmacists prescribe.
Implications of these findings on policy and practice of pharmacist prescribing
will be discussed in the next section.
4.7 Discussion
In this section findings of the qualitative phase will be discussed. The discussion
will begin with a recap of the aim and objectives of the qualitative phase
followed by a summary of the key findings of the qualitative phase highlighted
under specific objectives. The discussion will then reflect on the research
methods focusing on trustworthiness, reflexivity and researchers’ background,
before a consideration of the strengths and limitations of the qualitative methods
applied for data generation and analysis. The discussion of key findings will
provide an interpretation of interview findings, in terms of the implication on
policy and practice of pharmacist prescribing in GB.
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4.7.1 Recap of Phase 2 objectives
The aim of the qualitative phase was to explore further and provide richness to
the key findings of the quantitative phase; applying qualitative methodologies
and methods to probe the views, perceptions, and experiences of respondents
regarding prescribing practice. The intention was to provide a deeper insight
into the issues involved in the implementation, and possible factors that may
facilitate the development and implementation of pharmacist prescribing
practice and policy. The semi-structured telephone interview method was
utilised to meet the following specific objectives:
1. To clarify from the perspective of pharmacist prescribers why and how
factors identified from the quantitative phase enhanced, or impeded their
prescribing practice.
2. To describe measures already adopted by individual pharmacist
prescribers, and their views of the strategies needed for successful
implementation of pharmacist prescribing practice.
3. To define and clarify the pharmacist’s prescribing role from the
perspective of pharmacist prescribers themselves; and to explore their
perceptions of developments in the pharmacist’s prescribing role.
4.7.2 Key findings
One hundred and twelve out of 165 pharmacist prescribers, who responded to
the questionnaire survey in Phase 1, were invited to participate in Phase 2 of
the project. Of these, 34 were interviewed. For the sake of clarity, the key
findings are summarised in relation to the specific objectives.
1. To clarify from the perspective of pharmacist prescribers why and how
factors identified from the quantitative phase enhanced, or impeded their
prescribing practice.
Key findings
Available and adequate clinical, administrative and organisational support was
identified as the main factor that enhanced the prescribing practice of
respondents.
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A. Clinical support
 Clinical supervision by doctors enhanced pharmacist prescribers’
confidence in prescribing practice; this was especially the case in
hospitals and GP practices where pharmacist prescribers had pre-
existing working relationships with other health-care professionals.
 Cordial working relationships and good communication with other
health care professionals minimised inter-professional conflicts
around prescribing.
B. Administrative support
 Administrative staff in hospitals and general medical practices
arranged patient appointments, thereby allowing pharmacist
prescribers to focus on patient consultations and prescribing; this
was support was lacking in the community pharmacy setting.
C. Organisational support
 Strategic policies and priorities of NHS Trusts, Health Boards and
GP practices were perceived by respondents as having direct
bearings on the administration and logistics of pharmacist
prescribing services.
 Funding of pharmacist prescribing was perceived as inadequate
especially in community pharmacies, where respondents
expressed concern about the lack of budgetary provisions for
prescribing.
2. To describe measures already adopted by individual pharmacist
prescribers, and their views of the strategies needed for successful
implementation of pharmacist prescribing practice.
Key findings
Pharmacist prescribers adopted various measures to prescribe despite the
challenges they encountered in practice. In addition, they described strategies
needed for successful implementation of prescribing practice by pharmacists.
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A. Measures taken to overcome challenges to prescribing practice
 Frequent patient contact facilitated by availability of dedicated time
and space for patient consultation was mentioned by pharmacist
prescribers as one of the factors that allowed them to follow
patients up long-term and develop competence in managing
conditions in their chosen field of practice.
 Participants identified niche areas and gaps in the prescribing of
medicines; such as, travel medicine, supervised consumption of
methadone and sub-optimal management of chronic
cardiovascular conditions. Pharmacist prescribers apply specialist
knowledge of medicines to solve complex medication problems
associated with these conditions.
B. Strategies needed for successful prescribing implementation
 NHS organisations, the RPS and individual prescribers should
actively create awareness about the role of pharmacists in
prescribing.
 Pharmacist prescribers should agree with their organisations, the
scope and clear boundaries of the prescribing services they intend
to deliver, before undergoing the prescribing course.
 Key regulatory issues around the prescribing of CDs under the IP
model need to change, in order to facilitate prescribing practice in
areas such as palliative care and substance misuse.
3. To define and clarify the pharmacist’s prescribing role from the
perspective of pharmacist prescribers themselves; and to explore their
perceptions of developments in the pharmacist’s prescribing role
Key findings
A. Clarifying the prescribing role of pharmacists
 ‘Ideal’ structures for pharmacist prescribing require that the focus of
prescribing be defined and specified in each setting, taking cognisance of
differences in settings and facilities.
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 Pharmacist prescribing should be a partnership with other health
professionals, which capitalises on the pharmacist’s extensive skills and
knowledge of pharmacology, pharmacokinetics, drug interactions and
adverse effects to prescribe; following established diagnosis by a doctor.
 This partnership, it was perceived, would work best in the management
of patients with chronic conditions and multiple co-morbidities that often
require the use of multiple medicines.
B. Developments in pharmacist prescribing
 Issues perceived as crucial in the development of pharmacist prescribing
were: training of future pharmacist prescribers, patient safety priority of
pharmacist prescribers, and the benefits of pharmacist prescribing to
patients, pharmacists and other health professionals.
4.7.3 Reflections on the research method
4.7.3.1 Trustworthiness of the qualitative phase of the project
The main cited criticism of qualitative research, especially in the field of health
services research, is the seeming lack of ‘scientific rigour’. The argument has
often been that qualitative research merely collects personal opinions, clouded
with strong researcher bias; and that qualitative methods lack the necessary
quality indicators of reliability and validity commonly used to assess the strength
of quantitative research (172). Whereas reliability and validity (see Chapter 3)
were key considerations for questionnaire development in Phase 1, these
concepts cannot be applied in a similar manner to asses the quality of
qualitative research. Indeed, there are concerns that some qualitative
researchers have inappropriately used reliability and validity to portray ‘good’
qualitative research (173). Alternatively, qualitative researchers argue that it is
impractical to judge the quality of qualitative research using concepts of validity
and reliability. These quantitative concepts derive from different ontological and
epistemological perspectives; hence, qualitative researchers have replaced
these quantitative indicators of rigour with the ‘more-appropriate’ concept of
‘trustworthiness’ (109). Lincoln and Guba suggested four criteria for assessing
the ‘trustworthiness’ of qualitative research: credibility, transferability,
dependability, and confirmability (see Chapter 2). These criteria, as applied in
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the qualitative phase of the current project, will be presented here briefly to
provide the basis for judging the trustworthiness of the current research
findings.
‘Credibility’, the qualitative equivalent for internal validity in quantitative
research, provides confirmation that qualitative findings reflect the phenomena
being investigated. According to Lincoln and Guber, establishing the ‘credibility’
of qualitative research should answer the question of whether or not the
research findings truly reflect the experiences and contexts of research
participants (109). Qualitative researchers adopt various strategies to ensure
the credibility of their research findings. Shenton (174), lists 14 of these
strategies, by which qualitative researchers may confidently assert that their
findings accurately reflect the phenomenon investigated. The strategies listed
are: the use of already established methods to gather data, developing
familiarity and rapport with the environment and culture to be investigated,
random sampling, triangulation of data from different sources, tactics to ensure
honesty of informants, iterative questioning negative case analysis, frequent
debriefing sessions, peer scrutiny of research projects, reflective commentary,
background qualification and experience , member checks, thick descriptions of
phenomena and examination of previous research finding. (174). All of the
credibility steps outlined by Shenton (except random sampling and member
checks see later for explanation) were applied in various stages of this
research. Specifically, the research student engaged in a series of field visits to
pharmacist prescribers in various settings at the outset of the project. This
provided the research student with the opportunity to gain familiarity with the
culture and context of prescribing practice.
The research student also ensured the credibility of the research by
triangulation of the interview data with the quantitative results of Phase 1 (detail
in Chapter 5). Moreover, the interviews generated data on the views of
participants from a wide range of prescribing backgrounds which provided the
opportunity to test developing themes with respondents that had different
professional or personal characteristics. Significantly, the analysis considered
opposing or negative views, and the entire process iteratively tested new ideas
to be sure they were supported by the views of participants, rather than
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representations of the research student’s ideas. In the course of the interviews
and data analysis, the research student frequently discussed developing ideas
and concepts with research supervisors (two of whom were not pharmacists).
The supervisory team members thus provided guidance and direction based on
their varied academic expertise and experience. These frequent ‘debriefing
sessions’ (174), helped to ensure credibility of the qualitative phase of the
project. In addition, internal and external training sessions were arranged to
sufficiently equip the research student with necessary skills in qualitative data
generation, analysis and interpretation. These steps, applied at different stages
throughout the entire project, were reflected in the methods section in sufficient
detail so that it may be possible to extrapolate the findings beyond the current
research (transferability).
‘Transferability’, the qualitative equivalence of external validity or
‘generalisability’ in quantitative research, is the ‘criteria that provides other
researchers with the confidence to extrapolate qualitative research findings to
other situations outside the immediate context of the research’. It should be
acknowledged that qualitative research does not primarily aim to produce
findings that are necessarily ‘generalisable’ as is the case in quantitative
research. Instead, the goal of qualitative research is to gain understanding of
the complexities underlying phenomena (109). Transferability is achieved by
providing in-depth description of the study context which may explain the
meaning of particular views or experiences narrated by research participants
(175). In this way, other researchers can judge whether the context of the
research is sufficiently similar to their own, to warrant the application of the
findings. In the current project the context of the research was specified in
Chapter 1, where detail background on NMP and SP/IP implementation by
pharmacists in GB was provided. Therefore, the views and experiences
provided by research participants and the analysis and interpretation provided
by the research student should be viewed within this context.
‘Dependability’, the qualitative equivalence of reliability in quantitative research,
seeks to show that the research findings are stable over time (109). Unlike
reliability, which stipulates that another researcher using the same methods
under the same conditions should arrive at the same results (92), ‘dependability’
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is more concerned with whether or not another person reading the qualitative
research report would agree that the process which led to the findings were
carried out in a reasonable manner (176).This requires that the research
process is described in sufficient detail to provide a basis for judging the extent
to which good research practices were followed, and if need be, allow other
researchers to repeat the work (174). In the current project, a detailed account
of the qualitative method was provided. Moreover, a member of the project
supervisory team, experienced in qualitative interviews, ‘audited’ the research
process by checking the interview transcripts against digital recordings to
ensure the accuracy of transcription. In addition, transcripts were checked
against coding categories and emerging themes to ensure that the themes and
sub-themes accurately reflected the accounts provided by interview
participants. This process also ensured the ‘confirmability’ of the qualitative
findings.
‘Confirmability’, the qualitative equivalence of ‘objectivity’, ensures that as far
as possible research findings truly represent the views and perceptions of
research participants, and not the ideas and preferences of the researcher
(174). ‘Confirmability’ is established through ‘reflexivity’, which makes explicit
the researcher’s influence on the research process, including how data was
generated, analysed and interpreted (173). Qualitative researchers are
encouraged to embrace ‘subjectivity’ with regards to personal and professional
backgrounds which largely determines their emotional response to data
generated; this also impacts on the analysis and interpretation of data (96,177).
According to Searle, failing to embrace ‘subjectivity’ puts the qualitative
researcher at risk of being restricted to participants’ words, without gaining
understanding of what the words mean to the participant in the context of the
research topic (173). Hence, the researcher’s personal and professional
backgrounds may be harnessed to serve as a resource in gaining what Barbour
calls ‘analytical purchase’ (96). Therefore, a reflexive account detailing the
research student’s professional and personal background are presented in the
next section to allow readers of this thesis to make informed judgements of the
credibility of research findings.
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4.7.3.2 Reflexivity and researcher’s background
The researcher is a trained pharmacist from Nigeria, without prior experience of
the British health care system. His previous experience of issues connected
with implementation of pharmacy services were those gained from years of
practice in Nigeria and from reading the literature. At the start of the PhD
programme, the researcher visited several pharmacist prescribers to observe
their practice. In the course of discussion with these pharmacists, the
researcher was made aware of professional issues (such as low remuneration
of pharmacists relative to medical colleagues) confronting pharmacy in Britain,
which were in many ways similar to those in Nigeria. These discussions may
have influenced the researcher’s disposition; however, deliberate efforts were
taken as outlined above to ensure the ‘trustworthiness’ of the research process.
Some of these issues will be considered further under strengths and limitations
of the qualitative phase of the project.
4.7.3.3 Strengths and limitations of the qualitative phase
In Chapter 2, the general strengths and limitations of qualitative research
methods were reviewed. In particular, advantages and disadvantages of semi-
structured telephone interviews were presented. However, specific strengths
and limitations of the qualitative phase of this project are now presented.
4.7.4 Strengths
The qualitative phase of the current research was the first to interview
pharmacist prescribers based in England and Scotland since the
implementation of IP. In addition, participants were recruited from all practice
settings which provided an opportunity to explore views and experiences of
pharmacist prescribers across diverse backgrounds and contexts of prescribing
practice, including pharmacist prescribers who were not using their prescribing
qualification. This rich sample mix contributed to the quality and depth of data
generated. In contrast, other qualitative research published in the UK, indicate
that researchers have either selectively recruited participants from England,
Scotland, Wales or NI, or focused their studies on either SP or IP. Cooper et al.
relied on semi-structured interviews with 43 stake holders across the UK, which
included 8 pharmacist prescribers, to investigate stakeholders’ views of UK
nurse and pharmacist SP (178). However, their study was primarily concerned
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with the evaluation of SP by pharmacists and nurses in England (140,178), and
there was no indication that any of the 8 pharmacist prescribers they
interviewed were from outside England.
Participants in the current study arranged to be interviewed at their
convenience. This, along with the short duration of interviews, ensured minimal
disruption to the already busy schedules of pharmacists, and allowed them to
contribute maximally to the interview data. Shenton has argued that research
involving participants who are genuinely willing to freely give information,
ensures the ‘credibility’ of the resultant data (174). Moreover, Shenton proposed
‘iterative questioning’ involving the use of probes to elicit details on issues
raised by participants, in the hope that contradictions or deliberate falsehoods
may be identified, as a means of further establishing the trustworthiness of the
resultant data. This approach was applied in the current project for individual
interviews and the whole process of data generation. Therefore, conceptual
ideas formed from the accounts of interview participants were thoroughly tested
in subsequent interviews and those that were not supported by information from
the research participants were discarded. Hence, current findings are credible
representations of participants’ views and experiences of pharmacist
prescribing practice in GB.
Conducting telephone interviews had the advantage of avoiding logistic and
cost challenges that would otherwise have been involved in arranging face-to-
face interviews with 34 pharmacist prescribers across GB. Musselwhite et al.
argue that telephone interviews allow respondents to relax in the familiarity of
their own environment and freely volunteer information on the topics being
discussed. The authors in their discussion paper on the telephone interview
method of data collection in clinical and nursing research, provided evidence
from a review of the literature suggesting that absence of face-to-face contact in
telephone interviews is, in fact, advantageous to the research process. They
report both interviewer and interviewee as being potentially less affected by
non-verbal expressions such as facial approval or disapproval of information
provided (179). Similarly, in the study by Cooper et al. the authors did not
consider the possibility of less interaction and lack of rapport associated with
telephone interviews to be of concern (178). Reviewing the apparent neglect of
Chapter 4 – Semi structured telephone interviews
192
telephone interviews in the qualitative research literature, Novick argues that
non-verbal cues when present are not always necessary, especially in projects
like the current study, where data analysis is focused more on interview
transcripts and the ideas and concepts from these, rather than behavioural
aspects of practice which would require observational field notes (117).
A further strength of the qualitative phase of the project relates to the
application of the ‘framework’ approach to data analysis. The strength of this
approach is described in terms of ‘transparency’ and ‘accessibility’ which
provided a means of re-considering and refining ideas as they were formed
during the analysis (101). Whilst the research student was solely responsible for
transcribing, analysing and interpreting the data, the analytical process made it
possible for coding categories, emerging themes and sub-themes to be
independently checked for appropriateness by members of project supervisory
team.
4.7.5 Limitations
In terms of limitations, the recruitment of pharmacists was lower than
anticipated and hence research was limited to all those who agreed to be
interviewed. In the purposive sampling strategy planned, it was anticipated that
more pharmacist prescribers would accept the invitation in order to permit a
selection of the individual who are eventually interviewed. This notwithstanding,
more interviews were conducted than earlier planned (see methods for
explanation). Moreover data saturation occurred in the analysis of interviews
findings whereby subsequent interviews did not yield new coding categories
(180). Thus confirming adequacy of the sample recruited for the current
research (171,180).
The relatively short duration of interviews (15-20 minutes) may have limited the
depth of data generated. While some qualitative researchers suggest that this
duration would not permit full exploration and in-depth discussion of the issues
under investigation (117,118), the literature review by Novick (117) did not find
sufficient evidence to support this claim. Irrespective of the duration of
interviews, Sturges and Hanrahan directly compared face-to-face interviews
with telephone modes of data generation in their study of interactions between
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prison officers and visitors in three prison facilities in the USA. The authors
concluded that the depth and quality of data generated was similar for both
telephone and face-to-face modes of interview (119).
Findings of the current study were based on views and perceptions of
individuals, and should be interpreted with caution. Issues such as recall and
social desirability bias, which may present a threat to the ‘trustworthiness’ of the
data should be noted (174). Social desirability bias may have been minimised
by the use of telephone rather than face-to-face interviews (117,118).
‘Member checking’ or participant validation, which involves cross-checking
emerging conceptual ideas with interview participants, was not employed in this
study (174). Whilst such member checks may enhance the credibility of
qualitative findings, it was considered by the research team to impose
excessive demands on pharmacist prescribers. Moreover, the value of such
checks is still debatable as Mays and Pope argued; research participants
usually approach the issues from their individual perspectives, which may
contradict the overall perspective provided by the researcher from the accounts
of different participants (111). Barbour, also points out that member checks in
projects such as the current study situated in the field of health services
research, which require cross-sectional collection of data may add more trouble
than value to the research (181).
4.8 Interpretation of findings
The key findings of the qualitative phase of the research will be discussed in
terms of their implications for the policy and practice of pharmacist prescribing
in GB. The discussion is organised according to the specific objectives of Phase
2. The impact of facilitators and barriers identified in Phase 1 on the practice of
prescribing pharmacists will be considered along with strategies adopted by
pharmacist prescribers, in overcoming challenges.
4.8.1 Implementing prescribing practice
‘Lack of opportunities’ to prescribe was described in the quantitative phase by
around one third of those who had not prescribed. Data from the qualitative
phase suggests that this lack of opportunity arose from several key barriers,
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including: administrative procedures, the need for CMPs in SP, the legal
restrictions of prescribing CDs under IP, funding limitations, lack of support, and
inadequate IT facilities for prescribing in the community pharmacy setting.
Administrative and organisational structures necessary for implementing
pharmacist prescribing practice appeared not to have been adequately
developed for optimum service delivery, particularly in the community setting.
Professional and physical isolation from other health professionals and
prescribers may have contributed to low prescribing practice implementation in
community pharmacy.
Professional and physical isolation of the pharmacist prescribers in the
community pharmacy setting had earlier been acknowledged by Weiss et al.
(182). The authors utilised semi-structured interviews with 23 SP pharmacists to
explore the implementation of pharmacist prescribing in England and Scotland.
They supplemented this approach with observational case studies of five SP
pharmacists who were prescribing, and one diary study of a pharmacist
prescriber who had not started SP practice. They found additional difficulties
with SP implementation in community pharmacies arising from: lack of access
to patients’ medical records, physical distance from the independent prescriber,
and lack of budgetary provisions to commission pharmacist prescribing services
(182). Others have reported similar findings. Lloyd and Hughes conducted focus
group discussions with 47 pharmacists enrolled in the first four cohorts of SP
course in Northern Ireland, to explore their views and professional contexts,
prior to the start of SP training (54). They repeated the interviews 12 months
after the pharmacists had qualified as prescribers (70). These qualitative
studies revealed that little progress had been achieved by pharmacist
prescribers based in the community setting.
There are key differences between the current project and the studies cited
above. The study by Weiss et al. was conducted at a time when pharmacist
independent prescribing policy was only being considered, and did not include
pharmacist prescribers from Wales. Lloyd and Hughes, on the other hand,
conducted their study in NI which was not within the scope of this research.
However, findings indicate that little progress has been made across GB and
four years post-implementation of pharmacist independent prescribing.
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Moreover, whilst the earlier cohorts of pharmacist prescribers perceived that the
introduction of IP would resolve most of the implementation challenges of SP
(54, 70,182), findings of the current study show that isolation of the prescriber
based within community pharmacies, continues to pose challenges to both SP
and IP models of practice. Perhaps, more worrying is the fact that these
challenges had been previously well recognised while implementing enhanced
patient centred clinical roles in the community setting (158,183). A systematic
review by Bond et al. to determine the contribution of community pharmacists in
the provision of enhanced clinical services in the NHS identified several
research papers from different countries on the subject. The authors reported
barriers to the adoption and implementation of pharmaceutical care practice
philosophies in the community setting, arising from isolation of community
pharmacists, which hindered their access to the patient medical record (157).
Pharmacist prescribers based in the community setting are also encumbered by
potential conflict of interest arising from business pressures and the ethical
dilemmas of sometimes having to dispense their own prescriptions.
Whereas the papers reviewed were published at a time when pharmacist
prescribing had not been implemented into practice, it is clear that the issues
involved are the same for all cognitive roles of the pharmacists that require
access to patients’ medical records from the community pharmacy setting. In
contrast, most of the challenges to prescribing practice identified in hospitals
have been resolved over time, according to Dawoud et al. who conducted pairs
of interviews with 17 SP pharmacists, three and six months after they registered
as prescribers in Southern England. (46). Indeed, findings of the current study
show that prescribing by pharmacists seems to more integrate within the
healthcare system in GP practices and hospitals than in community
pharmacies. In addition to professional support, prescribing in these settings
also reflects the availability and adequacy of facilities, administrative and clinical
support. Thus it could be argued, that pharmacists prescribing will only achieve
meaningful success when practitioners based in the community setting are fully
integrated with other health professions delivering services in the NHS. Such
developments are key factors in achieving quicker and safer access to
medicines as described within the aims of non-medical prescribing (35). It is
interesting that interview participants in the current study, elaborated extensive
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safety precautions they observe in delivering prescribing services. This was
also reported by Latter et al. who reviewed the evidence on the quality and
safety of nurse and pharmacist independent prescribing in England (184). The
same authors reported both pharmacist and nurse prescribing conforming to
safety and appropriateness indices (139,184)
4.8.2 Integrating pharmacist prescribing into ‘mainstream’ patient care
Findings revealed a perception among pharmacist prescribers based in general
medical practices and hospitals, that prescribing ‘worked well’ because they
practised in environments that they considered to be ‘fully integrated’.
Integration was described in terms of good working relationships with other
health professionals, administrative and other support staff. In addition, facilities
such as space for patient consultation and adequate IT for access to patients’
medical records in these settings are more likely to support pharmacist
prescribing practice. Full integration of pharmacist prescribers requires a close
working relationship between prescribers in community pharmacies and other
health professionals. The study by Weiss et al. reported SP as working
extremely well in environments with clear lines of communication and
responsibility, with effective relationships and understanding between SP and
other health professionals, and clearly defined roles for pharmacist prescribers.
(182). However, the relationship between GPs and community pharmacists has
often been defined by competitive and sometimes antagonistic attitudes
towards the expansion of pharmacists’ roles (5). The RPS and RCGP both
acknowledge that innovations which have expanded the role of pharmacists
from dispensing to patient-centred clinical roles over the last two decades, have
often been introduced without integration with GP services, hence limiting the
potential for enhanced patient benefits (185).
Despite efforts of the government to integrate community pharmacist into the
primary health team in Britain, the relationships between the GPs and
community pharmacists has remained significantly under-developed with little
co-operation between them (186). Bradley et al. investigated inter-professional
collaboration between pharmacists and GPs to determine the factors that
impeded integration of their services (187). The authors showed that a good
working relationship between pharmacists and GPs was a prerequisite to
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pharmacists’ performance of enhanced clinical roles. In addition, they found that
having both the pharmacists and GPs located together fostered a greater level
of integration of community pharmacists’ services. Although Bradley et al. were
not specifically concerned with pharmacist prescribers, their findings are
relevant for pharmacist prescribing. Interview participants perceived that outside
hospitals and general medical practices, the prescribing environment in prisons,
health centres and other such specialised health institutions represented the
most integrated settings which supported the optimal delivery of prescribing
services. Bradley et al. described a conceptual model of collaboration between
community pharmacists and GPs. They interviewed GPs and community
pharmacists involved in the provision of local pharmaceutical services in
England, and used findings to describe three levels of collaboration: ‘isolation’,
‘communication’ and ‘collaboration’ (188). Isolation represents the lowest level
of integration; characterised by physical separation which does not permit close
relationship and trust between the two groups of professionals, as experienced
by participants in the current interview who were based in the community
pharmacy setting. It is a welcomed development therefore, that both the RPS
and the RCGP have issued a joint statement detailing over 60 specific
recommendations on working together to break down the barriers between
community pharmacists and GPs in order to improve patient care (185).
In terms of practice, integration of pharmacist prescribers based in the
community setting may initially require pharmacists to implement prescribing
practice within GP practices, as described by those active community
pharmacist prescribers. In addition, community pharmacy based prescribers
will require access to patient’s medical records held by GPs. This requires a
major policy initiative on the part of Government and NHS organisations
providing the impetus to develop pharmacist prescribing facilities, especially the
IT link across all practice settings. This was also recognised as a key building
block for change that would allow joint access and responsible sharing of
patient information for improved efficiency, safety and cost effectiveness of
patient care across the NHS in GB (185). It is particularly reassuring that the
Scottish Government in its second ‘eHealth Strategy’ for the NHS in Scotland,
has shifted emphasis from the procurement and development of IT
infrastructure to harnessing optimal benefits from existing technologies. The
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Government’s strategy is to encourage the use of existing IT facilities to
facilitate easier and more efficient collaboration among healthcare providers
involved in the delivery of health services across Scotland by 2014 (189).
4.8.3 Appropriate IT facilities for pharmacist prescribing practice
Inadequate or lack of IT facilities for access to patients’ medical records in the
community pharmacy setting, not only hinder integration of pharmacist
prescribing practice into the ‘mainstream’ of patient care, but also contradicts
‘best practice’ recommendations for the implementation of pharmacist
prescribing. Policy documents guiding the implementation of pharmacist
prescribing in GB, require that pharmacist prescribers enter detailed information
about their consultation and prescribing into the shared medical records of the
patients immediately after the encounter (38,190). By stipulating this guideline
for the implementation of pharmacist prescribing, the Department of Health and
the Scottish Executive had pre-supposed that pharmacist prescribers would
have access to patients’ medical records, and share same with other health
professionals. However, this has not turned out to be the case, especially for
prescribers based in the community pharmacy setting. Consequently, the
majority of participants in the current study who were based in community
pharmacies only managed to utilise their prescribing qualification in GP
practices. Participants who prescribed in community pharmacies described the
process as cumbersome and inefficient, with reports of pharmacist prescribers
travelling specifically to access patient records, before and after the
consultation. This does not encourage prescribing in the setting that has the
highest potential for achieving enhanced access of patients to medicines
envisaged by the Crown committee (16). Hence, participants perceived that
providing the necessary IT facilities for access to patients’ medical records, was
one of the biggest steps that could be taken to enhance their practice as
prescribers. They argued that such a strategic initiative would fully integrate
community pharmacies into the mainstream of patient care and facilitate
electronic prescribing.
In Scotland, the basic IT infrastructure for delivering NHS services which could
integrate community pharmacies has been created in the form of a central
database. This database contains Emergency Care Records (ECR) which are
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electronic summaries of medical information about all individuals registered with
GP surgeries under the NHS (191). This integrated system created in 2006 is
automatically updated twice daily, with prescribing information and adverse
reaction from all GP practices in Scotland. A cross-sectional questionnaire
survey of 1,210 patients registered in one GP surgery in Scotland, achieved a
response rate of 23% (n=283). The study found that a majority of the patients
did not remember being informed about the central database, but they did not
mind their records being uploaded to the central database once they read the
information about it (192). Although this was a small study of patients in only
one GP surgery, feedback from clinicians who have accessed the Scottish ECR
has been overwhelmingly positive. Libby et al in a letter response to an article
in the British Medical Journal, commented on the success of the ECR, and
reported that by 2010, health professionals in Scotland had accessed the
database more than 5 million times, including the increasing use of these
records by hospital pharmacists for medicines reconciliation (193).
Although the report did not specifically evaluate the use of the ECR database
for prescribing by pharmacists, the report indicates potential benefits for
prescribers. It is particularly encouraging that the Scottish Government in its
second ‘eHealth Strategy’ 2011-2017, plans to expand the ECR with Palliative
Care Summary (PCS) and Key Information Summary (KIS), which contain
detailed information on diagnosis, anticipatory plan of action for use during
emergencies. Perhaps even more relevant, is the plan of the Scottish
Government to ensure that by 2014, all Health Boards are using clinical portals
or electronic windows which will make the necessary patient information
available to all health professionals at the point of care (189). When achieved,
this level of information access will significantly enhance the practice of
pharmacist prescribers within the community setting. Unfortunately, such IT
access is less advanced in the English NHS.
The DoH had for many years planned to introduce an integrated National Health
Service records system to allow NHS staff get easy access to accurate medical
histories of patients. Consequently, the government embarked on a ‘National
Programme for Information Technology’ with a proposed investment of £12.7
billion over 10 years beginning from 2002 (194). According to the original
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timetable of the DoH, everyone in England and Wales was to have their own
electronic health records containing: contact details of the patient and their
registered GP, previous and ongoing conditions, current medication and
allergies by March 2005 (195). The NHS care record is expected to create two
sets of information: the ‘national summary care records’ which contain basic
information with limited clinical data, could be accessed nationally by patients
and authorised NHS staff. The second set of records, the ‘detailed care
records’, is to contain more comprehensive clinical information, to allow local
organisations to share clinical information for services like prescribing (196).
However, the development of the IT backbone for creating a central electronic
medical record for all patients in England has been problematic and the
government no longer intends to replace all NHS computer systems, meaning
that it is no longer possible to integrate records in all NHS organisations (194).
This has serious implications for pharmacist prescribers, particularly those in
the community setting.
4.8.4 Strategies for successful prescribing practice
Objective 2 of the interview phase centred on strategies adopted by participants
to overcome challenges in their prescribing practice. Successful strategies may
be of importance to further pharmacist prescribing. Respondents reported
‘identifying niche areas’, ‘increased promotion’ or ‘advertisement’, ‘increased
number of pharmacist prescribers’ and ‘agreeing formal prescribing roles’.
Active promotion and advertisement of developments and services was also
noted by Lloyd et al (70),who argued that advertisement of pharmacist
prescribing made the role more visible to patients and other health
professionals thus enhancing its acceptability. Similarly, the study by Weiss et
al. emphasised the importance of creating awareness and understanding about
the benefits and rationale for introducing pharmacist prescribing (182).
Findings from the interviews suggest that pharmacist prescribing practice can
be best promoted by focusing on specific niche areas of practice. Courtenay et
al. have similarly shown that non-medical prescribing practice is facilitated by
having well defined prescribing roles, with a well defined set of patients or
conditions that are agreed between pharmacist or nurse prescribers and their
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managers (197). The authors, who conducted semi-structured interviews with
28 NMP leads in one strategic heath authority in England, also noted that lack
of evidence on the benefits of commissioning prescribing services hampered
the development of prescribing services in areas like community pharmacy
(197). This may explain the perception by the current research participants that
promoting pharmacist prescribing practice could be achieved through research,
to demonstrate favourable outcomes of pharmacist prescribing. Outcomes
such as improved patient care and better use of pharmacists’ skills were
mentioned as benefits in the current study.
However, there is little published research evidence in the literature to
demonstrate positive clinical outcomes of pharmacists prescribing. Most
research to date has focused on prescribing processes and patients’
satisfaction with, or perceptions of pharmacist prescribing. One survey of 127
patients attending a pharmacist-led hypertension clinic achieved a response
rate of 87%, of which 57% perceived that pharmacist prescribers offered better
standards of care than they had received from their usual carers (75). Similarly,
Stewart el al. had previously demonstrated positive views of patients and the
general public towards pharmacist prescribers. Patients particularly were
reported to have high regard for the knowledge and skills of pharmacist
prescribers, whom they thought offered better medicines management than
nurses (73, 74). Humanistic and economic outcomes also deserve attention;
the study by Latter et al. included discreet choice experiments and economic
evaluations to compare NMP with GP prescribing (139). The authors used a
hypertension vignette to determine the benefits of patient derived utility from GP
prescribing and pharmacist IP services. They found that patients equally
preferred prescribing services offered by their own GPs and pharmacist
prescribers, above prescribing by any available doctor in the GP practice. They
reported higher cost saving to the practice in the combined model of GP and
pharmacist prescribing for hypertension than traditional GP prescribing alone
(139). Despite these positive reports, there remains the urgent need for
outcome studies to contribute to the evidence base in support of pharmacist
prescribing.
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The suggestion from the interview participants to increase the number of
pharmacist prescribers is noteworthy. Ironically, Stewart et al. while
investigating the intention of 4,300 GB pharmacists to participate in prescribing
training, achieved a response rate of 55% and found that a majority of
pharmacists who described themselves as ‘venturesome’, ‘innovators’ and ‘role
models’ had not even thought about training to become prescribers two years
after the introduction of SP (63).There is a lack of strategic direction on the
selection of pharmacists to undertake training and the issue of specialist versus
standard practice remains unresolved. There are parallels with innovations in
clinical pharmacy and pharmaceutical care. These concepts revolutionised the
practice of pharmacy only when individual practitioners increasingly changed
their daily practices in line with these philosophies (198). Similarly, development
of the ‘practice pharmacist’ role in GP surgeries and PCTs in the UK, which
started opportunistically, has by increased involvement of pharmacists become
the norm in practice (199).
Silcock et al. noted that the engagement of pharmacists in primary care began
with a few ‘privileged’ pharmacists capitalising on opportunities to manage drug
budgets allocated by health authorities. However, as more pharmacists got
involved, the pharmacy profession took the initiative, negotiated and agreed
formal roles with the Department of Health; and currently, the role of ‘practice
pharmacist’ transcends the management of drug budgets, and is also
concerned with overall prescribing quality. This role has so developed and
become integrated, that it is now the norm for ‘practice pharmacist’ to set the
agenda for prescribing and medication review for PCTs and GP practices (199).
This also reflects the general progression of pharmacy practice, from the
compounding and advisory roles of apothecaries, through the age of
industrialisation and product-centred dispensing role of pharmacists and finally,
the patient-centred age of clinical pharmacy practice (3, 5).
4.8.5 Clarifying the prescribing role of pharmacists
Objective three focused on defining the prescribing role of pharmacist from the
perspective of interview participants. From the narratives, precise prescribing
roles and responsibilities often appeared to be unclear, largely attributed to poor
understanding of the role by stakeholders, e.g. health professionals and
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patients. Others have reported similar findings in which stakeholders were
either unaware or lacked understanding of the role of pharmacists in
prescribing. Cooper et al. reported a perception that lack of awareness and
understanding of pharmacist prescribing among pharmacists, doctors, patients,
and even commissioners of prescribing services, constituted a major barrier to
the implementation of pharmacist prescribing practice (178). Similarly, Lloyd et
al. reported three main barriers to pharmacist prescribing implementation to
include a ‘lack of awareness’ among other health professionals (70).
Participants in the current study thus described their own ideas of well-defined
roles and responsibilities for pharmacist prescribers. They proposed that the
‘ideal’ prescribing role of pharmacists as one in which pharmacists apply their
expertise and skills in the management of patients with disease conditions that
require multiple drugs, with high potential for medicines mismanagement
(significant pharmacokinetic and pharmacodynamic issues). They consider that
this would be appropriate use of skills in pharmacotherapy. Participants
delineated clinical examination and diagnosis to nurses and doctors. It should
be noted that these findings were based on the perceptions of pharmacist
prescribers only, as the study population did not include nurse prescribers or
doctors. However, Weiss and Sutton, drawing on findings of 23 semi-structured
interviews with pharmacist prescribers in England and Scotland, reported a
similar perception among the early cohorts of SP pharmacists (68).
The exclusion of diagnosis from the prescribing responsibilities of pharmacists
in this study, contrasts with the official definition of a pharmacist independent
prescriber “An independent prescriber is responsible for the assessment of
patients with undiagnosed and diagnosed conditions and for decisions about
the clinical management required, including prescribing” (16). Moreover, Weiss
points out that clinical reasoning underlie decisions about diagnosis,
management and referral of patients; thus suggesting that diagnosis and
prescribing decisions are inter-wound in the same clinical reasoning process
(200). Yet interview participants stated categorically that diagnosis was the
responsibility of doctors. This finding supports other work which indicated that
doctors and pharmacist prescribers were more comfortable with independent
prescribing in conditions that had already been diagnosed (70); as obtained in
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the SP model. Ironically, pharmacist prescribers in this and other studies, have
also reported substantial limitations in their practice of SP, generally preferring
IP practice (49, 50). Consequently, the ideal role proposed by interview
participants raises two issues:
i. Aligning these ideal roles within the framework of SP and IP
ii. Relative contribution of pharmacist prescribers compared to other non-
medical and medical prescribers
In terms of policy, it is expedient to identify how the ideal prescribing role of
pharmacists fits within the existing framework of SP and IP. Cooper et-al.
queried whether both models were needed because of the apparent tension
arising from the differences between them. They argued that flexibility in the IP
model, without the statutory requirement for the use of CMPs presents an
advantage that could improve access of patients to medicines. However, such
flexibility comes at the expense of the security and patient safety assurance
inherent in the CMP requirement of SP (178). Interestingly, for pharmacist
prescribers in this study, IP was reported as ‘freeing’ them from unnecessary
bottlenecks and excessive documentation required in SP; but did not
necessarily translate to independence in diagnosis and prescribing. It is clear
from the narratives of interview participants that pharmacist prescribers
preferred the flexibility and freedom of IP, but still wanted diagnosis to remain
the responsibility of doctors, similar to the situation in SP. Therefore, the
findings may suggest development of a hybrid role that combines features of
the current SP and IP models.
The second issue reiterates the need for clearly defined inter-professional
working around the prescribing process. Interview participants suggested a
collaborative working arrangement, in which health professionals worked in
partnership with each other. This supports the argument by Weiss and Sutton,
that prescribing is an integrated process involving different components that
potentially require inputs from different health professions (68). In this respect,
the ideal prescribing role advocated by pharmacist prescribers is a multi-
disciplinary cooperation, harnessing the unique knowledge and skill of each
member of the health team. A good working relationship among health
professions has been identified as an important factor for the successful
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implementation of pharmacist prescribing (70). Indeed, some GPs have been
highly supportive and positive towards pharmacist prescribing, viewing it as an
opportunity for GPs to focus on more specialised diagnostic roles.
The prescribing partnership suggested by interview participants echoes the
Government’s objective articulated in the NHS plan. The plan aimed to remove
unnecessary inter-professional boundaries and introduce new ways of
delivering services in the NHS (159,201).
4.8.6 Developments in pharmacist prescribing practice
One key issue in the implementation of pharmacist prescribing is delivering a
sustainable workforce with the capacity to meet patient and healthcare needs.
The training of future pharmacist prescribers has been noted by others. Cooper
et al. reported the views of stakeholders that prescribing will eventually become
an integral role of pharmacists and be encompassed within the training of
pharmacy undergraduates. Interview participants in the present study, noted the
significance of training on the development of pharmacists prescribing practice.
However, the low level of planned participation in prescribing training identified
by Stewart et al. among pharmacists (63) may impose a direct limitation on the
development of pharmacist prescribing practice in GB.
Furthermore, participants in the current study emphasised the value of clinical
examinations and patient consultation skills acquired during the period of
learning in practice; but they were sceptical about the consultations skills aspect
of current prescribing training courses. They pointed out, that the consultation
skills component of pharmacist prescribing training course was currently
inadequate in terms of ‘hands-on’ practical experiences. This limitation in the
prescribing course had been noted previously by several researchers (60-62).
Thus, any future training of pharmacist prescribers should prioritise the issue of
developing expertise in clinical assessment and diagnosis where such is
relevant to the eventual role of the pharmacist in prescribing. Weiss suggests
that the traditional model of medical training, which combines basic biomedical
science with engagement in patients’ clinical problems, is only one way of
developing expertise in diagnosis (200). It is therefore useful that some
universities have focused research on developing this aspect of pharmacist
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prescribers’ training. Stewart et al. have developed and validated a tool for the
assessment of competence and performance of pharmacist prescribers with
regard to patient consultation (57). These authors adapted and modified the tool
used for the assessment of GP consultation competencies and skills. Such tools
will become increasingly valuable in the development of pharmacist prescribing,
by ensuring the continued competence of pharmacist prescribers post-
qualification, through CPD activities.
Important to the process of prescribing is the continuing professional
development and training of pharmacist prescribers. Qualitative findings
revealed a lack of focused CPD activities for prescribing practice. Participants
perceived that available CPD programmes were more generic for pharmacy and
not particularly tailored towards developing competencies in prescribing
practice. Moreover, pharmacist prescribers felt that there was too much
emphasis on documenting CPD, which according to them was not of much
practical help to their practice. Cooper et al. noted similar concerns in their
study, which pointed out that training often failed to equip pharmacist
prescribers with the latest clinical knowledge (178). Therefore, as pharmacist
prescribing becomes more enshrined in the patient care culture in the NHS, it
may be expedient to develop specific programmes and opportunities for
pharmacists (and other non-medical and medical prescribers) to extend their
competency in prescribing.
4.9 Summary and conclusion
In the qualitative phase of the project, the views, experiences and perceptions
of pharmacist prescribers on the implementation of prescribing practice were
explored in semi-structured telephone interviews. This work showed that limited
prescribing opportunities identified in Phase 1 are compounded for prescribers
based in community pharmacies because of the geographical location of their
practice environments, which are isolated from other health professionals. In
addition, lack of appropriate IT facilities hinder remote access to patients’
medical records for effective prescribing from the community setting. Thus,
participants who have succeeded in prescribing practice, have done so in
environments which provide adequate clinical and administrative support,
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enhanced by pre-existing relationship and good communication among health
professionals.
Results of the quantitative phase of the research on the apparent lack of clarity
in the prescribing role of pharmacists were also explored. Participants provided
detailed accounts of their views and perceptions and proffered descriptions of
‘ideal’ roles of pharmacists in the prescribing process. This emphasised the
application of pharmacist expertise in the management of chronic, co-morbid
conditions which often depend on the use of multiple medicines. Application of
the current findings into practice, and specific recommendations for policy and
research will be provided in Chapter 5. Findings of both quantitative and
qualitative phases are brought together to draw an overall conclusion to the
research project.
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Chapter Five: General Discussion
In this final chapter, key findings of the two phases will be integrated to provide
the basis for conclusions and recommendations. The discussion will provide a
recap of the overall research aim and critically evaluate projects as to whether
the research objectives were met. This will lead into a discussion of key findings
from both phases of the research to highlight contributions of the project to the
knowledge base on the research topic. Recommendations for policy and
application of key findings to practice will lead into a discussion of further
research before drawing an overall conclusion to the project.
5.1 Recap of the project aim
The aim of the research was to explore developments in SP and IP since
implementation; focusing on an investigation of the structures and processes of
prescribing practice by pharmacists in Great Britain. To achieve this aim, a two-
phased project utilising the ‘sequential-mixed methods’ strategy (86) was
designed. The initial quantitative phase applied a cross-sectional questionnaire
design to survey all pharmacist prescribers (n=1643) registered with the
RPSGB as of January 2009. The aim in this phase was to identify facilitators
and barriers associated with pharmacists’ prescribing practice and to quantify
the relationship between them. In the subsequent qualitative phase, the
research student conducted semi-structured telephone interviews with 34
pharmacist prescribers out of 165 who indicated interest from the quantitative
phase. Qualitative interviews explored in-depth, the views; perceptions; and
experiences of participants with prescribing practice to provide deeper insight
into the structures and processes of pharmacist prescribing practice.
Quantitative results in Phase 1 identified significant association between the
pharmacy practice setting of respondents and their engagement in active
prescribing practice. Thus it became apparent from Phase 1, that experiences
of pharmacist prescribers in one setting could be extrapolated and applied to
practice in other settings. This provided the rationale for expanding the research
focus in Phase 2 to also include pharmacist prescribers in secondary care
hospitals (details in Chapter 4).
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5.2 Critical appraisal of the research process
The specific strengths and limitations of the quantitative and qualitative methods
employed in this project are discussed in Chapters 3 and 4 respectively. Either
of these methods was considered sufficiently robust, and contributed to the
understanding of the prescribing practice of pharmacists in GB. However, the
main strength of the project was the utilisation of a mixed methods approach
which permitted the triangulation of both quantitative and qualitative data to
achieve a comprehensive understanding of the research topic. Results of the
quantitative phase added to the present evidence-base, by providing an update
on the nature and extent of prescribing activities currently undertaken by
pharmacists in GB. This phase also provided the quantitative evidence for the
importance of IT facilities, and the pharmacy practice setting as predictors of
prescribing practice. In contrast, the qualitative phase elaborated the identified
challenges, and revealed that, most of the challenges associated with
prescribing practice were related to a seeming lack of clarity in the prescribing
role of pharmacists, which was expressed by study participants. The iterative
nature of the qualitative phase also allowed the in-depth exploration of the
views, perceptions and experiences of interview participants to identify
strategies already adopted by pharmacist prescribers, possible future solutions
for overcoming the challenges to prescribing practice.
Thus, each phase provided a unique and distinct perspective to the project.
However, both phases were related and connected at all stages of the project.
At the design stage, it was apparent that adopting a mixed-methods design was
a pragmatic choice to meet the research aims (see Chapter 2). Combining
quantitative and qualitative methods produced a comprehensive explanation of
the structures and processes of pharmacist prescribing in GB. This was
achieved in two ways: firstly, qualitative findings complemented the statistical
results of the quantitative phase by offering explanations of pharmacists’
experiences with prescribing implementation, and thus enhancing the credibility
of the research process (202). Secondly, both quantitative and qualitative
methods converged in some of the findings, hence the qualitative data
corroborated and confirmed (120), the quantitative results. Analysis of open
questionnaire responses yielded ‘lack of defined prescribing roles’ as the central
challenge to prescribing practice of pharmacist; this was supported by similar
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findings from analysis of interview transcripts, which further strengthened the
overall research outcome. Therefore the integrated findings may be translated
and applied to improve the general implementation and practice of pharmacist
prescribing in GB (see recommendation for policy and practice) .
In terms of limitations, it was not possible to sustain the initial focus of the
research on pharmacist prescribers based in primary care settings. This was
due to minimal prescribing activities being implemented in the community
setting. George et al. investigated early experiences of pharmacist prescribers
and also showed that the level of prescribing in the community pharmacy
setting was low (48, 58). However, their study was conducted during the early
periods post implementation of SP; therefore, it was understandable that there
would be initial implementation challenges. The assumption at the outset of the
current project was that passage of time and the subsequent introduction of IP
might have changed and advanced prescribing practice in community
pharmacies, hence the initial focus on the primary care setting. Expanding the
focus in Phase 2, of the project means that the quantitative results missed
process data such as information about therapeutic areas managed, and the
number of patients served by pharmacist prescribers in secondary care.
However, this does not invalidate the conclusions drawn in the current study as,
the key findings were based on complete data provided by participants in all
practice settings.
Another limitation of the project concerns the focus on only the perspective of
pharmacist prescribers themselves. This excludes stakeholders e.g. doctors,
nurses, non-prescribing pharmacists, and NHS managers responsible for
implementing the policy. Others excluded are: academics responsible for
training pharmacist prescribers, patients and the general public. Therefore, it
should be recognised that the findings are not irrefutable evidence of the
structures and processes of pharmacists prescribing. Some of the issues raised
by pharmacist prescribers were often conjectures and perceptions about the
roles of other stakeholders in the prescribing process. Such issues can only be
sufficiently addressed by the relevant stakeholders; for instance, pharmacist
prescribers while attempting to clarify their own role in prescribing, also
specified some responsibilities to other health professionals. Whilst such
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findings meet the specific objectives of the current project, they also raise
questions that can only be answered with further research to explore other
stakeholders’ perspectives in the implementation of pharmacist prescribing (see
later).
5.3 Integration of key findings from the two phases of the
research
In this section, the original findings of the current doctoral project which extend
the knowledge base, in the subject of pharmacist prescribing in GB will be
presented. This will be organised around the issues raised in the literature
review (Chapter 1) which highlighted the gaps in knowledge, as follows:
5.3.1 Barriers and challenges to implementation of prescribing practice
The literature review in Chapter 1 established that SP implementation
encountered several challenges. Pharmacists who were responsible for
implementing SP thought the challenges were more in general medical
practices than hospitals (46, 47). However, a survey of the qualified pharmacist
prescribers showed that more of prescribers were active prescribing in primary
care than in hospitals (48). At the time of the current study it was not evident
whether those initial implementation challenges had been resolved.
This study provides statistical evidence of the relationship between pharmacy
practice setting, facilities such as IT links and the extent of prescribing activities.
The project is the first to identify by means of factor analysis, that pharmacy
practice setting more than other demographic characteristics, predicts the
prescribing practice of pharmacists. Similarly, this project has for the first time;
provided the quantitative evidence to support previous anecdotal assertions,
that facilities in community pharmacy setting are insufficient to support optimal
implementation of pharmacist prescribing practice. The qualitative findings
revealed further, that inadequate facilities in the community setting mainly
implied the lack of IT infrastructure, necessary for access to patients’ medical
records and electronic prescribing, in addition to problems associated with the
lack of dedicated space, and adequate privacy for patient consultation and
prescribing in most community pharmacies.
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In addition, quantitative and qualitative findings of the current project have
provided an update on the status of pharmacist prescribing implementation in
GB, to show that the facilitators and barriers of pharmacist prescribing practice
identified in earlier studies, have not changed much, after more than five years
of pharmacist prescribing implementation. The development of structures for
pharmacist prescribing practice appears to lag behind progress in the
implementation of pharmacist prescribing practice, especially in the community
setting. Where pharmacist prescribers have overcome challenges to succeed in
prescribing practice, they have achieved this by identifying a niche area of
practice where they apply specialised knowledge to solve complex medication
problems. Pharmacist prescribers have maintained frequent patient contact and
follow-up of patients allowing them to develop competence in these therapeutic
areas of practice.
5.3.2 Progression from SP to IP
Information from the literature review in Chapter 1 indicated the difficulties of
using the CMP in SP practice, which made that prescribing model too
cumbersome and many of the early cohorts of pharmacist prescribers viewed
SP only as a ‘stepping-stone’ to IP practice(46). Pharmacist prescribers
generally perceived IP as more flexible and thought it would be much easier to
implement than SP (46, 48, and 54).Thus with the introduction of IP, it became
necessary at the outset of the current project to update the status of pharmacist
prescribing practice in GB.
Quantitative results in the current project have shown that barriers to
pharmacist prescribing practice include: lack of opportunity, administrative
procedures, resource limitations and lack of defined prescribing roles.
Qualitative findings further revealed that the prescribing role of pharmacists is
not often clearly understood and supported by relevant stakeholders in the
prescribing process. Hence, the current study finding suggest that that
pharmacist prescribers should firmly agree with their organisations, the scope
and clear boundaries of the prescribing services they intend to provide before
embarking on the prescribing course.
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Furthermore, the currents study participants described the ‘ideal’ prescribing
role of pharmacists: as one that utilises the expertise and skills of pharmacist
prescribers in the management of patients with conditions which require
concomitant use of multiple drugs. Thus, current study participants appear to
favour a ‘hybrid’ prescribing model which combines features of SP and IP.
Under this ‘hybrid’ prescribing model, pharmacist prescribers embrace the
flexibility of IP which does not need the cumbersome patient specific CMPs, but
at the same time they seemed to prefer prescribing within the defined
boundaries of diagnosed conditions as is the case in SP.
5.3.3 Inter-professional perspectives
The literature review in Chapter 1 identified opposition and resistance to
pharmacist prescribing implementation. This was especially reported among
some doctors who perceived the new role of pharmacist as a threat to their
professional status in the care of patients (65, 66). Other researchers who
investigated the early implementation of pharmacist prescribing argued that
doctors were more likely to accept the SP than IP model of practice, because
they could maintain overall control under SP (54, 69, 70). Therefore, it was
necessary to study pharmacist prescribing processes in terms of their
interaction with doctors and other health professionals post implementation of
IP
Current study findings found that the cooperation and support of doctors is vital
to the successful implementation of pharmacist prescribing, as was shown to be
the case in hospitals and GP practices. In contrast, prescribing practice
appeared to be greatly hindered in the community pharmacy setting, where
pharmacist prescribers are professionally and physically isolated. In this
environment pharmacist prescribers lack the formal support of doctors.
Moreover, current study findings indicate that prescribing practice is easier to
implement in settings such as: prison health centres and other such specialised
health institutions which provide pharmacist prescribers with the opportunity for
face-to-face contact and easy communication with doctors. In addition to the
support and cooperation of doctors, the support of other healthcare staff in
administrative functions such as arranging patient appointments made the
difference between the ease of prescribing practice in hospitals and GP
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practices, compared to the hindered and difficult prescribing practice in
community pharmacies despite the ease of access to patients and better
opening times in this setting (see Chapter 3).
5.3.4 Development of pharmacist prescribing
Literature review had shown evidence of the benefit of pharmacist prescribing
training, especially the PLP on the implementation of SP (58-60). The literature
review also revealed evidence of some dissatisfaction on the part of pharmacist
prescribers with the content and mode of delivery of the prescribing course
(61,62). Therefore, it was imperative at the outset of the current research to
investigate the impact of prescribing training on practice.
The current study findings showed that development of pharmacist prescribing
practice is to a large extent hinged on increasing the size of pharmacist
prescribing workforce as described by interview participants. However, the
pharmacist prescribing workforce may only increase dramatically if pharmacy
undergraduates are trained to qualify as prescribers on graduation. This idea
generated mixed opinions from the current study participants. Whilst the
majority of study participants opposed the idea of pharmacy students
graduating from University qualified to prescribe, there seemed to be consensus
of opinion that the taught elements of the prescribing course could be
introduced in the undergraduate programme, leaving the PLP to be undertaken
post graduation. However, there is no sufficient evidence in the current findings
to support definite conclusions hence the issue of training pharmacy
undergraduates for prescribing will need to be investigated further.
Apart from the key findings summarised above which extend the knowledge
base on the subject of pharmacist prescribing, a unique contribution of the
current project was in application of a ‘sequential-mixed methods’ strategy in
the study (86). According to Phillips and Pugh, there are nineteen different ways
to define originality in a PhD thesis, one of which is to use a different
methodological approach to address a research problem (203). Many of the
previous studies on the subject of pharmacist prescribing have either relied on
qualitative or quantitative approaches to study one dimension of the problem.
When a mixed methods approach has been used, researchers have always
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applied qualitative methods to explore the topic and generate questions to be
addressed in subsequent quantitative surveys. However, in the current project,
the ‘sequential-mixed-methods’ strategy allowed key issues of prescribing
practice identified by means of statistical analysis of data in the initial
quantitative phase, to be explained by in depth qualitative methods. Using this
approach, it has been possible, for example, to translate statistical significance
of the products of factor analysis into practical relevance for prescribing practice
(see Chapter 3).
5.4 Application of key findings to policy and practice
The relevance of key findings will be described under specific
recommendations for policy and for practice
5.4.1 Recommendations for policy
5.4.1.1 Recommendations for Government
Findings of the current research emphasised the problem of community
pharmacy prescribers’ access to patients’ medical records, which results from
the inadequate IT infrastructure in the NHS. In terms of pharmacist prescribing,
it is essential that the IT infrastructure is developed with a plan to link
community pharmacies with other NHS service providers. In Scotland, where a
national data base already exists, the Government should consider community
pharmacies, along with accidents and emergency units and out-of-hour services
among the points for receiving un-planned care, and the pharmacist prescriber
authorised to access the summary care records (191). The recent publication of
the Scottish Government’s ‘eHealth strategy 2011-2017’ (189), presents a
golden opportunity to provide community pharmacies with remote access to
patients’ medical records. This will improve practice, and also enhance research
in patient outcomes by making it possible to link the dispensing data of
medicines with specific diagnosis in the summary care records. On the other
hand, England may need to re-appraise its strategy on the abandoned national
rollout of the IT backbone which was intended to central electronic medical
records of all patients (194). The DoH should embark on a critical evaluation of
the current programme of IT development for the national database of health
records with a view to completing the project. This should include education of
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the public about the potential benefits, while addressing the security concerns
related to the privacy of personal records. When this is done, the project will
generate enough public support to justify any possible financial investments.
5.4.1.2 Recommendations Policy makers
In terms of policy, it is essential that NHS managers and organisations critically
review their strategies for implementing pharmacist prescribing. It may be
necessary to plan separate strategies for different settings, for example
providing additional incentives to motivate community pharmacies to invest in
the creation of appropriate facilities such as dedicated clinic space and time for
pharmacist prescribers to engage in prescribing practice. As the number of
pharmacist prescribers continues to grow, NHS managers should ensure that
needs are properly assessed and clear demands for pharmacist prescribing
services exist before more pharmacists are sponsored for prescribing training.
Similarly, the roles these pharmacists will perform in prescribing practice should
be clearly stated at the outset of any services commissioned by the NHS. This
way, time and resources committed to the training are guaranteed to be utilised.
In the short term, NHS managers should identified qualified pharmacist
prescribers in their organisations who are not prescribing, and create the
enabling environment for them to immediately begin to apply their prescribing
skills in practice.
NHS managers should promote integration and team work among health
professionals, by commissioning services according to skills so as to optimise
the potentials of all professional; for example, where a community pharmacist
prescriber is commissioned to undertake medication reviews for a GP practice,
the input of the pharmacy in meeting the QOF target should be recognised and
any financial incentives should be shared between the practice and the
community pharmacy.
The relevant agencies need to formulate clear guidelines for practice especially
as regards the prescribing and dispensing of medicines by pharmacist
prescribers based within community settings.
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5.4.1.3 Recommendations for the RPS
The RPS should articulate clear roles and responsibilities for pharmacists in
prescribing, and develop a position paper, to serve as a basis for negotiating
future contractual frameworks for delivering enhanced pharmaceutical services
such as prescribing in the NHS. The RPS should also intensify the promotion
and advertisement of pharmacy services to other health professional groups like
specialty registrars and consultants in various medical conditions. Such
promotion should include disseminating results of research that demonstrate
favourable outcome of pharmacists in the prescribing process. The RPS should
also capitalise on the high accessibility of community pharmacies to reach the
general public with the message of pharmacist prescribing being publicised with
printed leaflets, posters and media campaign.
The RPS should encourage individual pharmacist prescribers to participate in
research by providing them with incentives; this could be achieved by
negotiating with the GPhC to accept a certain level of participation in research
for CPD purposes. In addition, pharmacist prescribers should be encouraged to,
access grant opportunities such as those provided by the Pharmacy Practice
Research Trust, to engage in practice based research. This will provide them
with the opportunity to demonstrate the value of their involvement in prescribing,
as way of promoting their services.
5.4.2 Recommendations for practice
In terms of practice, existing pharmacist prescribers should actively seek gaps
in service delivery and expand their practice into new therapeutic areas.
Qualified prescribers who are not using the prescribing qualification in practice
should identify niche areas to develop prescribing practice; this may involve
seeking opportunities where prescribing is more likely, such as the GP practice
and health centres. In addition, pharmacist prescribers should document details
of their prescribing practices and procedures, so that examples of good practice
could be indentified and used to promote the pharmacist prescribing services.
Individual pharmacist prescribers should also continue to seek new practice
frontiers by constantly assessing needs and putting forward business case for
pharmacist prescribing to NHS commissioners. Pharmacists should also
become involved in prescribing networks to provide peer support and mentoring
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to colleagues that may be taking up prescribing newly, or those that may be
encountering challenges in their practice.
5.5 Discussion of further work
Most of the previous research on pharmacist prescribing has focused on views,
attitudes and perceptions of pharmacist prescribers, other health professionals
and patients. The present study has extended the evidence and contributed
significantly to the understanding of issues involved in prescribing
implementation. However, the study has also raised some issues that will
require further investigation.
5.5.1 Clarifying the role of pharmacists in the prescribing process
Findings of the current research suggest a need for clarifying the roles and
responsibilities of pharmacists in relation to those of other health professionals
in the prescribing process. Since this conclusion reflected the views and
perceptions of pharmacist prescribers only, it is necessary to include key
experts and opinion leaders representing a wide range of stakeholders,
including pharmacists (prescribers and non-prescribers), doctors, nurses, NHS
managers, academics and representatives of patient groups. The aim will be to
define and develop consensus around the specific responsibilities for
pharmacists in the prescribing process, in relation to the functions already
performed by doctors and nurses.
The Delphi technique would be a suitable method for this investigation. The
method has been used to define professional roles in health services which in
this case, would be to clarify the specified responsibilities of each health
profession in the prescribing process. This technique would permit the
application of qualitative approaches to derive quantitative estimates of
agreement among expert stakeholders in the prescribing process (204). This
process will define clear, specific and mutually agreed roles for pharmacists,
which could be implemented either as the proposed ‘hybrid’ prescribing model,
or within the existing models of SP or IP.
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5.5.2 The evidence-base to promote pharmacist prescribing
The current study findings emphasise the need for strong research evidence of
benefits of pharmacists prescribing relative to other non-medical and medical
prescribing, the question is whether patients managed by pharmacist
prescribers experience different clinical outcomes than those managed by other
prescribers? The aim will be to compare the ‘effectiveness’ of pharmacists as
prescribers with other health professional prescribers in selected disease
conditions.
This aim could be achieved by applying comparative effectiveness study
designs to test a hypothesis, that no difference exists in the desired clinical
outcome of patients managed by different categories of prescribers. Data for
matched cohorts of patients managed by different category of prescribers will
be collected prospectively or retrospectively from clinical data recorded in the
routine care of patients. Such practice data should capture key patient
characteristics, consultation and other components of the prescribing process
delivered by each profession that may affect patient outcome. Applying
multivariate statistical procedures, it will be possible to identify differences in
chosen clinical end points in groups of patients that are attributable to the
prescribers managing them (205).
5.5.3 Integrating pharmacist prescribing in the community setting
The current study has established that minimal prescribing is currently
implemented in the community pharmacy setting compared with the other
settings. Considering the potentials of this sector on overall prescribing practice,
it is necessary to study in-depth the structures and process that community
pharmacists have adopted to prescribe despite the challenges identified in the
current study.
This will apply in-depth qualitative case studies approaches that combine non-
participant observations with interviews in selected community pharmacies
where prescribing is working well, to investigate specific details of prescribing
practice in these sites.
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5.6 Overall conclusion
In this research project, the author has applied a quantitative method to update
the status of prescribing implementation in GB. This has revealed that the
structures of pharmacists prescribing practice are still evolving; many barriers to
prescribing implementation have persisted more than five years after the
introduction of the policy. The study has highlighted limitations in the structures,
especially within the community pharmacy sector which may be detrimental to
the development of pharmacist prescribing. Similarly, the processes around the
delivery of pharmacist prescribing services still require further development, in
order to enhance the implementation of pharmacists prescribing policy; towards
increasing the access of patients to medicines and making better use of
pharmacist skills, as intended by the introduction of the NMP policy in GB.
The qualitative phase of the project provided deeper insights into the facilitators
and barriers of pharmacists’ prescribing practice. This led to comprehensive
explanations of the prescribing process, and highlighted the need for further
research to clarify the roles and responsibilities for all health care professionals
to be implemented in the IP/SP models or patient care. Applying these findings
in practice will require bold and decisive policy initiatives that may change the
way health services are currently delivered in the NHS. Importantly, the findings
of the current research provide the background information for appraising
pharmacist prescribing implementation to further develop the policy. Ultimately,
this should result in the prescribing service that is fit for purpose; enhancing the
quality of patient care.
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I have adequate administrative
support for my prescribing
practice
1.000 .299 .281 .193 .176 .130 .232 .219 .182 .103 .119 .090 .231 .249 .310 .361
I am remunerated appropriately
for my prescribing practice
.299 1.000 .195 .031 .096 .053 .204 .058 .092 .012 -.004 -.109 .178 .230 .137 .173
My access to information
technology is adequate for my
prescribing practice
.281 .195 1.000 .449 .164 .126 .199 .272 .146 .007 -.019 .017 .099 .154 .195 .244
I have sufficient access to
patients' medical records for my
prescribing practice
.193 .031 .449 1.000 .235 .042 .206 .253 .067 .068 -.116 .135 .053 .133 .240 .220
Sufficiently strong correlations (close to .3 and above) shown in bold
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will/does facilitate my prescribing
practice
.176 .096 .164 .235 1.000 -.032 .159 .189 .083 .167 .013 .189 .097 .137 .241 .235
I have adequate peer support for
my prescribing practice
.130 .053 .126 .042 -.032 1.000 .194 .076 .106 .060 .009 .021 .140 .207 .157 .201
My other health professional
colleagues fully support my
prescribing practice
.232 .204 .199 .206 .159 .194 1.000 .343 .227 .217 -.053 .128 .227 .313 .377 .359
I have adequate communication
with doctors in relation to my
prescribing practice
.219 .058 .272 .253 .189 .076 .343 1.000 .253 .178 -.001 .200 .037 .138 .294 .329
Sufficiently strong correlations (close to .3) shown in bold
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I have adequate
communication with other
pharmacist prescribers
.182 .092 .146 .067 .083 .106 .227 .253 1.000 .122 .056 .049 .226 .143 .199 .248
My prescribing has had an
impact on patients' access to
medicines
.103 .012 .007 .068 .167 .060 .217 .178 .122 1.000 .003 .295 .058 .094 .318 .287
It would be convenient for
patients to get medicines
prescribed in a community
pharmacy
.119 -.004 -.019 -.116 .013 .009 -.053 -.001 .056 .003 1.000 .079 .100 .132 .035 .111
My prescribing practice has
had a positive clinical impact
on patient care
.090 -.109 .017 .135 .189 .021 .128 .200 .049 .295 .079 1.000 -.032 .107 .312 .321
Sufficiently strong correlations (close to .3) shown in bold
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My professional line manager
has good awareness and
understanding of non-medical
prescribing
.231 .178 .099 .053 .097 .140 .227 .037 .226 .058 .100 -.032 1.000 .414 .077 .098
My professional line manager is
supportive of my prescribing
practice
.249 .230 .154 .133 .137 .207 .313 .138 .143 .094 .132 .107 .414 1.000 .348 .369
My prescribing role has lived up
to my expectations
.310 .137 .195 .240 .241 .157 .377 .294 .199 .318 .035 .312 .077 .348 1.000 .762
I feel satisfied with my role as a
prescriber
.361 .173 .244 .220 .235 .201 .359 .329 .248 .287 .111 .321 .098 .369 .762 1.000
Sufficiently strong correlations (close to .3) shown in bold
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Appendix 10 NoSREC advice for telephone interviews in Phase 2
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Appendix 11 Participants’ information sheet- telephone interview
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Appendix 12 detailed interview guide Phase 2
Exploring Developments in Supplementary and Independent prescribing by pharmacists in Great Britain Interview schedule
***SWITCH ON DIGITAL RECORDER*** Name of Prescriber
Date Time
A. Introduction
Hello, can I speak to [name of pharmacist], please?
IF NO: OK, I had arranged to call at this time. Should I call again in ten minutes or
email them to re-schedule?
Write the outcome in your diary chart and take the appropriate action (call
back, email)
Hello, [name of pharmacist]. I’m [student’s name], the pharmacy student from Robert Gordon University ringing to interview you about the transition from
supplementary to independent prescribing. Are you still okay to do the interview now? It will take around ten to fifteen minutes.
IF NO: That’s okay. When would you like me to call back?
(offer to email if pharmacist is not sure)
Thank pharmacist
Write the new day/date/time here and in diary chart:
IF YES thank pharmacist and continue:
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B. Housekeeping
As you are aware from the information sheet, this conversation is being audio recorded to make sure that I don’t miss important points by relying on my memory or
notes. If you find this uncomfortable at any stage, just ask me to stop recording. I would emphasise that the interview is confidential and the audio record will be
destroyed once the interview has been transcribed. The transcript is also coded to protect your identity. If you decide after the interview you no longer wish to be a
part of the research, please let us know within the next seven days. The contact details are on the information sheet. Is that all okay?
IF NO:
That’s fine. I won’t use the audio recorder but I’ll need a bit more time to write
down notes as we go through the sections and I may ask you to repeat some
answers
Reminders:
 Make sure the audio recorder is switched off
 Take time to write detailed notes
 If in doubt, ask the pharmacist for clarification before you move on to the
next section
*** IF YES, CHECK THAT DIGITAL RECORDER IS WORKING***
In case of technical problem! Explain, apologise and rearrange interview day/date/time
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SECTION 1; Demographic questions
Note Sex of interview participant MALE FEMALE
OK, [name of pharmacist], firstly I’d like to ask a few details about you.
How long have you been registered as a pharmacist? When did you register as a prescriber? (get details
of type of prescriber)
SP IP
Ask for age range
What is your main practice setting as a
pharmacist?
Is this also your prescribing setting? If not
probe why they prescribe here and not in main
practice setting.
Hospital primary care medical
practice
community pharmacy Other settings (ask for specifics)
Pleas tell me approximately how many hours of your working
week is spent prescribing?
Approximately how many patients do you prescribe for, in
a week? (clarify to exclude medication review)
Which patient groups do you manage as a prescriber? In case of multiple groups ask for main one and why that was chosen
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SECTION 2; Questions to clarify why and how specific factors facilitate and/or hinder implementation and further development of prescribing practices
of pharmacists
Please tell me what works well in your prescribing practice? - Probe for what they consider as the key or most important thing that works for them in their
prescribing practice?
What did you or the other health professionals do to make this experience successful? Probe: What was the outcome of this encounter?
Why is (factor discussed above) important to your prescribing practice? – Probe for how this factor works
How can you tell that (factor mentioned) is working well? Probe for specific examples of how the mentioned factor worked and clarify their perception of a
successful prescribing practice
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Section 3; Question to ascertain and clarify their aspirations, and possible developments of their prescribing role
What would you consider the ideal role for you as an individual in prescribing practice? (Probe for specific examples)
If given the opportunity, what would you like to do differently in the way you prescribe? -Probe for how and why they would change what they mentioned
What would you consider the ideal prescribing role for pharmacists in general? (Probe for details on the role of the pharmacist in a multi-disciplinary team
Please tell me about your views about patient consultation diagnosis and prescribing for pharmacist? (Probe for details about how they are doing it now)
What advice would you give a new pharmacist prescriber?
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SECTION4 Questions to explore their views on the development of pharmacist prescribing role in general
What do you consider the key developments in pharmacist prescribing? Probe for details
What is your view on the future training of Pharmacists for prescribing? (Probe when to train PG or UG, mode of training)
Are there any other developments in the practice of pharmacist prescribing you want to discuss?
Well that’s all of my questions. You’ve been very helpful and I appreciate you taking the time to speak to me. If you think of anything else you would like
to add, please get in touch.
Thank pharmacist and say Goodbye!
Appendices
266
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Appendix 14 sample interview transcript
Please can you talk me through your experience of implementing pharmacist prescribing
in terms of what has worked really well?
I haven’t had any real problems, the patients are all quite happy, the doctors are all quite happy
the surgeries are all very happy that some body else is doing their work for them. So I think I
really don’t have very many issues; as far as that goes on the positive side, on the negative side
setting it up took a bit of time, getting the admin took quite a lot of time, and the admin problems
were the main ones, getting the patients booked in etcetera. Once I got that sorted out and
somebody else was doing that for me that worked very well, you really can’t do your own admin,
you can’t get time
So if you had to choose one factor as the most important that has worked for you what
would that be?
It has to be cooperation from other health care professionals in the surgery, cooperation from
the surgeries have been exceptionally good
Why would you consider that the most important?
Well if you don’t have cooperation, you are just not going to get anywhere at all; you can’t work
on your own.
Ok talking about the things that have not worked well can you say more about the admin
problems please?
Yes the admin side was a nightmare, we have no IT connections with the surgeries, so you
have to see the patients in the shop, gather all your information, walk up to the surgery, put it all
in the computer that all takes time, so that limits you to where you can go…, I do actually run a
couple of clinics in the surgeries and that is so much easier because you are sitting in the
surgery, you have the computer up in front of you, you have all the records of the patient so
there is no paper work because you put it straight on to the computer, it makes life so much
easier.
Has anything been done to resolve this problem?
It is a political thing, it is funding, so it is getting the IT up and running so it is really a Scottish
Executive level there is nothing that can be done locally because you have got all the IT staff,
but sharing the patients’ records and confidentiality etcetera, has to be a national agreement, it
is really way above my head I have to say
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So at the moment you work by…,
I see some of the patients in the pharmacy I see some in the surgery it all depends on how we
can organise them. We have to go for the best option for each surgery and it is certainly
different for some of them. I have two surgeries that the patients come to the shop and that
works very well apart from the fact that I have then got to go up to the surgery to put up the
records myself.
Can you tell me a bit more about your prescribing practice in the community pharmacy?
I run two clinics a Friday morning and a Friday afternoon for two different surgeries. The
patients are contacted by the surgery and they get a letter to say they are coming to see me in
the shop, so they know that already, but the appointments and all the arrangements are made
by the surgery; and on the Thursday I get the list down and I get the patient summary, just the
same as the doctor would use….so I get a copy of that and the patient will come up at the set
time, and I will see them and I will use the summary for the interaction as it were to have the
consultation and I have data collection sheet that I use to make sure that I have asked them all
the right questions and covered the right ground , take a note of all that, do the…, well most of
the spirometry ones I do the spirometry test for the respiratory patients take the results back
and my information back up to the surgery, and I put it on to the computer; so that all has to fit
into a four hour clinic because that is what you are paid for so you can’t go over that which
means that I only see about five or six patients generally if it is too many then it is more than
that, spirometry takes about half an hour.
So with the advantage of doing clinics in the two settings what could would you say is
needed to make prescribing work all through?
I hope we can have IT connection. If I could access patient records from the shop on my
computer, you know, a separate computer system; then life would just be a breeze quite frankly.
But until that happens and we have been talking about this for how long? Ten years at least to
my knowledge maybe a bit longer, and every year they keep saying…..will be up and running
and here we are, we are still……so it is just an absolute nightmare and I think it is extremely
difficult to expand the service in any meaningful way unless we have IT connection. You know
that the new pharmacy contract, chronic medication service, we are supposed to have some
sort of IT website we can go to, to put the information on the patient…, we wont actually have
access to patients records but we will be able to fill out some so sort of data collection sheet
that would automatically go to the surgery and upgrade the surgery. Well, that apparently is not
working so heaven only knows when that is really going to come in; but that is the first step, we
really need to share patient records; and there has been this idea of: oh it is confidential
information, but I find that rather…straight away, you are telling me that I cant be trusted to
know what a patient is on or what is happening to them. They are going to tell us anyway, we
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know what they are on, we already have a lot of these information and patients will tell you what
is wrong with them so I really don’t see what the issue is; I understand that it is central that the
IT is very robust and that can’t ne hacked into etcetera but you know from my point of view that
is not my problem, somebody else should be doing it. I am delivering a clinical service here and
I am being held back because of a lack of IT connection. So I really don’t know what the answer
to that is to be quite honest.
So what would be the ideal prescribing role for you as an individual prescriber?
Well, it is exactly what I just said; I want a computer in my consultation room in the shop that I
can just switch on and patient would have a mark card or something to give me authority to
access their records or some way of doing that a password or something basic with a CHI
number for example and I can just go on to that and up comes the records and it would be just
like doing it in the surgery which is what I do with some of the clinics and it is just like being a
doctor or a nurse or whoever works in the surgery it is so much easier; and then you have all
their records, their referral letters and all the rest of it, you know everything about them and that
is much safer isn’t it?
What do you thing should be the goal for the pharmacy profession in terms of
prescribing?
I think we should have such a situation where patients can come in and be seen by us for
chronic diseases, which is this new CMS is coming along so we should be able to prescribe for
those people. So if you have somebody like me that is also a prescriber there must be some
way of amalgamating the fact that we are doing a chronic management service and we are
doing some sort of patient medication programme, or profile or whatever for these patients and
an action plan for them and should be able to prescribe as well within your competencies. Now
that is the difficult one because I could put up a notice and say: right asthma patients come and
see me and I can deal with you, but if they come in with heart disease I might have to say: oh
sorry I don’t deal with that, you would have to go to the guy down the road for that, so you can
see that, that is quite a difficult concept isn’t it? If we had drop in centres which were manned by
a group of people, so there will be a doctor, a nurse and a pharmacist a bit like a mini GP
practice but in town working at the weekend, evening and that sort of thing, I think that would be
great, but not every pharmacy could do that. I work in a big town centre pharmacy that is one
thing but how would you do that in a small rural shop? It wouldn’t work would it? so I don’t really
have one answer, but I do think that if we are able to prescribe then we should be able to run
specific clinics; so I could may be say I would do an asthma clinic for patients in this locality, any
asthma patient should be able to come to me from any surgery and I should be able to deal with
it as long as I keep the surgery informed of what I am doing. I guess if I had my IT connection
that would be easy. I am not sure where we are going with this to be honest. It is a difficult one
to see how we can all do it; I think you are going to have specialism, aren’t you? You have to do
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the training for the independent prescribing and not every body wants to do that
Taking you back to the drop in centre you mentioned, how do you envisage the roles of
different professions would play out in practice against the background that each is
presumably qualified to diagnose and prescribe for patients?
Well every profession has its strengths isn’t it? So to me a GP should be defining what is wrong
with a patient so they should be deciding on what illness they have got and that should be there
main role; to assess the patient and say right: Mrs Smith definitely has got this and Mrs Smith
has definitely got that or what ever and deal with more complicate patients. People like me can
prescribe for the patients that we have been trained for, so I could be doing diabetes, I could be
doing heart failure but with chronic disease situations. So I think the doctor is dealing much
more with the acute, seriously acute not over the counter acute; and the nurses fit in there as
well, because they are fare better at examination skills than we are, they are more hands on so
they are doing the treatments, the dressings, the bloods all those sorts of things. I could train up
to take bloods but what is the point of me wasting time doing that when I am definitely better at
medication and prescribing? so I think we have all got strengths so if you got us all working
together as I do already in the surgery, that works very well so we all know what we all are
doing, and the doctors know what I can do and what I can not do, and they send me patients for
assessment for example they would say I think this patient had got asthma, I think this patient
has got COPD, can you have a look and then see what you think? Then I give them a report
back and say well, in my opinion it is X, Y and Z and we discuss it and we end up with a
diagnosis, or we refer them on if we are not happy and that works extremely well; and if I want
the bloods done, or I want the patients examined…, you know, I can listen to chests my self for
that matter but there are more advanced skills that nurses have that we don’t have. I am not
going to train up as a nurse, I do not have time, and I see that as a complete waste of my time
to be honest; because that is not what I trained for, I am trained to deal with medication. So
often you will get nurses running clinics for example where I am sitting they will do a
hypertension clinic; a hypertension clinic for a nurse consist of taking the blood pressure and
talking about health , they don’t look at the medication apart for saying are you taking your
medication, are you happy on it any side effects? But they don’t manipulate the dosages, they
don’t initiate new drugs or stop drugs, any of that they would have to go back to the GP where
as I can do all that. So that is the crosses over between professions, some of the surgeries
have a nurse led clinic and then the patient goes straight through to the pharmacist for the
drugs and that works very well. There are a few practices in XXX that do that and they have
been extremely successful. There is a GP in the background should a patient be identified as
being seriously ill, say we find one or two heart block patients with their pulse rates were down
thirty something and they automatically get passed to see the doctor to assess because that is
really outwit our remit, we are dealing with the stable chronic essentially.
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So what is happening with the pharmacy profession taking this scenario forward?
I suppose one of my worries is that we could have a two tier system couldn’t we? We would
have pharmacists that wouldn’t do too much and other pharmacists that are more specialised
and I think it will be extremely difficult to have everybody working at the level at which I work at;
and if every was working at my level, who on earth is doing the prescriptions? So that is why
you need the checking technicians. I am a firm believer in checking technicians, I think they are
wonderful and I really can not understand why pharmacists haven’t embraced that aspect of the
modern pharmaceutical service. Possibly if you are in a small rural pharmacy and can’t afford to
pay a checking technician and there is only two of you anyway, then it is not relevant; but for the
bigger stores, I think it is a wonderful idea and we really are going to have different layers of
service…, I think that is true anyway, isn’t it? If you run your small local pharmacy, there are
certain services they won’t offer because they can’t manage it or there is no that need. You
know, not every where has methadone consumption because there may not be methadone
addicts you know, so it is really…, we have to be flexible and I think every pharmacy has to
have the capability of stepping up and doing something more. A lot of the private guys, small
individual pharmacies supply a wonderful service; they have walk in centres for…, drop in
centres for various diseases…, smoking cessation is a typical example, that is relatively new, it
wasn’t around when I started and now we have people queuing up to do smoking cessation and
we have proved that we can do that; and then you have got the diets now and all these diet
things are coming out because you have got obesity clinics, you can have a hypertension clinics
relatively easily, although manipulating drugs and sort blood test results, that is the more difficult
stuff that is why you do need the IT, but you could do it to a certain level, you can certainly take
blood pressures and check for glucose in urine and finger pricking tests and all the rest of them.
There is a lot we could do but whether we want to be doing that? We don’t really want to
become mini doctors, we are pharmacists, so there is the danger there isn’t it? We might go too
far and that…, I suppose at the moment it is very interesting just now because we are not sure
what we are going to do, we are trying things out; so what I do is unusual as in not as a
pharmacist; but I have proved that you can do it, it is possible, and we have the training or we
can get the training, some of us have the facilities and the patients are quite happy to come and
some of them are extremely enthusiastic about coming into the pharmacy because it is so much
easier for them; and we are open on a Saturday and a Sunday when the surgeries are not and
for me that is a big plus.
This picture you have painted is interesting; but I suppose one of the things that may
come up is that pharmacists don’t run the service all the time, so what happens in the
time the pharmacist is off?
Well, I see…, Right…, it is just like any other clinic in the surgery, what happens when the
doctors is off? Or what happens when the nurse is off? They simply don’t run the clinic…, if you
are doing a wafarin clinic and the patient needs testing every week then you have a serious
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problem, but if you are doing an asthma clinic the fact that you are not there for two weeks is
irrelevant because if the patient comes in with an acute asthma attack they wouldn’t be seeing a
pharmacist any way, they would be seeing the doctor. So it runs very well because the clinics I
do at the surgery, when I was on holiday they simply don’t run and the patients are not booked
in an there is no problem so I don’t see that as an excuse; you will always get somebody
criticising but in actual sense it is not relevant, because it doesn’t stop the surgeries functioning
so why should it stop us functioning.
So in the light of this, what are your thoughts about the training of future pharmacist
prescribers?
Well I gathered that a lot of it is now actually embedded into the undergraduate course but
unfortunately the society has not recognised those ran by some institutions; so they are leaving,
they have actually done the course work of independent prescribing but they are still going to
have to do the week’s course and pass the sort of assessment so I think it is very unfortunate
that if you have done the work what is the point of redoing it? I do think however, that it is a
good idea to qualify, to do your pre registration year and may be getting some practice under
your belt before you rush off to do the prescribing. That depends on what level you are doing
prescribing because if you think about over the counter prescribing like minor ailment scheme,
that is prescribing in a sense, well it is prescribing but not just at that advanced level and every
pharmacist does it, and some of them are very good and you horn your interpersonal skills don’t
you? When you are doing that type of thing; you usually find that most pharmacists are
extremely good at that type of thing, because that is so much a part of the job being able to
communicate; but whether I would want a newly qualified, pre registration, just finished, just
qualified, finding their feet suddenly turns around and say oh by the way you are running a clinic
every week at such and such a level and you need to upgrade your skills so that you can do
that, that might be a bit too fast for some of them because it is all about confidence. I don’t think
there is a pharmacist anywhere in the country who is qualified who could not run an asthma
clinic for example, it is not rocket science, it is a question of knowing what you are suppose to
be assessing, knowing how to assess it, doing it in a logical manner based on the guidelines
which are freely available and there is lots of paper work etcetera and then knowing what the
computer system at the surgery wants to know, knowing what box to be ticked so that they get
their QOF point which is another sore point of course, that they are getting paid for all this and
we are doing the work which is another point; so really anybody could do it but not every body
wants to do it, some people maybe just don’t fancy that type of thing, they don’t want to be a
prescriber because it is a lot of responsibility to have your signature on it, I think a lot of
pharmacists are not happy about taking on that responsibility, that is the impression that I get.
Should we in that case expect prescribing to become the mainstream activity of
pharmacy?
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You have really got me on that one…, I enjoy doing it, but I worry I suppose that if we move
into prescribing totally, we have then moved away from medicines haven’t we? We have
become like mini doctors and I do think our knowledge of drugs is our strength, that is what we
have been trained for, that is our knowledge base isn’t it? and much bigger extent than anybody
else, so I would be unhappy about just being a prescriber I think you need to balance it up with
other things and the likes of CMS where they come up with a clinical management plan for the
patients, that means discussing all of the medication not just for a little area. It is a much better
beef that is a wider base we are dealing with every medicine. My worry is that we become so
specialised so I can only speak on…, if you are not asthmatic I can’t talk to you and that would
seriously worry me. I do have a broad background, I feel as a pharmacist I can function with any
disease to a certain level, I won’t necessarily be able to run a detailed clinic but I should be able
to sit down with anybody who is on repeat medication and discuss every single drug on that list
at some level and I do think that is our strength and I really would fight to keep that
So in this prescribing model…,
Certainly I am bringing in the medication side plus a bit of the diagnosis when you ask patients
these questions and you can work well with a nurse you can work well with the doctor
depending on what model you set up you can go either way and I think the GPs are very
appreciative of what we do and certainly the feedback that I get…, I don’t think it is because
they are being nice to me, if they thought I wasn’t doing a good job they would tell me because
patient safety is out there isn’t it? And the nurses are…, the nurses don’t like taking
responsibility for prescribing because if you look back and see when nurses were given
prescribing rights, it was before ours and yet they haven’t made as much success of it as I
would have expected. I know overall professionally there are a lot of nurses prescribing far more
than pharmacists, but if you thing of the number of nurses, it is a huge profession the biggest
health care profession in the country far more than the doctors for example; so for the fact that
only a small proportion of them are prescribing surprises me, I would have thought they would
have grasped that a lot of them don’t want to know, they don’t want the responsibility assigned. I
don’t know what the recently qualified ones are like but certainly, the ones that are working in
practice at the moment are not that keen.
What key advice would you give a pharmacist who is about to start prescribing?
You have to have…, whether you are independent or supplementary, because I suppose
everybody is coming in as independent now although you can also practice as supplementary,
have a clinical management plan. I know legally, you don’t need one, but I think you are very
foolish if you don’t have one because it sets out what you are doing, what drugs you are going
to be prescribing; you know, I don’t put specific drugs I put the BNF chapters I would just say I
am doing all the inhaled corticosteroids for example and I just put BNF chapters because to sit
down and go through every single drug you are going to use, will take ages and I just have a
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generic CMP for each group of patients ,I don’t do individual ones because again that is too
time consuming, it is a nightmare; and it changes so often because patients may need a change
and you have to write another one ….but the reason you need a CMP is that you know what
you have agreed to do, the doctor knows what you have agreed to do and what you are happy
to do, you have agreed with the GP how you are going to function, what you are going to be
doing and what level you are going to work, and every body knows as well, because the CMP is
either in the protocol book that everybody has got or it might be attached to each individual
patient you see, which ever way of doing it is up to your self. But if the GPs want to know what I
do, all they have to do is look at that and say X is capable of doing this or she can prescribe
that; that is fine I can give her that patient; and the nurses also know what you are doing and it
then means that if somebody asks you to do something outwit your remit and say couldn’t you
just do this, couldn’t you just do that? You can say: well, no actually I am not comfortable with
that; that is the level I am at; but you can always change your CMP as you acquire new skills
you can add to it. It is constantly moving.
Is there any other issue you thing is important in pharmacist prescribing that should be
brought to light?
Well I suppose it is the funding because at the moment the clinics which have been running
were funded by the Scottish Executive and that funding has been stopped from this September
coming, that will no longer exist and there is no proviso, no mechanism to keep it going unless
the surgeries are prepared to pay for it out of there own pockets and I just don’t see that is
going to happen. So I suspect we will all suddenly find ourselves not prescribing; you have
trained all these people up and you have left them nimble what are they going to do? Now what
mu surgery has done, I am paid for by the xxx health board so the clinics that I run for the
surgeries with my xxx hat on, will still continue because that money comes from somewhere
else, but the clinics which I run with my community pharmacy hat on, are at serious danger of
stopping and I think it is a great pity that we haven’t got the funding streams for it, they haven’t
thought this through. They brought us in as a pilot which, has been running for five or six years
now and then all of a sudden they are going to pull a tape on it and all of a sudden everybody
thinking oh wait a minute we are not sure about that, so you feel you have done all that work,
you have done all that training and then you are not going to be able to do it
If the Executive is paying for it, and the GPs are getting the services what does the
community pharmacy get?
Nothing at the moment apart from the fact that my time is paid for, so they get compensated for
my time but they don’t make a profit out of it; it was seen very much as a bridge building
exercise :
A. to try and get pharmacists trained up and to give them the confidence to do these
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clinics
B. the other side was, get used to doctors using pharmacists and knowing that
pharmacists can run these clinics to a certain level and they would be clinically
responsible for what they were doing and then provide a bit of an improved service and
we have proved that but no body has thought what we are going to do with it in the
future,
So here we are we have suddenly come to the end of the clinics and we are all floundering
around and no body really knows what is going to happen and all very unfortunate; and
although the CMS is coming in, that is not to the level that I work at; that is all very much sitting
there saying hello Mrs Smith, you have got six items here, and have you any side effects? Do
you not like the taste of your gaviscone? Well, we could change that and do all that sort of thing
and you need pain killers or I don’t like pain killers.., oh we could give you something else if you
have got side effects, that is not the level that I work at, I am diagnosing asthmatics, COPD
patients, I am doing spirometry testing, with the hypertension we are looking at blood test
results, we are manipulating drugs etcetera and that is all going to disappear because you can’t
do that in the shop it is certainly not going to work, so I think it is most unfortunate and I am not
sure what is going to happen so we have proved that we can do things and then there is no
continuity. By the time you have written up your research, things might have changed of course
(she laughs) but at this precise moment in time we are [peaky] in the middle.
Let us hope things change for the better…,
Well…, XXX, you know XXX? She works for XXX, have you bumped into her? Right run up to
her room and ask her about that, she works for YYY so she will be more in the know, so you
can pin her to the wall
Thank you very much; I am very sorry I have taken longer…,
Oh it is alright don’t worry, I am quite happy to talk
All the same I am very grateful thank you
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Appendix 15 Abstract Oral presentation at the Royal Pharmaceutical Society
conference London-UK, September 2010
Oral Session 3- access to medicines
15 Trainingundergraduatepharmacystudents for prescribing: views of primary care
based pharmacist prescribers in Great Britain
M. Dapar, D. McCaig, S. Cunningham, L. Diack and D. Stewart
Robert Gordon University, Aberdeen, United Kingdom
Focal points
 Incorporating prescribing training in the undergraduate curriculum may be one way to prepare future
pharmacists for prescribing practice.
 We surveyed pharmacists who were actively prescribing in primary care for their views regarding
prescribing training for pharmacy undergraduates.
 A majority of pharmacist prescribers had concerns about the risk and safety implications of new
graduates prescribing.
Introduction
One key aim of non-medical prescribing is to improve patient access to medicines.[1] To help achieve this, it is
desirable for more pharmacists to participate in prescribing training and for prescribing to become a standard
element of pharmacy practice. However, a published national survey of pharmacists’ planned participation in
supplementary prescribing (SP) training identified that only a minority had any training plans.[2] One other factor
which may hinder involvement in prescribing training is that The Royal Pharmaceutical Society of Great Britain
(RPSGB) stipulates a minimum of two years post registration experience prior to enrolling in prescribing training.3
The aim of this study was to determine the views of qualified pharmacist prescribers working in primary care,
regarding the prescribing training of pharmacy undergraduates.
Method
Design: Cross sectional questionnaire survey mailed to all pharmacist prescribers registered with RPSGB (n =
1653 in April 2009), with two reminders at monthly intervals. Pharmacists who indicated that they were actively
prescribing in primary care (general medical practice and community pharmacy) settings were asked their views
on undergraduates completing prescribing training as part of the undergraduate course. The North of Scotland
Research Ethics committee advised that formal approval was not required.
Results
The response rate was 42.3% (695/1653). Of these, 333 (47.9%) were based in primary care and 68.5% (n =
228/ 333) were actively prescribing. A majority (69.3% n = 158/ 228) of these had concerns about the introduction
of pharmacist prescribing training at the undergraduate level; with only a fraction (23.7% n = 54/228) supporting
this development; the remaining (7.0% n = 16/228) did not make comments. Key themes from the analysis of
open comments are given below:
1. Risk and patient safety: Pharmacist prescribers generally felt that the processes of prescribing were
associated with responsibilities such as ensuring safe and effective prescribing. This requires experience and
maturity which new graduates may not necessarily have.
2. Image and prestige: Prescribers, who supported the idea of prescribing training for undergraduates,
argued that prescribing was the future of pharmacy. They expressed the opinion that pharmacists graduating as
prescribers would enhance the image of the profession structure the implementation of prescribing contrary to
what they described as the current ‘piece meal’ approach. They pointed out that prescribing needed to be
‘demystified’. Conversely, those who objected tended to comment that prescribing was an exclusive activity and
not suitable for all pharmacists. They felt that prescribing would be devalued if every pharmacist were to
prescribe. Some expressed the fear that new graduates as prescribers could tarnish the image of pharmacy.
3 Logistics of the training course: Those supporting undergraduate training alluded to the ease of studying
the course at that level. However, those objecting noted the waste of time and resources if no immediate
prescribing roles were available.
Conclusions
Views and concern about incorporating prescribing training in the undergraduate curriculum have been presented
from the perspective of pharmacist prescribers in primary care only and hence may be biased. Issues raised
require in-depth qualitative research to inform future training plans and processes.
References
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3. Anonymous; outline curriculum for training programmes to prepare pharmacist prescribers; Royal Pharmaceutical Society of
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Communications
Oral communications
Main conference
com-088
CURRENT STATUS OF PRESCRIBING BY
PHARMACISTS IN GREAT BRITAIN
Maxwell LP. DAPAR, Dorothy J. MCCAIG, Scott
CUNNINGHAM, Lesley DIACK, Derek C.
STEWART
School of Pharmacy and Life Sciences, Robert
Gordon University, Aberdeen, United Kingdom
Pharmacist prescribing has been implemented in
Great Britain (GB) since 2003. Access to medical
records, clinical governance issues around clinical
management plans and communication were
identified as key factors influencing the successful
implementation of supplementary prescribing
(SP). Most research has focused on pharmacists’
views and experiences in the early years post
implementation of prescribing practice. However,
key innovations such as the subsequent
introduction of pharmacist independent prescribing
and seven years of SP experience makes it
imperative to update the status of pharmacist
prescribing in GB.
Objective
To define the level of implementation into practice
of pharmacist prescribing and to identify factors
associated with implementation.
Methods
Design: Cross sectional questionnaire survey.
Population: All pharmacist prescribers registered
with the Royal Pharmaceutical Society of Great
Britain (n=1653). The questionnaire was mailed in
Apri l 2009, wi th two reminders at monthly
in terva ls . Ma in outcome measures were
prescribing activities and influencing factors.
Data relating to prescribing practice were reported
using descriptive statistics. Chi square was used
to test for association between demographic
variables and prescribing activity.
Results
Response rate was 42.3% (n=695). A majority of
the respondents 68.1% (n=473), had written
prescriptions. Respondents in hospital (H) and
general medical practices (GP) settings were
more likely to have prescribed than those in
community pharmacies (CP) (Ȥ2 12.10 P<0.01).
There were however, no significant differences
between the two groups of pharmacist prescribers
in terms of sex, age and length of experience as
pharmacists.
The ratio of prescribing in each setting was H
44.1% (n=211) GP 42.1% (n=201) and CP 7.9%
(n=38) and other settings 5.9% (n=28). Most
prescribers based in H and GP prescribed within
the same set t ing. However, ha l f o f the
pharmacists based in CP prescribed in GP the
setting.
Conclusion
Pharmacy practice setting is the main determinant
of respondents engaging in prescribing practice.
com-094
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PHARMACIST PRESCRIBING IN GREAT
BRITAIN: WHY DO QUALIFIED PHARMACISTS
NOT PRESCRIBE?
Maxwell LP. DAPAR, Dorothy J. MCCAIG, Scott
CUNNINGHAM, Lesley DIACK, Derek C.
STEWART
School of Pharmacy and Life Sciences, Robert
Gordon University, Aberdeen, United Kingdom
Since the introduction in Great Britain of
pharmacist prescribing, studies have focused on
structures and processes of its implementation.
However, data suggest that one in three qualified
pharmacist prescribers are currently not
prescribing.
Objective
To explore why qualified pharmacist prescribers
do not prescribe.
Methods
Design: Cross sectional questionnaire survey of all
registered pharmacist prescribers in GB (n=1653).
Respondents who had not prescribed gave open
comments on their reasons. The themes emerging
from these were categorised using framework
analysis.
Results
The two main themes and their sub themes are
discussed below:
Procedural factors: Aspects of clinical governance,
such as the lack of defined roles and insufficient
resources in terms of inadequate funding and
facilities; poor remuneration; and a lack of
sustainability of pharmacist prescribing services
once commissioned were the main procedural
factors impeding prescribing.
Some pharmacist prescribers had to ‘invent’
prescribing roles for themselves, sometimes
confusing patients and other healthcare
professionals. Similarly, inadequate facilities and
strategies for implementing pharmacists’
prescribing at the level of the Trusts and Health
Boards often deterred many qualified prescribers
from using their skills. For example, there were
issues around prescribing quality assurance, such
as the audit of prescriptions written by
pharmacists and legal restrictions on prescribing
of items, such as unlicensed medicines
compounded from licensed ingredients.
Personal factors: Most qualified pharmacist
prescribers who were not using their qualification
cited lack of opportunities, due to their personal
circumstances, including: maternity leave; change
of job or practice setting; and enrolling in further
educational programmes. Moreover, many
pharmacist prescribers had extensive managerial
duties and responsibilities competing for attention
with patient focused clinical duties including
prescribing.
Conclusion
This study has identif ied both procedural
(external) and personal (internal) factors that may
explain why some pharmacists that qualify as
prescribers are not able to integrate prescribing
into their routine practice.
com-091
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Poster Sessions
50 Facilitators and barriers to pharmacist prescribing:Exploringtheassociationofpharmacy practice
setting
M.L.P. Dapar, D.J. Mc Caig, I.T.S. Cunningham, L. Diack and D.C. Stewart
School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK
Introduction
Research on pharmacist prescribing has mainly centred on early experiences related to supplementary prescribing (SP).
George et al. [1] and Weiss et al. [2] first identified facilitators and barriers to successful implementation of SP. Among
others, lack of access to patients’ medical records (PMR) was noted as a barrier particularly in community pharmacy.
Further research focussing on practice setting is warranted post introduction of independent prescribing (IP). The aim of
this study was to explore the association of practice setting on facilitators and barriers in relation to their prescribing
practice.
Methods
Validated and pre-piloted postal questionnaires comprising five sections: factors that may influence prescribing, current
prescribing practice, changes to prescribing practice since initial registration as a prescriber, the future of prescribing
and demographic characteristics were mailed to all prescribers on the register of the Royal Pharmaceutical Society of
Great Britain (n = 1653) in April 2009. Only the attitudinal facilitators/barriers and demographic characteristics are
reported here.
Results
Response rate was 42% (n = 695); 73% (n = 498) female, 70% (n = 493) between ages 30 and 49 years. Almost 50%
(n = 307) had more than 20 years experience as pharmacists. More than 68% (n = 472) had written a prescription with
those working in GP surgeries or hospitals more likely than those in community pharmacy setting (x2 = 12.1 P <0.01).
Table 1 Attitudinal facilitators and barriers of pharmacist prescribing in relation to their practice setting
CP (%)
Disagree/ Agree
GP (%)
Disagree/ Agree
HOSP (%)
Disagree/ Agree
I am remunerated appropriately for my prescribing
practice
51.3 28.2 49.3 35.2 51.9 37.4
I have sufficient access to patients’ medical records for my
prescribing practice*
20.3 75.9 3.5 95.8 2.4 96.1
Independent prescribing will/does facilitate my prescribing
ractice*
11.8 72.4 5.6 89.4 4.4 89.2
My other health professional colleagues fully support
my prescribing practice*
21.5 69.6 10.6 79.6 9.7 81.1
I have adequate communication with other pharmacist
prescribers
39.2 50.6 33.6 50.3 29.6 58.1
It would be convenient for patients to get medicines
prescribed in a community pharmacy**
1.3 91.1 15.5 53.5 17.9 50.7
I feel satisfied with my role as a prescriber 14.1 71.8 13.9 74.3 13.5 72.0
CP, Community pharmacy; GP, General medical practice; HOSP, Hospital. *Chi square significant at P < 0.05; **Chi square significant at P <
0.01. Total response for each practice setting less than 100%; remaining fractions were neutral.
Respondents agreed across pharmacy practice settings that they had adequate administrative and peer support, and that
their prescribing roles made positive impacts on patients’ access to medicines. However, they disagreed that they were
appropriately remunerated for prescribing. Issues of access to PMR, support of other health professionals and
convenience of patients getting prescribed medicines elicited greater differences (Table 1).
Conclusion
This study has shown the importance of practice setting in relation to the implementation of pharmacist prescribing,
with barriers identified more in community pharmacy compared with other settings. Qualitative research is required to
gain more insight. It is important that facilitators are harnessed for future prescribers and barriers resolved to
enhance the uptake into prescribing training and practice. Findings should be interpreted with caution due to the low
response rate which limits generalisability.
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